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ABSTRACT 
This study was conducted as an exploratory analysis of the potential interaction between 
genetics and cardiorespiratory fitness level on cognition in healthy older adults. The main 
questions were 1) can genetic status moderate the effect of cardiorespiratory fitness level 
on cognition and 2) can cardiorespiratory fitness level influence the effect of genetic status 
on cognition. 
 
A cross-sectional sample of healthy older adults were recruited for a longitudinal 
randomized controlled exercise intervention. Participants were admitted into the study 
based on their sedentary lifestyle and this analysis was conducted on data collected at the 
outset of the intervention. 
 
Dopamine-related genes were chosen based on dopamine’s influence on cognition and its 
sensititvy to aging. The Catechol-O-Methyltransferase (COMT) and Dopmaine Beta 
Hydroxylase (DBH) genes were chosen because their protein products influence levels of 
dopamine within the brain. Further, each gene has two common functional single 
nucleotide polymorphisms which effect the functionality of the protein product. 
 
Two growth factor genes, Insulin-like Growth Factor I and Brain Derived Neurotrophic 
Factor, were chosen based on the role they play in brain development and overall health as 
well as their moderation by exercise. 
 
The primary measure of cardiorespiratory fitness was maximal oxygen uptake (VO2) and 
neuropsychological assessments were collected either through computer-based or paper-
and-pencil methods. 
 
Overall, results suggest that genetic status did interact with cardiorespiratory fitness level 
to influence both working and spatial memory as well as various aspects of executive 
functioning including response inhibition, maintenance and coordination of multiple sets, 
and cognitive flexibility.  
 
Results of the study point to the need for approaches beyond single gene assocations such 
as genome wide association studies (GWAS), epigenetic analyses, gene-gene interactions 
and interactions with environmental factors to take into consideration all the factors that 
contribute to the variability in the cognitive aging process. 
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Chapter 1: Introduction 
It is well known that many changes occur in human cognition over the lifespan. 
Unfortunately, after the age of 30, many of these changes are declines as opposed to 
improvements. For example, research has shown aging-related declines in several aspects 
of cognition along with concominant declines in brain structure, function, and 
neurochemistry (Hedden & Gabrieli, 2004; Strong, 1998; Yankner, Lu, & Loerch, 2008; 
West, 1996). While there exists a global aging-related decline, there are still individual 
variations in the degree to which these declines occur since many factors contribute to 
these changes. 
In this thesis, I will focus on two specific factors that have both been implicated in 
contributing to individual differences in many aspects of aging-related declines – 
cardiorespiratory fitness and genetics. As a lifestyle factor, increase of cardiorespiratory 
fitness level has been associated with healthier aging and reduced age-related declines in 
brain structure, function, and cognition (Colcombe, Kramer, McAuley, Erickson, & Scalf, 
2004; Erickson & Kramer, 2009; Gomez-Pinilla & Hillman, 2013; Lista & Sorrentino, 2010; 
Mcauley, Kramer, & Colcombe, 2004; Prakash, Voss, Erickson, & Kramer, 2015). Several 
studies have shown that aerobic exercise interventions can ameliorate or even improve 
different types of age-related declines by increasing participants’ cardiorespiratory fitness 
levels (Colcombe & Kramer, 2003; Colcombe et al., 2004a, 2006; Etnier et al., 1997). Cross-
sectional research has also shown that older adults who are aerobically fit generally 
perform better on cognitive tasks compared to those less fit (Voss et al., 2010; Erickson et 
al., 2009b; Colcombe et al., 2003, 2004a). 
Genetics is a major biological determinant of cognitive abilities. Although everyone 
has the same general genetic makeup, there are small nuances in the genetic code that can 
cause differences in the availability and functionality of proteins in the body. Single 
nucleotide polymorphisms (SNPs) occur in the human genome and contribute to almost 
90% of human genetic variation. These SNPs can cause individuals to have different 
versions of the same genes, and depending on location, can translate to more or less of a 
particular protein. During the early and middle years of human development, these 
variations may or may not have detectable phenotypes; however as aging takes its toll, 
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differences can become more apparent. For instance, Nagel et al. (2008) found that a SNP 
on a dopamine gene (specifically the Catechol-O-Methyltransferase gene) had a genetic 
effect on cognition in older adults, but not middle-aged adults, providing some evidence 
that genetic effects may be magnified with aging. 
The majority of studies have investigated the influence of cardiorespiratory fitness 
and genetics on cognition in healthy older adults independently, but a growing number 
have begun looking at an interactive effect (e.g. Deeny et al., 2008; Erickson et al., 2013;  
Etnier et al., 2007, 2015; Schuit, Feskens, Launer, & Kromhout, 2001; Stroth et al., 2010; 
Voelcker-Rehage, Jeltsch, Godde, Becker, & Staudinger, 2015). The possibility exists that the 
influence of cardiorespiratory fitness levels may outweigh genetic effects, or that 
maintenance of cardiorespiratory fitness levels may be more important for some 
individuals than others. In this thesis, I explore the interactive effect of cardiorespiratory 
fitness level and genetics on cognitive abilities in a cross-sectional sample of healthy older 
adults. 
In the following sections I first review the literature on age-related structural, 
functional, and neurochemical brain changes, followed by how these changes relate to 
behavior since behavior is the outcome of interest. The effects of cardiorespiratory fitness 
and genetics are briefly reviewed here and will be discussed in further detail in individual 
chapters. 
 
Age-related Declines 
 Structural and functional brain changes. There is evidence for a general age-
related reduction in gross brain volume with substantially greater declines in the 
prefrontal and frontal regions in comparison to sensory cortical regions (Cabeza, 2001a; 
Colcombe, Kramer, Erickson, & Scalf, 2005; Raz et al., 1997, 2005). This reduction in brain 
volume, at least for older adults without a diagnosis for age-associated neuropathologies 
such as Alzheimer’s disease, does not appear to be an actual loss of neurons, but reductions 
in synaptic integrity and density (Hof & Morrison, 2004; Morrison & Hof, 2007), volumetric 
and structural white matter changes (Colcombe et al., 2004a; O’Sullivan et al., 2001), loss of 
dendritic processes, and reductions in the number of synapses (West, 1996). Postmortem 
studies have shown that there is a slow but persistent rate of decline in overall brain 
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weight and volume of about 2% per decade ( Cabeza, 2001b). However, using an in vivo 
MRI method, Raz et al. (1997) found an average rate of decline of 4.9% per decade for 
prefrontal gray matter and the correlation between age and prefrontal volume was 
significantly larger than with any other brain area. Although polymodal and visual 
association cortices do exhibit sizeable age-related declines, the prefrontal cortex (PFC) 
shows the most sensitivity to age, while primary sensory (Raz et al., 2005) and motor areas 
remain relatively stable throughout the lifespan (Raz et al., 1997). Further, while marked 
volume loss in the PFC occurs with normal healthy aging, similar losses in the medial 
temporal lobes and hippocampus are often indicators of pathologic aging (Cabeza, 2001b; 
Raz, 2000; Yankner et al., 2008). Medial temporal and hippocampal volume losses have also 
been observed in healthy aging populations, but to a much lesser extent than pathologic 
populations (Jack et al., 1998). Although evidence supports a general aging-related 
structural decline in the brain, there exists a large amount of individual variability (Raz et 
al., 2005). 
Advent of neuroimaging techniques such as functional magnetic resonance imaging 
(fMRI) and positron emission tomography (PET) has marked the cornerstone of our 
understanding of the functional changes in neural recruitment that might be associated 
with healthy aging. One of the common observations in several functional imaging studies 
is the additional recruitment of neuronal resources in the prefrontal cortices of older 
adults. For example, Reuter-Lorenz et al. (2000) found that during both a verbal and spatial 
working memory task on which older and young adults had high accuracy, older adults 
showed bilateral anterior activations, while young adults showed unilateral activations (i.e. 
left for verbal and right for spatial). The authors concluded that that the reduced anterior 
lateralization in older adults was compensatory, such that additional recruitment reflected 
an augmentation of task performance. Cabeza (2002) formalized this observed pattern into 
a model called hemispheric asymmetry reduction in older adults (HAROLD). However, 
there is still debate as to whether the HAROLD pattern of activation is compensatory or an 
indication of decline. For example, Colcombe et al. (2005) reported significantly greater 
bilateral PFC activation for poor-performing compared to good-performing older adults 
during inhibition on incongruent trials of a Flanker task. The authors suggest that bilateral 
activations are only compensatory to the degree that the functions subserved by the 
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recruited areas play a complementary role in task performance. This finding also points to 
the existence of individual variability in the functional changes associated with healthy 
aging. 
In general, the extant literature points to the main fact that changes in brain 
structure and function are pervasive during aging, particularly in the PFC. And although 
general declines are observed, there is a great deal of individual variability.  
Cognitive changes. The amount of cognitive decline associated with aging varies 
with the type of cognitive domain being tested. For example, crystallized cognitive abilities 
such as verbal and numeric abilities, autobiographical memory, and emotional processing 
remain relatively stable or even improve throughout the lifespan. However, fluid abilities 
such as processing speed, working memory, and executive control decline with age and the 
decline accelerates close to death (Hedden & Gabrieli, 2004; Park & Gutchess, 2002). The 
age-sensitivity of executive control is of particular interest because of its importance to real 
world functioning. Executive control refers to cognitive processes associated with planning, 
coordination, and monitoring of other cognitive operations (i.e. a central executive; 
Baddeley, 1992, 2010; Salthouse & Miles, 2002). This decline in executive control is 
associated with the concomitant aging-related structural and functional changes of the 
prefrontal cortex (PFC; discussed above), which is known to subserve, in part, executive 
control processing (Raz et al., 2005; West, 1996).  
There are many aspects of executive control and many different tasks that can be 
used to assess the integrity of these different aspects of executive control processing. For 
example, one facet of executive control is active mental manipulation as opposed to passive 
storage of relevant information, often referred to as updating (Baddeley, 1992, 1996, 2010; 
Johnson, Raye, Mitchell, Greene, & Anderson, 2003; Langley & Madden, 2000; Miyake et al., 
2000). Short-term passive storage is often preserved in older adults (Hedden & Gabrieli, 
2004; Park & Gutchess, 2002), whereas the ability to manipulate the stored information 
declines with age (Chen & Li, 2007; Van der Linden, Brédart, & Beerten, 1994). Updating 
can be tested by asking participants to monitor and code incoming information for task 
relevance, and then continuously manipulate, evaluate, and replace old, irrelevant content 
with newer, more relevant information to successfully complete the task (Chen & Li, 2007). 
In 2007, Chen & Li used separate measures of updating, processing speed, and fluid 
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intelligence to show that increased age is associated with reductions in updating ability, 
and that this reduced efficiency is associated with poorer performance on fluid intelligence 
tests. They found that older participants were slower on speed tasks, performed poorer on 
fluid intelligence assessments, and had a decreased percentage of correct responses in 
updating tasks (e.g. running memory task). More importantly, using a series of hierarchical 
regression analyses, they verified that age-related differences in updating variables was at 
least partially independent of the age-related differences in speed variables. Furthermore, 
they created a structural equation model with good convergent validity of each of their 
constructs (i.e. speed, updating, and fluid intelligence) and good discriminate validity 
between the speed and updating constructs after controlling for age. This model showed 
large path coefficients from age to both speed and updating, indicating an association 
between increased age and slower processing speed and poorer updating efficiency. In 
addition, the model provided evidence that updating mediates (at least in part) age-related 
effects on fluid intelligence. 
Another aspect of executive control is the ability to maintain and coordinate 
multiple task goals, which I will refer to as coordination. Two main aspects of coordination 
are time-sharing and shifting. Time-sharing refers to the effectiveness of coordinating two 
simultaneous tasks, distinct from the efficiency of performing each task separately 
(Salthouse & Miles, 2002). Shifting refers to the ability to maintain and coordinate a set of 
task goals in order to shift between one and another. In simplest terms, shifting involves 
disengaging an irrelevant task goal, followed by active engagement of a relevant task goal 
(Kramer, Hahn, & Gopher, 1999; Miyake et al., 2000). In the laboratory, time-sharing and 
shifting are often assessed using dual task and task-switching paradigms respectively. 
Briefly, dual task paradigms require participants to perform two tasks simultaneously (e.g. 
vowel/consonant letter judgment and odd/even number judgment) while task-switching 
paradigms require participants to switch between two different tasks (e.g. 
vowel/consonant letter judgment followed by an odd/even number judgment). These 
types of tasks are also referred to as tasks of divided attention.  
In 2002, Salthouse & Miles had young and old adults perform three different 
primary tasks separately and in concurrence with a common secondary task. They found 
significant correlations among time-sharing costs in all three dual task conditions, 
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providing evidence for a separable time-sharing construct. Furthermore, the time-sharing 
factor was distinct from factors representing perceptual speed and other cognitive factors, 
providing more evidence of a distinct executive factor. This time-sharing factor was 
correlated with age such that increasing age led to increasing disruption in time-sharing. 
Increased age was also associated with lower levels of performance in each task separately 
and concurrently, even after single task accuracy was adjusted for across age. Additionally, 
two separate meta-analyses of tasks of divided attention found significant age differences 
above and beyond the effects of general slowing (Verhaeghen & Cerella, 2002; Verhaeghen, 
Steitz, Sliwinski, & Cerella, 2003). 
In 1999, Kramer, Hahn, and Gopher utilized three different versions of a task-
switching paradigm and found that switch trial reaction times were significantly longer for 
older adults than young adults. These effects were robust across a range of preparation 
intervals, different levels of working memory load, and whether or not the switch was 
predictable. They also found that older adults made more perseverative errors on the 
Wisconsin Card Sorting Test (WCST), indicating impairment in the ability to shift from one 
rule to another and in the ability to stop the use of one rule and initiate the use of another. 
This leads into the final aspect of executive control discussed here – the ability to 
inhibit dominant or automatic responses when necessary or to actively suppress one 
response in order to make another (Miyake et al., 2000). Older adults show deficits in tasks 
requiring this type of inhibitory processing. One of the most commonly used tasks to assess 
inhibitory executive control is the Stroop task. In the Stroop task, participants are 
presented with color words printed in different ink colors. They are then asked to report 
on the ink color and not the meaning of the word. In general, performance of this task is 
poorer when the color word and the ink color are in conflict – the Stroop effect. This task 
utilizes the difficulty of inhibiting the automaticity of reading (i.e. task irrelevant 
information) in order to perform the weaker task-relevant reporting of the ink color 
(Stroop, 1935). In 1999, Brink and McDowd conducted an experiment comparing the age 
effects of quantitative (i.e. variations in number of choices of colors) versus qualitative (i.e. 
name the ink color of a block versus name the ink color of a color word) measures. By 
analyzing proportional Stroop effect scores to control for general age-related slowing, they 
found that age did not interact with choice, but did interact with task type such that the 
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young and old performed comparably on the Color-Block Task, but the young 
outperformed the old in the Color-Word Task. This shows that the effect of generalized 
slowing cannot fully explain the age differences in the performance on the two tasks and 
that inhibitory processing is disproportionately affected by age. 
The Flanker task is also commonly used to test inhibitory executive processing. In 
the Flanker task, participants are shown five arrows and asked to report on the direction of 
the central arrow. There are two conditions to this task. In the congruent condition, the 
flanking arrows are in the same direction (<<<<<) as the central arrow. In the incongruent 
condition, flanking arrows are in the opposite direction (<<><<), and participants must 
inhibit the irrelevant distracting information of the flanking arrows in order to make a 
correct response. Colcombe et al. (2005) reported that older adults were reliably slower to 
respond to both congruent and incongruent trials compared to young adults. More 
importantly, the older adults were proportionally more disrupted by incongruent trials 
than young adults when proportional interference scores were assessed (i.e. [incongruent 
response time – congruent response time]/congruent response time). Also, there was no 
reliable correlation between congruent response time and proportional interference 
scores, showing that the main deficit was in inhibitory processing of incongruent items and 
not a result of a main effect of slowed response time. 
Taken together, evidence points to a general age-related deficit in executive control 
processing. Declines in the ability to update memory stores, coordinate multiple tasks, and 
inhibit irrelevant information can have severe repercussions on a person’s quality of life 
during aging. Therefore, it is important to understand and explore the different factors that 
contribute to or alleviate this age-related cognitive decline. 
 
Cardiorespiratory Fitness 
Lifestyle factors are increasingly being recognized as simple ways of promoting 
physical and cognitive health. There is an ever growing literature examining the physical, 
cognitive, and neural changes associated with physical activity, cardiorespiratory fitness, 
and exercise, and how these may contribute to brain health. The non-human animal 
literature points to cardiorespiratory fitness as a factor that can contribute to individual 
differences in age-related cognitive, neurochemical, and structural differences. The 
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beneficial effects of exercise may act directly on the molecular machinery of the brain itself 
by influencing neurotrophic factors (Cotman & Berchtold, 2002) and neurotransmitters 
such as dopamine. For example, (Gilliam et al., 1984) found increased D2 receptor binding 
within the striatum in young exercised rats. Further, MacRae, Spirduso, Walters, Farrar, & 
Wilcox (1987) found exercise diminished age-related declines in dopamine metabolism 
and D2 receptor density.  
 Additionally, Neeper, Gómez-Pinilla, Choi, & Cotman (1995) found that voluntary 
wheel running increased levels of BDNF mRNA in the rat hippocampus. These increased 
mRNA levels were observed within days in both male (Neeper, Gómez-Pinilla, Choi, & 
Cotman, 1996) and female (Berchtold, Kesslak, Pike, Adlard, & Cotman, 2001) rats and 
levels were sustained after several weeks of exercise. Further, there was also a parallel 
increase in BDNF protein. Additional studies have found that voluntary wheel running, 
above and beyond just an enriched environment, leads to neurogenesis, increased cell 
survival, and improved spatial navigation (Kobilo et al., 2011; van Praag, Christie, 
Sejnowski, & Gage, 1999; van Praag, Kempermann, & Gage, 1999), and physical activity can 
promote brain vascularization (Black, Isaacs, Anderson, Alcantara, & Greenough, 1990). 
In older humans, baseline measures of cardiorespiratory fitness (i.e. VO2 peak) have 
been positively associated with preserved cognitive function over a period of six years 
(mean age at baseline = 69; Barnes, Yaffe, Satariano, & Tager, 2003). In addition, several 
cross sectional studies have found that higher levels of cardiorespiratory fitness can 
attenuate age-related cognitive declines (e.g. Hillman, Weiss, Hagberg, & Hatfield, 2002; 
Renaud, Bherer, & Maquestiaux, 2010; Spirduso, 1975). Supporting these cognitive 
findings, increased levels of cardiorespiratory fitness have also been associated with 
increased brain volume specifically in the frontal and temporal cortices (Colcombe et al., 
2003, 2006), as well as hippocampi in older adults (Erickson et al., 2009b). 
Further evidence comes from randomized controlled trials in which relatively 
sedentary older adults, usually over the age of 60, are randomized into an aerobic training 
group (e.g. walking) or a non-aerobic control group (e.g. stretching and toning). These 
studies have presented mixed results due to differences in cardiorespiratory fitness 
assessment, but in general show that exercise induced increases in cardiorespiratory 
fitness positively influence cognition (Kramer & Erickson, 2007). Further, in a meta-
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analysis of aerobic fitness training studies with older adults, Colcombe & Kramer (2003) 
found that aerobic exercise training increased performance, regardless of the type of 
cognitive task, training method, or participant characteristics. In a more recent meta-
analysis, Smith et al. (2010) corroborated the Colcombe & Kramer meta-analysis, 
specifically finding modest effects of aerobic fitness training on attention and processing 
speed, executive function, and memory. Although aerobic exercise training has relatively 
broad effects on perceptual and cognitive processes, the benefits seem to be largest for 
executive control processes (Colcombe & Kramer, 2003; Kramer & Erickson, 2007). The 
literature also suggests that 6 months of moderate aerobic exercise is sufficient to show 
benefits on cognitive function, with the greatest benefits again on executive control 
processes (Erickson & Kramer, 2009). Specifically, Colcombe, Kramer, Erickson, et al. 
(2004) found that healthy older adults that were aerobically trained for 6 months showed 
improved inhibitory processing in a Flanker task and a change in the pattern of fMRI 
activation, becoming more similar to that displayed by younger controls. In another study, 
Colcombe et al. (2006) showed that walking three days a week for ~1 hour per day for six 
months increased frontal and temporal gray matter volume, as well as anterior white 
matter volume, in healthy older adults. Overall, the take home message is that physical 
activity, exercise and cardiorespiratory fitness show a positive relationship with cognition 
in healthy older adults. 
 
Genetics   
Genetic factors also contribute to variability in the myriad of aging-related declines. 
Twin studies have contributed to the understanding of the extent to which genetics versus 
environmental factors play a role in various aspects of human behavior, and how these 
contributions may change with aging. For example, a study of male twins between 69 and 
80 years old reported a heritability of 79% for a latent trait of executive control (Swan & 
Carmelli, 2002). Further, in a review of several twin studies from various centers, Lee, 
Henry, Trollor, & Sachdev (2010) found genetic influence on processing speed and 
executive functions seems to increase with increasing age; and further, that environmental 
factors seem to show increased influence after the age of 65. This implicates the possibility 
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of using external resources, such as exercise interventions, to potentially rescue genetically 
predetermined behavioral outcomes in older age. 
A person’s genetic makeup can influence how much a certain neurochemical is made 
along with its availability and distribution, and in turn affect brain structure and function. 
Although general declines in brain structure and function are observed with aging, one’s 
genetic makeup can influence the effect these declines will have on cognition. Allelic 
association has been utilized to investigate the role of particular genes in specific behaviors 
by inferring neurochemical brain changes. 
Allelic association is an approach that integrates the fields of cognitive neuroscience 
and molecular genetics. This technique finds its roots in studies examining the heritability 
of certain aspects of cognition, mostly twin studies (Bouchard, Lykken, McGue, Segal, & 
Tellegen, 1990; Fan, Wu, Fossella, & Posner, 2001). Since the human genome cannot be 
experimentally manipulated, the target for such studies is naturally occurring genetic 
variation responsible for some phenotype – the more specific the better. Because allelic 
association studies look for correlations between alleles in a population as opposed to 
within families, the power to detect genes with a small effect size is greatly increased (Liu 
et al., 1996; Plomin & Craig, 1997).  
Harris & Deary (2011) define a candidate gene study as “a study that investigates 
associations between genetic variants in a gene suspected of influencing a trait of interest 
(by virtue of the function or chromosomal location of the gene) and the trait.” At the outset 
of this approach it is important to choose candidate genes with a well-defined measurable 
phenotype. Most studies focus on candidate genes with functional markers that result in 
amino acid coding differences or have a physiological effect (Deary, Wright, Harris, 
Whalley, & Starr, 2004; Goldberg & Weinberger, 2004; Greenwood & Parasuraman, 2003; 
Mattay & Goldberg, 2004; Parasuraman, Greenwood, Kumar, & Fossella, 2005; Plomin & 
Craig, 1997). These genes are chosen by how the gene products play a molecular and 
cellular role in areas of the brain involved in specific types of behavior or disease. Allelic 
variation arises from small differences that occur in the chain of nucleic acids making up 
the gene. The most common variation is called a single nucleotide polymorphism (SNP), 
defined as “a position on a chromosome where humans are known to differ with regard to 
which base pair occurs” (Harris & Deary, 2011). SNPs can lead to changes in the gene 
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product – either in function, production, or distribution. Candidate gene studies can 
provide insight into a relationship that is difficult to investigate in humans, but results 
should also be interpreted with caution since the effect size of one single gene on behavior 
is quite small. More recent investigations attempt to incorporate multiple gene variants or 
interactions with external factors (Raz & Lustig, 2014) and will be discussed further in the 
general discussion section. 
For the purposes of this study we chose genes with SNPs that have a well-defined 
effect on components influencing the dopaminergic system (i.e. COMT, DAT1, DBH) and the 
levels of growth factors (i.e. BDNF and IGF1). Additionally, these neurochemicals are 
involved in cognition and are modulated with aging and variability in cardiorespiratory 
fitness level (see Table 1.1 for a review of the genes). Each gene will be discussed in detail 
in the following chapters. 
 
Summary 
The purpose of this thesis is to explore the potential interaction between genetics 
and cardiorespiratory fitness level. What contributes to the variability in the amount of 
beneficial effects that are seen with increases in cardiorespiratory fitness level? Could it be 
that there is a predisposition for the amount of benefit one can receive from increased 
cardiorespiratory fitness? Is it possible that our genetics can determine to what extent our 
environment will influence our brain functioning or cognitive abilities?  
Or from a perpendicular perspective, is it possible that we can “rescue” ourselves 
from a predisposition for a disadvantaged cognitive ability? Is it possible that some of us 
have “bad” genes that determine that our attention spans or multitasking abilities are 
“bad"? But, if we exercise and increase our cardiorespiratory fitness levels, might we show 
greater cognitive benefits because we are starting out at a “lower” baseline than others? 
Whereas if we have the “good” genes, then there really isn’t much room for us to improve, 
but being healthy is always better for a long and healthy life. The interaction between 
genetics and cardiorespiratory fitness could be a reason why we see inter-individual 
variability in the benefits of exercise interventions. 
 To test this potential interaction between genes and cardiorespiratory fitness level 
on cognition in older adults, we conducted a cross-sectional study with a group of healthy 
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sedentary older adults. We collected cardiorespiratory fitness levels and a complete 
neuropsychological battery of tests specifically chosen to investigate different aspects of 
cognition. We also collected blood to genotype particpants for a variety of candidate genes 
known to affect the dopamine system or neurotrophic factors. This thesis presents a 
statistical analysis of the effects of genotype alone and more importantly, of the interactive 
effect between genotype and cardiorespiratory fitness level on multiple behavioral 
measures in healthy sedentary older adults. 
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Chapter 2: General Methods 
 
Participants 
 Older adults between the ages of 58 and 81 years of age were recruited from the 
local community of Urbana-Champaign, Illinois (N = 842). Blood was collected from 242 
participants and sent to collaborators for genotyping. The final sample size used in this 
study varied depending on voluntary drop out, failure to complete the maximal graded 
exercise test, failure to complete or perform better than chance (e.g. < 50% error rate) on 
any test(s) in the neuropsychological test battery, failure to complete the first fMRI session, 
or a failure in genotyping for any of the genes of interest (COMT, DBH, DAT1, BNDF, IGF1). 
Sample sizes are reported in individual sections of the thesis. 
Eligible participants had to demonstrate strong right handedness with 75% or 
above on the Edinburgh Handedness Questionnaire (Oldfield, 1971), score < 3 (total 15) on 
the Geriatric Depression Scale (Sheikh & Yesavage, 1986; Yesavage et al., 1982), have 
normal color vision and a corrected visual acuity of at least 20/40. All participants met or 
surpassed all criteria for participating in a magnetic resonance imaging study including no 
previous head trauma, no previous head or neck surgery, no diagnosis of diabetes, no 
neuropsychiatric or neurological condition including brain tumors, and no metallic 
implants that could interfere with or cause injury due to a magnetic field. Additionally, all 
participants received physician’s clearance to engage in a maximal graded exercise test. 
Finally, all participants signed an informed consent approved by the University of Illinois 
and were compensated for their participation.  
 
Blood Collection 
 Following an overnight fast, venous blood samples were collected into PAXgene 
DNA collection tubes (PreAnalytiX by Qiagen, Valencia, CA) and stored at -80C until 
analysis. One tube containing ~10 ml of whole blood was sent per subject. All tubes were 
sent on dry ice to prevent thawing during shipment to collaborators at George Mason 
University where the genotyping took place. Confirmation that the samples arrived in 
satisfactory condition was made via e-mail. 
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DNA Preparation 
DNA was purified from whole blood with a Flexigene DNA kit, following the 
procedure recommended by the manufacturer (Qiagen, Valencia, CA).  DNA yields were 
quantified with a Nanodrop UV/visible spectrophotometer (Thermo Scientific, Wilmington, 
DE). 
 
Genotyping 
 Genotyping was conducted at George Mason University and methods are described 
in detail within each chapter. 
 
Physical Assessment 
Cardiorespiratory fitness level. Participants were required to obtain consent from 
their personal physician before cardiorespiratory fitness testing was conducted. 
Cardiorespiratory fitness (VO2 max) was assessed by graded maximal exercise testing on a 
motor-driven treadmill. The protocol involved the participant walking at a speed slightly 
faster than normal walking pace (~30-100 m/min) with increasing grade increments of 2% 
every 2 minutes. A cardiologist and nurse continuously monitored measurements of 
oxygen uptake, heart rate, and blood pressure. Oxygen uptake (VO2) was measured from 
expired air samples taken at 30-second intervals until a maximal VO2 was attained or to the 
point of test termination due to symptom limitation and/or volitional exhaustion. VO2 max 
was defined as the highest recorded VO2 value when two of three criteria were satisfied: 1) 
a plateau in VO2 peak between two or more workloads, 2) a respiratory exchange ratio > 
1.00, and 3) a heart rate equivalent to their age predicted maximum (i.e. 220 – age). The 
primary measure was VO2 max (ml/kg), with higher values implicating higher 
cardiorespiratory fitness levels. From here on VO2 will be used interchangeably with VO2 
max. 
Other measures. Weightkg, heightm, and body mass index (BMI; weightkg/heightm2) 
were also recorded. 
 
 
 
 
16 
 
Cognitive Assessment 
Test administration was either computerized or paper-and-pencil. Response times 
were recorded either on a button box or keyboard with millisecond accuracy for tasks 
requiring response time (RT) measures. A stopwatch was used for timed paper-and-pencil 
tests. Participants were told to respond as quickly and as accurately as possible for timed 
tests.  
 
Verbal crystallized intelligence test. 
Kaufman brief intelligence test – verbal subscale. The verbal subscale of the 
Kaufman Brief Intelligence Test (K-BIT; Kaufman & Kaufman, 1990) was administered to 
the participants by lab personnel. This subscale consists of verbal knowledge and riddles, 
both assessing crystallized verbal ability. The primary measure was an age-scaled score of 
correct items divided by total number of items attempted; therefore, higher scores indicate 
better performance. 
 
Memory tests. 
Digit span test. Two versions of the digit span test, forward and backward, were 
administered verbally. For the forward version, a task administrator read a sequence of 
numbers out loud to participants (e.g. 4-5-1) who were instructed to repeat the sequence 
of numbers back to the administrator in the exact order read (e.g. 4-5-1). For the backward 
version, the task administrator read a sequence of numbers out loud to participants (e.g. 4-
5) who were instructed to repeat the sequence of numbers back to the administrator in 
reverse order (e.g. 5-4).  
For both versions, participants were given two trials for each list length (e.g. 4-5-1, 
then 2-4-9). For the forward version, list lengths began with a three number sequence and 
incrementally increased by one number if participants could correctly repeat the sequence 
for at least one of the trials. If participants incorrectly repeated the sequences of a 
particular list length in both trials, the previous list length was recorded as the maximum 
digit span. The test was conducted in the same way for the backward version, but list 
lengths began with a two number sequence.  The primary measure was the number of 
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digits in the maximum digit span (i.e. forward and backward separately); therefore, higher 
scores indicate better performance. 
Spatial memory test. Participants performed a spatial memory paradigm that has 
been previously associated with cardiorespiratory fitness and hippocampal volume in a 
sample of 165 older adults (methods adapted from Erickson et al., 2009b). Participants 
were first presented with a fixation crosshair (‘+’) at the center of the screen for one second 
and instructed to keep their eyes on the crosshair. Following the fixation, 1, 2, or 3 black 
dots appeared at random locations on the screen for a duration of 500 ms. The dots were 
removed from the display and the fixation cross re-appeared on the screen for 3 seconds. 
During this time, participants were instructed to try and remember the location(s) of the 
previously presented black dot(s). At the end of the 3 s delay, a red probe dot appeared on 
the screen in either the same location as one of the target dots (match condition) or at a 
different location (non-match condition). Participants had 2 s to respond to the red dot by 
pressing the “M” key for a match trial or the “X” key for a non-match trial. Forty trials were 
presented for each set size (1, 2, or 3 locations), with 20 match trials and 20 non-match 
trials. Several practice trials were performed before the task began in order to acquaint the 
participants with the task instructions and responses. Both response time (RT) and error 
rate (ER) were recorded for each memory load and median RT and ER were used as the 
primary measure; therefore, lower scores indicate better performance. 
 
Executive control function tests. 
Verbal fluency test (FAS). Participants were asked to say as many words as they 
could, excluding proper nouns, in 60 seconds from a given phonetic category. Each 
participant had 60 seconds to name as many words as possible that began with the letter F, 
then 60 seconds for words beginning with A, and then 60 seconds for S. The primary 
measure was the total number of words named across categories; therefore, higher scores 
indicate better performance. 
Flanker test. A modified Flanker paradigm (Botvinick, Nystrom, Fissell, Carter, & 
Cohen, 1999) was administered on a computer with a standard keyboard. For this task, 
participants were presented with five arrows in a row and instructed to indicate the 
orientation of the central arrow during two trial types, congruent and incongruent. Arrows 
 
 
18 
flanking the central arrow pointed in the same direction as the central arrow during 
congruent trials (e.g. >>>>>), and in the opposite direction during incongruent trials (e.g. 
>><>>). If the central arrow pointed to the left, participants were instructed to press the 
“Z” key, and if the central arrow pointed to the right, they were to press the “M” key. Both 
RT and ER were recorded for each trial type and median RT and ER were used as the 
primary measure. Cost scores were also calculated by subtracting the congruent condition 
median RT or ER from the incongruent condition median RT or ER; therefore, lower scores 
indicate better performance. 
Stroop test. Behavioral data from a modified version of the color-word Stroop test 
(Erickson et al., 2009a; Milham et al., 2001) was collected within an fMRI environment. 
Participants were presented with congruent, neutral, incongruent-ineligible, and 
incongruent-eligible stimuli in an event-related design. Congruent stimuli were color 
words that matched the printed ink color (e.g. ‘RED’ in red ink). Neutral stimuli were words 
not associated with color that were matched for frequency and length with the color words 
(e.g. ‘SHIP’ in red ink). Incongruent-ineligible stimuli were color words that did not match 
the set of potential responses, and thus did not match the printed ink color (e.g. ‘BLUE' in 
purple ink if ‘blue’ is not one of the potential responses). Incongruent-eligible stimuli were 
color words that did match the set of potential responses, but did not match the printed ink 
color (e.g. RED in purple ink and ‘red’ is one of the potential responses). There were two 
ink color sets that were counterbalanced across participants: 1) eligible = red, orange, and 
purple; ineligible = blue, green, and yellow, and 2) eligible = blue, green, and yellow; 
ineligible = red, orange, and purple. Participants responded with a simple button press on a 
button pad placed in their right hand with four buttons on the top (corresponding to each 
finger) and one button on the side (corresponding to the thumb). Depending on the eligible 
ink color set, the right index finger corresponded to red or blue, the right middle finger to 
orange or green, and the right ring finger to purple or yellow. Task administrators placed 
participants’ fingers on the correct corresponding buttons.  
Each condition consisted of 36 trials. For the incongruent-eligible condition, each 
ink color was paired with both response eligible color words 12 times during a session (6 
times per word). However, for the incongruent-ineligible condition, each ink color was 
paired with one of the three ineligible words 12 times (4 times per word). Each stimulus 
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was displayed for 1 s with a 1.5 s response window and a 3 s stimulus-onset asynchrony 
(SOA). A fixation crosshair (‘+’) was presented on the screen during all interstimulus 
intervals. An event-related stimulus design with 40% jitter was employed, such that the 
timing between trials varied to optimize the stimulus sequence and timing. Stimulus 
sequence and jitter for each participant was generated using OptSeq2 
(http://surfer.nmr.mgh.harvard.edu/optseq/). RT and ER were recorded for each trial type 
and median RT and ER were used as the primary measure.  
Wisconsin card sorting test (WCST). Participants completed a computerized 
version of the WCST (Psychological Assessment Resources, Inc.). Participants were 
required to sort cards displayed on the computer screen. The cards contained geometric 
designs and could be sorted into categories by shape, color, or number of items. The 
participants were asked to match each card that appeared in the lower portion of the 
computer screen with one of the four cards displayed at the top of the screen. The 
participants were told that the program would provide feedback about the accuracy of 
their decision (‘correct’ or ‘incorrect’), but the examiner could not give any additional 
instructions after the task began. The participant did not know the following, but after 
several trials of sorting cards correctly by a specific category, the category was changed 
arbitrarily, requiring the participant to adjust sorting accordingly. Total errors and percent 
perseverative errors were used as the primary measures; therefore, lower scores indicate 
better performance.  
Task switch test. Participants were required to switch between judging whether a 
number (1, 2, 3, 4, 6, 7, 8, or 9) was odd or even and judging whether it was low or high (i.e. 
less than or greater than 5). Numbers were presented individually for 1500 ms against a 
pink or blue background at the center of the screen with the constraint that the same 
number did not appear twice in succession. If the background was blue, participants used 
one hand to report as quickly as possible whether the number was high (“X” key) or low 
(“Z” key). If the background was pink, participants used their other hand to report as 
quickly as possible whether the number was odd (“N” key) or even (“M” key). Participants 
completed four single task blocks (2 blocks odd/even and 2 blocks high/low; single 
condition) of 24 trials each. Due to the difficulty of this task, participants then completed a 
practice dual task block in which they switched from one task to the other for 120 trials. 
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Finally, they completed a dual task block of 120 trials during which the task for each trial 
was chosen randomly (mix condition). Within the mix condition, there were two trial types: 
1) repeat trials in which the preceding trial involved the same rule set (e.g. odd/even trial 
followed by odd/even trial) and 2) switch trials were those when the preceding trial 
required the other rule set (e.g. odd/even trial followed by high/low trial). This task was 
similar to that of Kramer, Hahn, & Gopher (1999) and Pashler (2000); this version of the 
task was programmed and administered using E-prime software (Psychology Software 
Tools). Both RT and ER were recorded. The primary measures for this task were median RT 
and ER for each condition as well as each trial type within the mix condition. A global (mix 
condition – single condition) and a local (switch trial – repeat trial) cost score was also 
calculated for both RT and ER. Lower scores indicate better performance.  
Dual task test. Behavioral data for this task was collected within an fMRI 
environment. Participants were given separate button pads for each hand with four 
buttons on the top (corresponding to each finger) and one button on the side 
(corresponding to the thumb). Task administrators placed participants’ fingers on the 
correct corresponding buttons. During the task, participants were presented with two task 
conditions, single trials and dual trials, in an event-related design. During single task trials, 
participants were presented with either a single letter stimulus (‘A’ or ‘B’) or a single 
number stimulus (‘2’ or ‘3’). An asterisk was always presented above or below the single 
stimulus to act as a placeholder to match the dual task trial visual load. Instructions asked 
participants to indicate the identity of the stimuli with a simple button press. The left 
middle finger corresponded to the number ‘2’, the left index finger to the number ‘3’, the 
right index finger to the letter ‘A’, and the right middle finger to the letter ‘B’. During dual 
task trials, participants were presented with both a letter and a number (one above the 
other), and instructed to indicate the identity of both stimuli with corresponding button 
presses. Participants were told that they could respond to either the letter or number first, 
but that buttons should never be pressed simultaneously. Each condition consisted of 48 
trials (single task condition had 24 letter and 24 number trials). Each stimulus was 
displayed for 3 s with a 3 s response window and a stimulus onset asynchrony (SOA) of 1.5 
s. A crosshair (‘+’) was presented on the screen during all interstimulus intervals. An event 
related stimulus design with a 40% jigger was employed, such that the timing between 
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trials varied in order to optimize the stimulus sequence and timing. Stimulus sequence and 
jitter for each participant was generated using OptSeq2 
(http://surfer.nmr.mgh.harvard.edu/optseq/). Both RT and ER were recorded. For dual 
task trials, RTs for the first and second button press were recorded separately and a trial 
was counted as correct only if both the letter and number were identified correctly. The RT 
recorded from the second button press was used as the measure for dual trials. The 
primary measures were median RT and ER for each trial type. Cost scores were also 
calculated for both RT and ER by subtracting the single trial measure from the dual trial 
measure. Lower scores indicate better performance. 
 
Statistical Methods  
 Exact tests were used to ensure that the genotypic distributions were consistent 
with Hardy-Weinberg equilibrium. 
Analysis of variance and chi-square analyses were performed to determine whether 
genetic groups were equivalent with respect to potentially confounding variables (i.e. age, 
education, sex, mMMSE, BMI and VO2).  
The specific analyses are described in the specific sections. For figures representing 
genotypic analyses (supplementary figures in Appendix A and B), displayed values are 
estimated marginal means calculated after taking into account the control variables added 
into the model. Error bar values are the standard error values taken from bootstrap results 
based on 5000 bootstrap samples. For figures representing the interaction analyses (i.e. 
relationship between behavioral measure and cardiorespiratory fitness level for each 
genotypic/allelic group), all data points plotted in the scatter plot are raw, unadjusted 
scores, with lines fitted to the raw data for each group. The ΔR2 and p value are also 
included, and if significant (p  .05) or marginal, (p  .10), β and p value for each group is 
also included. 
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Chapter 3: Dopamine Related Genes 
Dopamine (DA) is best described as a modulatory neurotransmitter that is related 
to the gating of inputs and the modulation of postsynaptic neuronal activity through 
excitation or inhibition of neurons (Cooper, 2003, Chapter 9; Seamans & Yang, 2004). It 
plays an especially important modulatory role within the frontal cortex, which is critical for 
intact cognitive functioning (Bäckman, Nyberg, Lindenberger, Li, & Farde, 2006; Brozoski, 
Brown, Rosvold, & Goldman, 1979; Cools & Robbins, 2004; Savitz, Solms, & Ramesar, 2006; 
Seamans & Yang, 2004). Evidence for this was found in young adult monkeys who showed 
performance deficits on a spatial delayed alternation task after DA levels in the prefrontal 
cortex (PFC) were reduced by 80% through chemical injection of a selective 
catecholaminergic toxin, and these performance deficits were similar to those found in 
monkeys with ablated PFCs (Brozoski et al., 1979). Furthermore, reversal of these deficits 
was observed after administration of L-DOPA, a synthetic precursor for DA that can cross 
the blood brain barrier and subsequently be converted into DA. Beyond primate studies, in 
humans severe cognitive deficits are known to accompany Parkinson’s Disease (PD) and 
Huntington’s Disease (HD) in which the dopaminergic fronto-striatal system becomes 
severely impaired (Bäckman et al., 2006; Bäckman & Farde, 2001; Nieoullon, 2002).  
The fact that DA plays a significant role in cognitive functioning is apparent, but the 
neurobiological mechanism behind the DA system is complex. Dopamine can exhibit 
opposing functional effects depending on the level of stimulation, the particular synapse, 
neuron, receptor, or level of activity within the local network being acted upon (Seamans & 
Yang, 2004). DA is believed to affect cognition in an inverted-U shaped function such that 
moderate levels are ideal while high and low levels can be detrimental (Cools & Robbins, 
2004; Seamans & Yang, 2004).  
Part of this complexity is inherent in the fact that in the central nervous system 
(CNS), DA interacts with at least five receptor subtypes (D1, D2, D3, D4, D5) that can be 
subdivided into two families. The D1-like family includes the D1 and D5 receptor subtypes, 
and the D2-like family includes the D2, D3, and D4 receptor subtypes (Cooper, 2003; 
Seamans & Yang, 2004). DA can exert both direct and indirect effects on the excitability of 
prefrontal neurons through activation of these different receptors. Both families of 
receptors can be found post-synaptically, but some D2-like receptors are also found pre-
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synaptically where they act as autoreceptors (Bäckman et al., 2006; Cooper, 2003). 
Activation of these autoreceptors can slow firing rate and inhibit DA synthesis and release, 
thus they can be divided into 3 categories: 1) synthesis-modulating, 2) release-modulating, 
and 3) impulse-modulating (Cooper, 2003). It is interesting to note that the prefrontal and 
cingulate cortices lack synthesis-modulating autoreceptors, and thus can only regulate the 
release of DA and neuronal firing rates. D2 autoreceptors are 5-10 times more sensitive 
then post-synaptic receptors (Cooper, 2003), therefore low levels of DA will only stimulate 
autoreceptors, whereas high doses can stimulate both pre- and post-synaptic receptors. 
In general, D1-like receptor activations lead to increased excitability while 
activation of D2-like receptors seem to suppress excitability (Seamans & Yang, 2004). 
Similar to DA levels, D1-like receptor stimulation has an inverted U-shaped effect on 
behavior with over stimulation or blockade of D1-like receptors in the prefrontal cortex 
leading to disruptions. For example, using a delayed spatial win-shift task, Floresco and 
Phillips (2001) found that an injection of D1 agonist in the rat prefrontal cortex before a 
test phase, but after a 30-minute delay period, disrupted performance. It was believed that 
there was an ideal amount of DA available to perform the task after the 30-minute delay, so 
the addition of D1 agonist overloaded the circuit. However, an injection of the D1 agonist 
after a 12-hour delay improved performance when information from the training phase 
was degrading and the addition of the D1 agonist was able to boost the circuit (Floresco & 
Phillips, 2001).   
In humans, molecular imaging studies show that DA release in the frontal cortex and 
hippocampus is related to working memory performance (Aalto, Bruck, Laine, Nagren, & 
Rinne, 2005) while striatal DA release is seen during card-sorting (Monchi, Hyun Ko, & 
Strafella, 2006) and sequential learning (Badgaiyan, Fischman, & Alpert, 2007) in young 
adults. DA markers are also strongly related to performance in executively demanding 
tasks (Bäckman et al., 2000; Erixon-Lindroth et al., 2005; Volkow et al., 1998), which show 
the most pronounced age-related deficits (Winter et al., 2007). Taken together, this 
indicates that age-related differences observed in executively demanding tasks are 
partially a reflection of age-related deficits of the DA system and its ability to meet 
performance demands (Mattay et al., 2003). 
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The process of aging brings about general neurochemical changes in the brain such 
as region-specific declines in the concentration, synthesis, and number of receptor sites of 
neurotransmitters such as serotonin, acetylcholine, and dopamine. Small alterations in 
dopaminergic fronto-striatal loops may be an important contributor to the cognitive 
decline in normal aging due to the dense innervation between the caudate nucleus and the 
frontal cortex (Cabeza, 2001a). Mirroring volume losses, receptor losses are most 
conspicuous in the prefrontal cortex (Cabeza, 2001a; Strong, 1998). Goldman-Rakic and 
Brown (1981) observed a drastic 56% reduction in the concentration of dopamine (DA) in 
the prefrontal cortex of old monkeys (18 yrs) compared to young monkeys (2-3 yrs), while 
the levels of norepinephrine (NE) and serotonin (5-HT) levels remained relatively stable. 
DA was also reduced in the superior and posterior inferotemporal cortex and caudate 
nucleus by an average of 39%, 35% and 34% respectively. In contrast, levels in the parietal 
and occipital cortices and the hippocampus were unchanged across age. Not only was there 
a reduction in the concentration of DA, but catecholamine biosynthesis was also reduced by 
more than 60% in the prefrontal, temporal, parietal and occipital cortices. Furthermore, 
these neurochemical changes also translate into behavioral changes. Bartus, Flemin, & 
Johnson (1978) found that 18 yr old rhesus monkeys were severely impaired on a spatial 
delayed alternation task, the same task on which young adult monkeys were impaired after 
injection of a catecholaminergic toxin mentioned earlier (Brozoski et al., 1979).  
In a recent review of human literature,  Li & Rieckmann (2014) summarized that 
pre- and post-synaptic dopamine receptor density levels can decline up to 10% per decade, 
beginning around the third decade of life, and these changes in the dopamine system can 
translate to changes in cognition. For example, in a recent review, Ranganath & Jacob 
(2015) discussed studies that showed the importance of prefrontal D1 and D2 receptors in 
cognitive flexibility in non-human animals, concluding that D1 receptors may be necessary 
for stabilizing new mental representations after identification of effective strategies, while 
D2 receptors are important for the destabilization of prefrontal networks, allowing the 
exploration of new strategies. Part of the translation from dopamine to behavior stems 
from the key role dopamine plays in the tuning of the signal-noise-ratio (SNR) of neuronal 
signal transmission, known as neuronal gain control. Neurocomputational models have 
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provided insight into the behavioral effects caused by alterations in the SNR. For example, a 
simulated “old” network shows that reducing gain control leads to a reduced slope of the 
activation function and the SNR of information transmission results in suboptimal effects to 
neurocomputation. These effects include increases in random processing activations (i.e. 
noise) and reduction in the representation distinctiveness of activation patterns, which is 
similar to neuroimaging studies that see more diffuse brain activation patterns in older 
adults compared to more distinct patterns seen in young adults while performing the same 
task (Li & Rieckmann, 2014; Sikström, 2007). Alterations in the gain parameter also 
mirrors the inverted U-shaped curve of behavioral performance as a function of dopamine 
levels, providing more insight into the relationship between dopamine and behavior and 
the need for a delicate balance.  
In contrast to aging, exercise has been associated with increases in levels of various 
neurochemicals and improvements in overall brain health. For example, regular physical 
exercise in rats, specifically wheel-running, increases levels of brain catecholamines, 
particularly dopamine and noradrenaline (Sutoo & Akiyama, 2003). Further, exercise-
induced increases in levels of brain-derived neurotrophic factor lead to increased neuronal 
survival (Berchtold, Castello, & Cotman, 2010; Vaynman & Gomez-Pinilla, 2006) and even 
neurogenesis (Creer, Romberg, Saksida, van Praag, & Bussey, 2010; van Praag, 
Kempermann, et al., 1999). Further, exercise does not only induce short-term increases in 
neurotransmitter levels, but Meeusen et al. (1997) also showed that exercise training 
produced specific adaptations in basal neurotransmitter output in the rat striatum. 
In human studies, peripheral measures of dopamine are often used as indicators of 
central levels under the assumption that brain and systemic DA levels respond similarly to 
physical exercise. For example, Winter et al. (2007) found a positive linear correlation of 
elevated levels of peripheral DA and epinephrine with better retention of learned verbal 
material, and concluded that DA and epinephrine are mediators through which physical 
exercise improves learning. 
Since exercise can increase cardiorespiratory fitness levels, variations in 
cardiorespiratory fitness level may lead to individual variations in the amount and 
availability of dopamine. If this holds true, there is a possibility that behavioral 
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performance can be influenced by an interaction between cardiorespiratory fitness level 
and genes that specifically affect dopamine.  
 
Methods 
Sample 
The initial sample size of N = 242 was reduced due to participant drop out, 
experimenter error, failure to complete behavioral or fitness testing, and genotyping 
failure. The sample size was then reduced further with pairwise deletion of participants 
that performed below chance (i.e. > 50% error rate) on any behavioral test. Therefore, the 
sample size for each test varies and each is indicated within the results section. 
 
Genotyping 
 DBH 444 G/A (rs1108580). The DBH 444 G/A polymorphism was assayed after 
nested PCR, by using allele-specific Tm-shift primers in various combinations, together with 
automated melting curve analysis as previously described (Greenwood et al., 2009). The 
yields of the PCR products corresponding to the A and G alleles were equalized by adjusting 
the concentrations of their respective oligonucleotide primers.  
 DBH –1021 C/T (rs1611115). The DBH -1021 C/T polymorphism was assayed 
after nested PCR, by using allele-specific Tm-shift primers in various combinations, together 
with automated melting curve analysis (Lipsky et al., 2001; Wang, Kong, Zhang, Sun, & 
Geller, 2005) on an iCycler real-time PCR machine (Bio-Rad, Hercules, CA). The PCR 
product of the first round (outer) amplification was 344 base pairs (bp) in length. The PCR 
product of the second round (inner) amplification was 106 bp for the C allele, and 92 bp for 
the T allele. 
 COMT Val158Met (rs4680) and COMT C/G (rs4818). The COMT Val158Met and 
COMT C/G polymorphisms were assayed by DNA sequencing. First, a PCR fragment 290 
base pairs in length was amplified by PCR and purified by ethanol precipitation. Then the 
DNA sequence of this PCR fragment was determined by cycle sequencing with BigDye 
terminators on an ABI 310 capillary sequencer (Applied Biosystems, Carlsbad, CA). The 
Fryxell lab and other labs have previously shown that this approach allows reliable 
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determination of both homozygous and heterozygous SNP genotypes (Hare & Palumbi, 
1999; Söderlund, Canto, & Méndez, 2002).  
 
Statistical Analyses 
 Hardy-Weinberg equilibrium. Two hundred and forty-two samples were 
genotyped successfully for the DBH gene. The frequencies of the three DBH 444 G/A 
genotypes were .19 for G/G, .54 for G/A, and .27 for A/A. The frequencies of the three DBH -
1021 C/T genotypes were .71 for C/C, .27 for CT, and .02 for TT. The Hardy-Weinberg exact 
test showed the allelic distributions for both SNPs did not deviate from those expected, 
DBH 444 G/A: 2(1) = 1.87, p = .197; DBH -1021 C/T: 2 (1) = 0.00, p = 1.00.  
 Two hundred and forty-one samples were genotyped successfully for the COMT 
gene. The frequencies of the three COMT Val158Met genotypes were .17 for G/G (Val/Val), 
.54 for G/A (Val/Met), and .29 (Met/Met). The frequencies for the COMT C/G genotypes 
were .11 for G/G, .48 for GC, and .41 for C/C. The Hardy-Weinberg exact test showed the 
allelic distributions for both SNPs did not deviate from expectations, COMT Val158Met: 
2(1) = 2.51, p = .150; COMT C/G: 2(1) = 0.55, p = .571. 
SNP analysis. All performance measures were analyzed using analysis of covariance 
(ANCOVA) with age, education, and sex as covariates. Percentile bootstrapped 95% 
confidence intervals (CI) were calculated over 5000 samples for pairwise comparisons and 
are reported in text if there was a significant omnibus effect of the SNP.  
 SNP x Fitness Level interaction analysis. All performance measures were 
analyzed using stepwise multiple regression with control variables entered in the first step 
(e.g. age, education, and sex). The dummy coded SNP variable(s) and cardiorespiratory 
fitness level (i.e. VO2 scores) were both entered in the second step, and the SNP x Fitness 
Level interaction variable(s) was entered in the last step. If the SNP x Fitness Level 
interaction was significant (i.e. R2 was p  .05) or marginal (i.e. R2 was p  .10), simple 
slopes analysis was conducted to elucidate the nature of the interaction. For the simple 
slopes analysis, the control variables were entered in the first step, followed by the SNP 
dummy variable(s) in the second step, and then in the last step cardiorespiratory fitness 
level was added for each individual group (e.g. for DBH -1021 C/T, VO2 scores for T Carriers 
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with C/C Homozygotes coded 0 and VO2 scores for C/C Homozygotes with T Carriers coded 
0 as two separate interaction variables). For each group, the unstandardized beta (B), 
standardized beta (), t value, along with percentile bootstrapped p value and 95% 
confidence intervals (CI) calculated over 5000 samples are reported in text. 
 
Cognitive Assessment 
This section is included here to help remind the reader of the variables of interest 
for each particular test. Full descriptions of the tests can be found in Chapter 2: General 
Methods. 
Verbal crystallized intelligence. One test was used to assess verbal crystallized 
intelligence. 
K-BIT test. The primary measure was an age-scaled score of correct items divided 
by the total number of items attempted on the verbal subscale of the Kaufman Brief 
Intelligence Test (K-BIT; Kaufman & Kaufman, 1990). Higher scores indicate better 
performance.  
Memory. Two tests were used to assess various aspects of memory (i.e. short-term, 
working, and spatial).  
Digit span test. Two versions of the digit span test, forward and backward, were 
used to assess short-term and working memory, respectively. For both versions of the digit 
span, the primary measure was the total number of digits in the maximum span length 
repeated; therefore, higher scores indicate better performance. 
 Spatial memory test. The primary measures were response time (RT) and error 
rate (ER) for each of the three memory loads (i.e. 1, 2 or 3). Lower scores (i.e. faster RT and 
lower ER) indicate better performance. 
Executive control functioning. Six tests were used to assess various aspects of 
executive control functioning.  
Verbal fluency test (FAS). The verbal fluency test assessed fluid intelligence and the 
primary measure was the total number of words named in 180 seconds for three phonetic 
categories (i.e. 60 seconds for F, A, & S separately). Higher scores indicate better 
performance. 
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Flanker test. The Flanker test assessed inhibitory processing. The primary 
measures were RT and ER for the two trial types (i.e. congruent and incongruent). 
Comparison of these two trial types assessed the ability to inhibit conflicting information. 
Lower scores indicate better performance. 
  Wisconsin card sorting test. The Wisconsin Card Sorting Test (WCST) assessed 
many aspects of executive functioning including inhibitory processing and concept shifting. 
The primary measures were percent perseverative errors and total errors; therefore, lower 
scores indicate better performance. 
 Task switch test. The task switch test assessed maintenance and coordination of 
multiple sets. The primary measures were RT and ER for the two conditions (i.e. single and 
mix), which can be compared to assess the cost of maintaining one versus two rule sets. 
The mix condition can be further split into repeat and switch trial types, which can be 
compared to assess the cost of rule switching. Lower scores indicate better performance. 
 Dual task test. The dual task test assessed coordination of multiple sets. The 
primary measures were RT and ER for the two trial types (i.e. single and dual), which can 
be compared to assess the cost of responding to one versus two stimuli. Lower scores 
indicate better performance. 
 
Dopamine Beta Hydroxylase 
Dopamine beta hydroxylase (DBH) is an enzyme that catalyzes the conversion of 
dopamine (DA) to norepinephrine (NE; Cubells et al., 1998; Greene, Braet, Johnson, & 
Bellgrove, 2008; Parasuraman et al., 2005). Activity of the enzyme is highly correlated with 
levels of the protein, thus differences in protein level are assumed to reflect differences in 
enzyme activity (Cubells & Zabetian, 2004; Cubells et al., 1998). DBH found in plasma arises 
from the sympathetic nervous system (Cubells et al., 1998), while DBH levels in 
cerebrospinal fluid (CSF) are controlled by central noradrenergic neurons, where DBH is 
localized within synaptic vesicles and released together with NE (Cubells & Zabetian, 
2004). The locus ceruleus contains the largest population of noradrenergic neurons and 
accounts for most of the noradrenergic innervation of the forebrain (Cubells & Zabetian, 
2004). Although plasma and CSF DBH are under the control of different systems, a strong 
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correlation has been found between plasma DBH activity and CSF DBH activity (Hess et al., 
2009).  
Levels of DBH are under strong genetic control by the DBH gene such that 
heritability estimates are .98 for plasma levels and .83 for CSF (Hess et al., 2009). The DBH 
gene is known to have several polymorphisms that are in strong linkage disequilibrium 
(Kopecková, Paclt, & Goetz, 2006). Linkage disequilibrium is defined as two or more alleles 
at different loci that occur together within an individual at a greater frequency than chance 
(Bellgrove & Mattingley, 2008). One of these single nucleotide polymorphisms (SNP) is a 
guanine (G) to adenine (A) substitution at position 444, exon 2 (DBH 444 G/A; rs1108580) 
on chromosome 9 (Cubells et al., 1998; Parasuraman et al., 2005). The A allele is associated 
with lower plasma and CSF levels of DBH, resulting in less enzymatic activity (i.e. higher 
DA:NE ratio; Cubells et al., 1998). This SNP does not alter the primary structure of the DBH 
protein, but it is located at the splice junction between exon 2 and intron 2 of the DBH gene, 
which may alter the efficiency of mRNA splicing, thereby affecting levels of the mature DBH 
mRNA (Cubells et al., 1998).  
Another SNP of interest is a cytosine (C) to thymine (T) substitution 1021 base pairs 
upstream of the transcriptional start site in the 5’-flanking region of the DBH gene (DBH -
1021 C/T; rs1611115) that is hypothesized to affect DBH gene transcription (Cubells & 
Zabetian, 2004; Zabetian et al., 2001). This SNP accounts for 35-52% of the total variance of 
DBH plasma activity (Hess et al., 2009; Zabetian et al., 2001). The T allele of the DBH -1021 
C/T SNP is associated with low DBH plasma activity, while the C/C genotype shows the 
highest DBH activity (i.e. high DA:NE and low DA:NE ratio respectively; Hess et al., 2009). 
The T allele occurs at a frequency of approximately .22 in European populations, a rate 
considerably less frequent compared to the C allele (Zabetian et al., 2001). In 2003, 
Zabetian et al. showed that the alleles for each SNP occur together at the following 
frequencies: AC = .296, AT = .205, and CG = .429.   
 Although there is no direct research on the effect of either the DBH 444 G/A or DBH 
-1021 C/T SNPs on catecholamine levels in the human brain, a study on DBH knockout 
mice showed that the gene directly affects the balance of catecholamines in the prefrontal 
cortex (PFC; Bourdélat-Parks et al., 2005). Results indicated that norepinephrine (NE) was 
absent in the PFC of -/- mice, but only slightly reduced in +/- animals compared to wild-
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type (+/+) animals. On the other hand, dopamine (DA) in the PFC was increased twofold in 
+/- mice, fivefold in -/- mice, and the NE to DA ratio was reduced by ~35% in +/- mice 
compared to wild-type mice. It is therefore postulated that DBH can act as a rate-limiting 
factor for NE synthesis, leading to less efficient conversion of DA to NE and elevating 
vesicular and synaptic DA:NE ratios (Cubells & Zabetian, 2004). This can be functionally 
important to regions that receive noradrenergic innervation and contain DA receptors, 
such as the PFC.  
 
DBH Predictions 
In terms of how polymorphisms in the DBH gene may affect cognition, Parasuraman 
et al. (2005) found that increasing gene dose of the G allele of the DBH 444 G/A SNP was 
associated with increased memory accuracy at the highest memory load (i.e. memory load 
of 3 dots) in a spatial memory task in middle-aged adults. This task required participants to 
remember the location(s) of 1, 2, or 3 dots over a short delay period and then indicate 
whether the location of a probe dot matched the location of one of the previously seen dots. 
This task required participants to update dot locations for each trial. Further, Greenwood 
et al. (2009) also found that G allele carriers in a mixed sample of young and old adults 
showed the best performance on a similar task.  
In regards to the DBH -1021 C/T SNP, Greene et al. (2009) showed a linear decrease 
in errors of commission in a Sustained Attention to Response Task (SART) for increasing C 
allele dosage in healthy middle-aged individuals. The SART is an attentional task that 
requires participants to respond continuously to a stream of single digits (1-9), and to 
withhold response to a low-frequency digit (3) occurring only 11% of the time. A button 
press when the low-frequency digit appears is considered an error of commission 
indicating a lack of response inhibition. Therefore, increasing C allele dosage was 
associated with increased inhibitory processing (i.e. better executive control). 
In both studies, better executive functioning was associated with the allele leading 
to increased DBH activity and a decrease in the DA/NE ratio translating to lower PFC DA 
levels. This seems counterintuitive to the extant literature indicating the importance of DA 
to executive functioning (e.g. Robbins, 2000; Cools & Robbins, 2004; Li, Lindenberger, & 
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Bäckman, 2010). However, it may be indicative of the delicate balance that needs to be 
maintained between the different neurotransmitters in the brain, such that more is not 
always better. With the severe age-related decline in DA and relative sparing of NE levels 
specific to the PFC (Goldman-Rakic & Brown, 1981), there may be a switch in the direction 
of the DBH genotypic effect across the lifespan. Therefore I predict that in the current study 
with a healthy older adult cohort, the alleles that translate to a higher PFC DA/NE ratio (i.e. 
A allele for DBH 444 G/A and T allele for DBH -1021 C/T) will be beneficial to both memory 
and executive processing (e.g. set switching and response inhibition) and thus show the 
best behavioral performance.  
 In regards to an interaction between the DBH gene x Fitness Level, I predict 
cardiorespiratory fitness level will have a stronger relationship to performance in carriers 
of the alleles that lead to a lower PFC DA/NE ratio (i.e. G allele for DBH 444 G/A and C allele 
for DBH -1021 C/T). This prediction is based on evidence that DA levels are increased by 
exercise and exercise can increase an individual’s fitness level. Therefore, carriers of the 
alleles leading to a lower PFC DA/NE ratio have more to gain from increasing 
cardiorespiratory fitness levels. 
 
DBH Results 
DBH 444 G/A (rs1108580) 
There were no significant differences between the genotypic groups on age, 
mMMSE, BMI or VO2 (Table 3.1). There was a marginal difference between the groups on 
education, but this should not affect the results since education was controlled for in all 
analyses. Chi-square analysis showed there were no differences in the distribution of males 
and females between the groups. Means and standard deviations for the primary measures 
on the behavioral tests are reported in Table 3.2. 
 
Verbal crystallized intelligence. Verbal crystallized intelligence is believed to 
remain relatively stable among older adults (Hedden & Gabrieli, 2004;  Park & Gutchess, 
2002). Therefore, I hypothesize that there will be no significant group differences on 
performance of the KBIT test, a measure of verbal crystallized intelligence. Further, I do not 
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expect the DBH 444 G/A x Fitness Level interaction to affect performance on the test of 
verbal crystallized intelligence. 
KBIT test. As predicted, there was no effect of the DBH 444 G/A SNP or interaction 
between DBH 444 G/A X Fitness Level on performance for the KBIT test. The sample size 
for the KBIT test was N = 194, with genotypic group sizes as follows: G/G = 40, G/A = 106, 
A/A = 48. Analysis of covariance (ANCOVA) showed no significant differences between the 
groups, F(2, 188) = 1.74, p = .178.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 159, with genotypic group sizes as follows: G/G = 35, G/A = 89, A/A = 35. 
Hierarchical regression showed that the interaction between DBH 444 G/A x Fitness Level 
did not significantly explain any variance on the age-scaled scores, ΔR2 = .007, ΔF(2, 150) = 
0.732, p = .483. 
 
Memory tests. Performance on working and spatial memory tests decrease in older 
adults, in contrast to general sparing in tests of short term memory (Hedden & Gabrieli, 
2004; Park & Gutchess, 2002). Previous literature in middle aged adults points to the G 
allele of the DBH 444 G/A SNP leading to better performance on tests of working and 
spatial memory (Greenwood et al., 2009; Parasuraman et al., 2005). However, I predict that 
in older adults, the A allele that leads to a higher DA:NE ratio will lead to better 
performance. Further, I expect an interaction between DBH 444 G/A and cardiorespiratory 
fitness level such that the G carriers (i.e. allele that leads to higher DA:NE ratio in animals; 
Cubells et al., 1998) will specifically show a positive relationship between behavioral 
performance and fitness level.  
Digit span test. The sample size for the digit span test was N = 196 with group sizes 
as follows: G/G = 40, G/A = 107, A/A = 49. There were no significant group differences on 
either version of the test: forward span, F(2, 190) < 1; backward span, F(2, 190) = 1.37, p = 
.257. When cardiorespiratory fitness level was added to the model, the sample size was 
reduced to N = 161 with group sizes as follows: G/G = 35, G/A = 90, A/A = 36. The 
interaction between DBH 444 G/A x Fitness Level did not significantly explain variance in 
the length of span for either forward span, ΔR2 = .008, ΔF(2, 152) = 0.691, p = .503, or 
backward span, ΔR2 = .003, ΔF(2, 152) = 0.233, p = .793. 
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Spatial memory test. This study did not find an effect of the DBH 444 G/A SNP on a 
spatial memory test as previously reported in Greenwood et al., (2009; N = 96) and 
Parasuraman et al. (2005; N = 103). The sample size for the spatial memory test was N = 
196 with genotypic group sizes as follows: G/G = 40, G/A = 107, A/A = 49. There were no 
significant differences between the genotypic groups for any memory load on either 
response time (RT) or error rate (ER; Table A.1).  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 161 with genotypic group sizes as follows: G/G = 30, G/A = 90, A/A = 36. 
There was no significant interaction between DBH 444 G/A x Fitness Level on either RT or 
ER for any memory load of the spatial memory test (Table 3.3). 
 
Executive control function tests. Aging is thought to have the greatest negative 
effect on performance of tests of executive control (Hedden & Gabrieli, 2004; Park & 
Gutchess, 2002) and age-related declines in the dopamine system are believed to 
contribute to this cognitive decline (Li & Rieckmann, 2014). Based on evidence that the A 
allele of the DBH 444 G/A SNP leads to a higher DA:NE ratio (Cubells et al., 1998), I predict 
carriers of the A allele will show better behavioral performance, while G allele carriers will 
specifically show a postitve relationship between behavioral performance and 
cardiorespiratory fitness levels. 
Task switch test. The sample size for the task switch test was N = 157, with 
genotypic group sizes as follows: G/G = 30, G/A = 90, A/A = 37. Analysis of covariance 
(ANCOVA) showed no significant differences between the genotypic groups on response 
time (RT) for either condition: single condition, F(2, 151) = 2.33, p = .101; mix condition, 
F(2, 151) = 1.06, p = .350. However, there was a significant effect of genotype on error rate 
(ER) for the single condition, F(2, 151) = 4.28, p = .016 (Figure A.1a), with bootstrapped 
pairwise comparisons revealing the G/A group had a marginally lower ER compared to the 
G/G group, mean difference = -.040, p = .058, 95% CI [-.084, -.002], and the A/A group, 
mean difference = -.039, p = .060, 95% CI [-.080, -.002]. There was also a marginal 
genotypic effect on ER in the mix condition, F(2, 151) = 2.79, p = .064, with the G/G group 
having marginally more errors compared to the G/A group, mean difference = .048, p = 
.083, 95% CI [.003, .092], and the A/A group, mean difference = .057, p = .069, 95% CI [.005, 
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.109]. Further, there was a significant difference between the groups on a global error cost 
score (i.e. mix condition ER – single condition ER), F(2, 151) = 3.34, p = .038 (Figure A.1b), 
with the A/A group showing a significantly lower cost compared to both the G/A group, 
mean difference = -.048, p = .031, 95% CI [-.094, -.004], and marginally lower than the G/G 
group, mean difference = -.056, p = .065, 95% CI [-0.12, 0.00]. 
Further analysis of the mix condition showed no effect of the DBH 444 G/A SNP on 
RT for either repeat, F(2, 151) = 2.13, p = .123, or switch trials, F(2, 151) < 1, but there was 
a marginal genotypic effect on ER for repeat trials, F(2, 151) = 2.60, p = .077. Bootstrapped 
pairwise comparisons showed the G/G group had marginally higher ERs compared to both 
the G/A group, mean difference = .044, p = .100, 95% CI [-.005, .098], and the A/A group, 
mean difference = .051, p = .089, 95% CI [-.007, .111] (Figure A.2). There was also a 
marginal effect on ER for switch trials, F(2, 151) = 2.61, p = .077, with the G/G group again 
showing marginally higher ERs compared to the other groups: G/G vs G/A, mean difference 
= .051, p = .094, 95% CI [-.006, .114]; G/G vs A/A, mean difference = .063, p = .066, 95% CI 
[-.002, .132] (Figure A.2). However, there was no significant effect on a local error cost (i.e. 
switch ER – repeat ER), F(2, 151) < 1. 
 These results suggest that the DBH 444 G/A genotype may influence performance at 
a global level, maintenance of two sets as opposed to switching between the two tasks sets. 
These results also follow the prediction I made that in older adults the A allele leads to 
better performance in contrast to the reported results in middle aged adults where the G/G 
group showed better performance. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the task switch test was reduced to N = 131, with genotypic group sizes as follows: G/G = 
26, G/A = 77, A/A = 28. There was no interaction between DBH 444 G/A x Fitness Level on 
response time (RT) for either condition: single condition, ΔR2 = .017, ΔF(2, 122) = 1.15, p = 
.320; mix condition, ΔR2 = .024, ΔF(2, 122) = 1.72, p = .183. For error rate (ER), there was 
no significant interaction effect for the single condition, ΔR2 = .002, ΔF(2, 122) < 1 (Figure 
3.1a), but the interaction did marginally explain 3.9% of the variance in ER for the mix 
condition, ΔR2 = .039, ΔF(2, 122) = 2.82, p = .063. Simple slopes analysis showed ER 
significantly decreased across the mix condition trial types with increasing VO2 for both the 
G/G group, B = -0.015,  = -1.19, t(122) = -3.25, p = -.008, 95% CI [-0.027, -0.003], and the 
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A/A group, B = -0.009,  = -0.73, t(122) = -2.02, p = .038, 95% CI [-0.018, -0.001], but not 
the G/A group, B = -0.003,  = -0.37, t(122) = -1.17, p = .188, 95% CI [-0.008, 0.002] (Figure 
3.1b). However, there was no significant effect on a global error cost score (i.e. mix 
condition ER – single condition ER), ΔR2 = .024, ΔF(2, 122) = 1.61, p = .205. 
Further analysis of the task switch test mix condition showed no interaction effect 
on RT for either repeat, ΔR2 = .018, ΔF(2, 122) = 1.26, p = .288, or switch trials, ΔR2 = .021, 
ΔF(2, 122) = 1.48, p = .232. There was also no interaction effect on ER for repeat trials, ΔR2 
= .019, ΔF(2, 122) = 1.34, p = .266 (Figure 3.2a), but there was a significant effect on ER for 
switch trials, ΔR2 = .057, ΔF(2, 122) = 4.308, p = .016. Simple slopes analysis showed a 
significant decrease in ER with increasing cardiorespiratory fitness level for the G/G group, 
B = -0.020,  = -1.41, t(122) = -3.93, p = .001, 95% CI[-0.032, -0.009], marginally for the A/A 
group, B = -0.009,  = -0.68, t(122) = -1.91, p = .057, 95% CI[-0.020, 0.000], but a non-
significant relationship in the G/A group, B = -0.004,  = -0.38, t(122) = -1.21, p = .175, 95% 
CI[-0.009, 0.002] (Figure 3.2b). However, there was no interaction effect on a local error 
cost (i.e. switch trial ER – repeat trial ER), ΔR2 = .022, ΔF(2, 148) = 1.76, p = .176. This 
suggests that cardiorespiratory fitness level may not affect the groups equally. 
 
DBH -1021 C/T (rs1611115) 
There were no significant differences between the T Carriers and C/C Homozygotes 
on age, BMI or VO2, however the groups did significantly differ on education and mMMSE 
(Table 3.4). Chi-square analysis revealed a significantly different distribution of males and 
females in the groups. For the C/C Homozygotes, there were more females and fewer males 
than expected, while the opposite was true for the T Carriers. However, these differences 
should not affect the results since sex and education were already planned to be used as 
control variables. Due to the difference found in mMMSE, it was also added as a control 
variable for the following analyses. Means and standard deviations for the primary 
measures on the behavioral tests are reported in Table 3.5. 
 
Verbal crystallized intelligence. Verbal crystallized intelligence remains relatively 
stable in older adult populations (Hedden & Gabrieli, 2004). I do not expect to find a 
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significant allelic or interaction effect on performance of the measure of verbal crystallized 
intelligence.  
KBIT test. The sample size for the KBIT test was N = 194, with allelic group sizes as 
follows: C/C Homozygotes = 136, T Carriers = 58. As expected, there were no significant 
differences between the allelic groups on the KBIT test, F(1, 188) < 1. When 
cardiorespiratory fitness level was added into the model, the sample size was reduced to N 
= 159 with allelic group sizes: C/C Homozygotes = 109, T Carriers = 50. There was no 
significant interaction effect on the age-scaled scores, ΔR2 = .003, ΔF(1, 151) < 1. 
 
Memory tests. Performance on working and spatial memory tests decrease in older 
adults, in contrast to general sparing in tests of short term memory (Hedden & Gabrieli, 
2004; Park et al., 2002). Further, the literature points to the DBH -1021 C/T SNP 
influencing both working and spatial memory, but not short term memory and I expect to 
find similar results in this study. Specifically, no allelic effect on a test of short-term 
memory (i.e. forward span), but that T Carriers will out perform the C/C Homozygotes on 
the tests of working (i.e. backward span) and spatial memory due to more availability of 
prefrontal dopamine. I also hypothesize an interaction effect on both the working and 
spatial memory tests such that the C/C Homozygotes will show a larger fitness effect, with 
no effect on the test of short term memory. 
Digit span test. The sample size for the digit span test was N = 196, with allelic 
group sizes as follows: C/C Homozygotes = 138, T Carriers = 58. The allelic groups showed 
no significant differences on the number of digits for the forward span, F(1, 190) < 1 or the 
backward span, F(1, 190) = 2.61, p = .108.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 161 with allelic groups as follows: C/C Homozygotes = 111, T Carriers = 50. 
The DBH -1021 C/T x Fitness Level interaction did not significantly explain any variance in 
forward span, ΔR2 = .009, ΔF(1, 153) = 1.59, p = .210 (Figure 3.3a), but the interaction did 
significantly explain 2.9% of the variance in backward span, ΔR2 = .029, ΔF(1, 153) = 6.00, p 
= .015. Although, simple slopes analysis showed a non-significant relationship between the 
length of span and cardiorespiratory fitness level for both C/C Homozygotes, B = -0.03, β = -
0.19, t(15) = -0.86, p = .396, 95% CI [-0.08, 0.04] and T Carriers, B = 0.09, β = 0.67, t(153) = 
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2.00, p = .103, 95% CI [-0.01, 0.20], the slopes were significantly different from each other, 
B = 0.12, β = 0.86, t(153) = 2.45, p = .032, 95% CI [0.01, 0.22] (Figure 3.3b). This suggests 
the relationship between working memory and cardiorespiratory fitness level differs for T 
Carriers and C/C Homozygotes.  
Spatial memory test. Furthermore, T Carriers showed faster response times (RT) 
across all memory loads (i.e. 1, 2, and 3) on the spatial memory test, significant for memory 
load 1 RT, F(1, 170) = 5.14, p = .025, mean difference = -65.43, p = .029, 95% CI [-122.79, -
6.16] and memory load 2 RT, F(1, 170) = 4.94, p = .028, mean difference = -62.50, p = .027, 
95% CI [-116.79, -7.09], marginal for memory load 3 RT, F(1, 170) = 2.34, p = .088, mean 
difference = -52.98, p = .083, 95% CI [-112.40, 6.54] (Figure A.3). The sample size was N = 
176 with allelic group sizes as follows: C/C Homozygotes = 122, T Carriers = 54. Further, 
there were no significant differences on error rate (ER) for any memory load suggesting 
the differences in RT were not due to speed accuracy tradeoffs: memory load 1, F(1, 170) = 
1.36, p = .245; memory Load 2, F(1, 170) = 1.34, p = .249; memory load 3, F(1, 170) < 1.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 144 with allelic group sizes as follows: C/C Homozygotes = 98, T Carriers = 
46. The interaction between DBH -1021 C/T x Fitness Level had no significant effect on RT 
or ER for any memory load (Table 3.6). 
 Taken together, these results suggest the DBH -1021 C/T SNP influences working 
and spatial memory, but not short term memory. Further, the -1021 C/T SNP moderates 
the relationship between cardiorespiratory fitness level and spatial memory.  
 
Executive control function tests. Aging is thought to have the greatest negative 
effect on performance of tests of executive control (Hedden & Gabrieli, 2004; Park & 
Gutchess, 2002). C/C Homozygotes have less DBH activity, implying a lower DA:NE ratio 
(Hess et al., 2009), and have been shown to perform worse on some measures of executive 
control (Greene et al., 2009). Therefore, I expect to find the same allelic effect (i.e. C/C 
Homozygotes show poor performance) on the following tests of executive control function. 
Further, higher levels of fitness are associated with better performance on measures of 
executive control (Colcombe et al., 2004a). Taken together, I expect to find an interaction 
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effect such that the C/C Homozygotes will show a benefit from increasing cardiorespiratory 
fitness level, but the T Carriers will not show this relationship. 
Flanker test. For the Flanker test, the sample size was N = 187 with allelic group 
sizes as follows: C/C Homozygotes = 132, T Carriers = 55. The T Carriers were significantly 
faster than C/C Homozygotes on both trial types: congruent, F(1, 181) = 4.13, p = .044, 
mean difference = -29.83, p = .051, 95% CI [-59.33, 0.50]; incongruent, F(1, 181) = 4.09, p = 
.045, mean difference = -36.58, p = .049, 95% CI [-72.23, -0.61] (Figure A.4), but there was 
no difference between the groups on an RT cost score (i.e. incongruent trial RT – congruent 
trial RT), F(1, 181) < 1. Further, there were no differences between the groups on error 
rate (ER) for congruent, F(1, 181) < 1, or incongruent trial types, F(1, 181) = 1.21, p = .272, 
again suggesting differences in RT were not due to a speed accuracy tradeoff. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 153 with allelic group sizes as follows: C/C Homozygotes = 105, T Carriers = 
48. The interaction between DBH -1021 C/T x Fitness Level did not significantly explain 
any variance in RT or ER for either congruent or incongruent trial types (Table 3.7). 
Wisconsin card sort test (WCST). The sample size was N = 182 with allelic group 
sizes as follows: C/C Homozygotes = 131, T Carriers = 51.  There were no group differences 
on performance of the WCST measured by total errors or percent perseverative errors, 
both F(1, 176) < 1. When cardiorespiratory fitness level was added into the model, the 
sample size was reduced to N = 150 with allelic group sizes as follows: C/C Homozygotes = 
107, T Carriers = 43. The interaction significantly explained 3.1% of the variance in total 
errors, ΔR2 = .031, ΔF(1, 142) = 5.28, p = .023. Simple slopes analysis showed WCST total 
errors significantly decreased with increasing cardiorespiratory fitness levels for the T 
Carriers, B = -2.10, β = -0.95, t(142) = -2.58, p = .004, 95% CI [-3.57, -0.64], but not for C/C 
Homozygotes, B = -0.13, β = -0.12, t(142) = -0.24, p = .809, 95% CI [-1.21, 0.84] (Figure 
3.4a). The interaction also marginally explained 2.1% of the variance in percent 
perseverative errors, ΔR2 = .021, ΔF(1, 142) = 3.33, p = .070. However, simple slopes 
analysis revealed a non-significant relationship between percent perseverative errors and 
cardiorespiratory fitness level for both T Carriers, B = -0.65, β = -0.78, t(142) = -2.05, p = 
.109, 95% CI [-1.53, 0.11], and C/C Homozygotes, B = -0.04, β = -0.01, t(142) = -0.20, p = 
.851, 95% CI [-0.47, 0.36]. Further, the bootstrapped regression results showed the slopes 
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were not significantly different from each other, B = -0.61, β = -0.73, t(142) = -1.82, p = 
.156, 95% CI [-1.48, 0.19] (Figure 3.4b).  
 
Task switch test. The sample size was N = 156 with allelic group sizes as follows: 
C/C Homozygotes = 107, T Carriers = 50. There were no significant differences between the 
allelic groups on response time (RT) for the single condition, F(1, 151) < 1, but the T 
Carriers were significantly faster during the mix condition F(1, 151) = 6.20, p = .014, mean 
difference = -62.63, p = .016, 95% CI [-113.36, -13.37] (Figure A.5a). Furthermore, T 
Carriers showed a significantly lower global RT cost (i.e. mix condition RT – single 
condition RT), F(1, 151) = 5.21, p = .024, mean difference = -50.71, p = .014, 95% CI [-92.19, 
-9.81] (Figure A.5b). There were no allelic differences on error rate (ER) for either the 
single condition, F(1, 151) < 1, or the mix condition, F(1, 151) = 1.85, p = .176 (Figure A.5c). 
However, there was a marginal allelic effect on a global error cost score (i.e. mix condition 
ER – single condition ER), F(1, 151) = 3.88, p = .051, with T Carriers showing a lower cost to 
the mix compared to the single condition in terms of error rate compared to the C/C group, 
mean difference = -.037, p = .058, 95% CI [-.075, .001] (Figure A.5d). Thus T Carriers were 
not only faster, but also more accurate overall. 
Further analysis of the task switch test mix condition showed T Carriers were 
marginally faster than C/C Homozygotes on RT for repeat trials, F(1, 151) = 2.97, p = .087, 
mean difference = -42.95, p = .079, 95% CI [-89.77, 6.16], and significantly faster on switch 
trials, F(1, 151) = 6.28, p = .013, mean difference = -82.31, p = .017, 95% CI [-146.96, -
15.73] (Figure A.6a). There were no differences on ER for either repeat trials, F(1, 151) = 
2.50, p = .116, or switch trials, F(1, 151) = 1.20, p = .276. Further, there were no group 
differences on local cost scores (i.e. switch trial – repeat trial) for either RT, F(1, 151) = 
1.77, p = .184, or ER, F(1, 151) < 1. T Carriers were faster and more accurate overall, 
suggesting they are better at maintaining and switching between two memory sets. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 131 with allelic group sizes as follows: C/C Homozygotes = 88, T Carriers = 
43. The interaction between DBH -1021 C/T  X Fitness Level did not show a significant 
effect on RT or ER for any condition or trial type (Table 3.8). 
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Dual task test. The sample size for the dual task test was N = 158 with allelic group 
sizes as follows: C/C Homozygotes = 108, T Carriers = 50. T Carriers showed significantly 
faster response times (RT) on both single trials, F(1, 152) = 4.82, p = .030, mean difference 
= -62.06, p = .014, 95% CI [-113.51, -13.48], and marginally on dual trials, F(1, 152) = 2.77, 
p = .098, mean difference = -55.11, p = .091, 95% CI [-118.77, 9.57] (Figure A.7). Further, 
there were no differences between the groups on error rate (ER) for either single or dual 
trials, both F(1, 152) < 1, indicating there was not a speed accuracy tradeoff. There were 
also no group differences on cost scores (i.e. dual trial – single trial) RT, F(1, 153) < 1, or 
ER, F(1, 152) = 1.38, p = .242.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 151 with allelic group sizes as follows: C/C Homozygotes = 103, T Carriers = 
48. The interaction again did not show a significant effect on RT or ER for any trial type 
(Table 3.9). 
 
DBH Combined SNPs 
To further study the effects of the DBH gene on cognition in healthy older adults, I 
conducted an analysis using a combination of the two SNPs. I created a DBH Low DA group 
(i.e. high DBH translating to low DA:NE) which included those that were G/G Homozygotes 
on DBH 444 G/A and C/C Homozygotes on DBH -1021 C/T. I compared this group to a DBH 
High DA group (i.e. low DBH translating to high DA:NE) which included those that were 
A/A Homozygotes on the DBH 444 G/A SNP and carried the T allele on DBH -1021 C/T.  
There were no significant differences between the DBH Low DA and DBH High DA 
groups on age, education, BMI or VO2; however, the groups did significantly differ on 
mMMSE (Table 3.10). Chi-square analysis revealed a marginal difference on the 
distribution of males and females in the groups. For the DBH Low DA group, there were 
more females and fewer males than expected, while the opposite was true for the DBH High 
DA group. However, this difference should not affect the results since sex was already 
planned to be used as control variable. Due to the difference found in mMMSE, it was also 
added as a control variable for the following analyses. Means and standard deviations for 
the primary measures on the behavioral tests are reported in Table 3.11. 
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Verbal crystallized intelligence. Since verbal crystallized intelligence remains 
relatively stable in older adult populations (Hedden & Gabrieli, 2004), I do not expect to 
find a significant allelic or interaction effect on performance for any of following measures 
of verbal crystallized intelligence.  
KBIT test. The sample size for the KBIT test was N = 49, with group sizes as follows: 
DBH Low DA = 32 and DBH High DA = 17. There were no group differences on the age-
scaled scores for the K-BIT test, F(1, 43) = 1.44, p = .237. When cardiorespiratory fitness 
level was added into the model, the sample size was reduced to N = 41 with group sizes as 
follows: DBH Low DA = 28 and DBH High DA = 13. The interaction between DBH x Fitness 
Level did not significantly explain any variance in age-scaled scores,  
ΔR2 = .000, ΔF(1, 33) < 1. 
 
Memory tests. Performance on working and spatial memory tests decrease in older 
adults, in contrast to general sparing in tests of short term memory (Hedden & Gabrieli, 
2004; Park et al., 2002). I predict that there will be no effect of DBH gene status on the test 
of short-term memory (i.e. forward span), but that the DBH High DA group will out perform 
the DBH Low DA group on the tests of working (i.e. backward span) and spatial memory 
due to more availability of prefrontal dopamine. I further hypothesize an interactive effect 
for both the working and spatial memory test such that there will be a larger effect of 
cardiorespiratory fitness level in the DBH Low DA group, with no effect on the test of short 
term memory. 
Digit span test. The sample size for the digit span test was N = 49, with group sizes 
as follows: DBH Low DA = 32, DBH High DA = 17.  There were no differences between 
groups on the length of span for either the forward span, F(1, 43) < 1, or the backward 
span, F(1, 43) = 1.63, p = .208.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 41 with group sizes as follows: DBH Low DA = 28, DBH High DA = 13. The 
interaction between DBH x Fitness Level did not significantly explain any variance in the 
forward span, ΔR2 = .000, ΔF(1, 33) < 1, or backward span, ΔR2 = .052, ΔF(1, 33) = 2.31, p = 
.097.  
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Spatial memory test. The sample size was N = 49, with group sizes as follows: DBH 
Low DA = 28, DBH High DA = 16. The DBH High DA group showed a trend towards faster 
response times (RT) compared to the DBH Low DA group across all memory loads: 
memory load 1 RT, F(1, 38) = 2.55, p = .118, mean difference = -85.66, p = .094, 95% CI [-
184.78, 9.90]; memory load 2 RT, F(1, 38) = 3.36, p = .074, mean difference = -91.35, p = 
.080, 95% CI [-190.59, 7.11]; memory load 3 RT, F(1, 38) = 3.66, p = .063, mean difference = 
-104.08, p = .063, 95% CI [-214.27, 6.11]. Further, there were no significant differences on 
error rate (ER) for any memory load: memory load 1, F(1, 38) < 1; memory load 2, F(1, 38) 
= 1.41, p = .243; memory load 3, F(1, 38) < 1, suggesting potential differences in RT were 
not due to speed accuracy tradeoffs.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 36 with group sizes as follows: DBH Low DA = 24, DBH High DA = 12. The 
interaction between DBH x Fitness Level had no significant effects on RT or ER for any 
memory load (Table 3.12). 
 
Executive control function tests. Aging is thought to have the greatest negative 
effect on performance of tests of executive control (Hedden & Gabrieli, 2004; Park & 
Gutchess, 2002). Both the G allele for DBH 444 G/A and the C allele for the DBH -1021 C/T 
are thought to result in less DBH activity (Hedden & Gabrieli, 2004; Park & Gutchess, 2002) 
implying a lower DA:NE ratio which may lead to worse performance on some measures of 
executive control (Greene et al., 2009). In contrast, higher levels of cardiorespiratory 
fitness are associated with better performance on measures of executive control (Colcombe 
& Kramer, 2003; Kramer & Erickson, 2007). Therefore, I expect the DBH High DA group 
will outperform the DBH Low DA group, but that there will be a positive effect of 
cardiorespiratory fitness level within the DBH Low DA group. 
Flanker test. For the Flanker test, the sample size was N = 47 with group sizes as 
follows: DBH Low DA = 32, DBH High DA = 15. As predicted, the DBH High DA group was 
significantly faster than the DBH Low DA group on both trial types: congruent, F(1, 41) = 
4.96, p = .031, mean difference = -77.53, p = .058, 95% CI [-158.23, -3.81]; incongruent, F(1, 
41) = 5.11, p = .029, mean difference = -89.48, p = .045, 95% CI [-179.08, -13.43] (Figure 
A.8). Further, there were no differences between the groups on error rate (ER) for 
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congruent trials, F(1, 41) =1.04, p = .314, or incongruent trial types, F(1, 41) = 1.84, p = 
.182, suggesting differences in RT were not due to a speed accuracy tradeoff. However, 
there was no difference on a RT cost score (i.e. incongruent RT – congruent RT), F(1, 41) < 
1, suggesting that the DBH gene may influence overall performance of the task and not 
specifically the more demanding incongruent trial types. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 40 with group sizes as follows: DBH Low DA = 28, DBH High DA = 12. The 
interaction between DBH x Fitness Level did not significantly explain any variance in RT or 
ER for either congruent or incongruent trial types (Table 3.13). 
Task switch test. For the task switch test, the sample size was N = 42 with group 
sizes as follows: DBH Low DA = 25, DBH High DA = 17. ANCOVA showed no group 
differences on response time (RT) or error rate (ER) for either the single or the mix 
condition (Table A.2). However, the DBH High DA group showed a marginally lower global 
ER cost (i.e. mix condition ER – single condition ER), F(1, 36) = 3.17, p = .083, mean 
difference = -.074, p = .094, 95% CI [-.161, .005] (Figure A.9).  
Further analysis of the task switch test mix condition showed no significant group 
differences on RT or ER for either repeat or switch trials (Table A.2). There was no 
difference on a local cost score (i.e. switch trial – repeat trial) for either RT, F(1, 36) = 1.24, 
p = .272, or ER, both F(1, 36) < 1.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 41 with group sizes as follows: DBH Low DA = 28, DBH High DA = 13. The 
interaction between DBH X Fitness Level did not show a significant effect on RT or ER for 
either condition (Table 3.14). Further analysis of the mix condition showed no differences 
between the groups on RT or ER for either trial type (Table 3.14). However, the interaction 
did significantly explain 10.2% of the variance in local ER cost (i.e. switch trial ER – repeat 
trial ER), ΔR2 = .102, ΔF(1, 27) = 4.83, p = .037. Simple slopes analysis revealed local ER cost 
decreased with increasing VO2 for the DBH low DA group, B = -0.012, β = -1.84, t(27) = -
3.57, p = .001, 95% CI [-.019, -.005], but not the DBH High DA group, B = -0.003, β = -0.47, 
t(27) = -0.80, p = .430, 95% CI [-.011, .005] (Figure 3.18b). 
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Catechol-O-Methyltransferase 
The Catechol-O-Methyltransferase (COMT) gene encodes for a methylation enzyme 
that metabolizes catecholamines including dopamine (Axelrod & Tomchick, 1958). 
Although the enzyme has a wide distribution throughout the body and brain, it plays a key 
role in the prefrontal cortex where there is a low level of dopamine transporters (DAT; 
Chen et al., 2004). Therefore, prefrontal synaptic dopamine (DA) is mostly inactivated by 
diffusion, receptor internalization, and COMT action. This is evidenced by studies in COMT-
knockout mice that show increased DA levels in the PFC, in contrast to normal DA levels in 
the striatum, a brain area where DATs are abundant (Gogos et al., 1998; Karoum, 
Chrapusta, & Egan, 1994). Since COMT seems to control the basal DA neurotransmission 
levels within the PFC, it is a great candidate for possible individual differences in human 
behavior. To investigate this possibility, two common SNPs have been studied in the COMT 
gene, COMT Val158Met (rs4680), which affects enzymatic activity, and COMT C/G 
(rs4818), which affects enzyme availability.  
COMT Val158Met is a functional SNP that causes a methionine (Met) to replace a 
valine (Val) in the amino acid sequence at codon 158. This change to Met produces a less 
thermostable enzyme, such that the Met/Met variant shows 40% less enzymatic activity 
compared to the Val/Val, resulting in higher PFC DA levels (Chen et al., 2004; Lotta et al., 
1995; Savitz et al., 2006). Through positron emission tomography, Slifstein et al. (2008) 
showed that young adult Val homozygotes had higher levels of D1 receptor binding in 
cortical and limbic regions compared to Met allele carriers, indicative of lower DA tone. 
This differential effect was not found in striatal regions as would be predicted due to the 
differential distribution of the DAT between cortical and striatal regions. 
Another SNP, COMT C/G, affects mRNA secondary structure, consequently affecting 
protein synthesis, but not the functioning of the enzyme itself (Nackley et al., 2006). 
Carriers of the C allele are believed to have lower COMT activity due to less efficient protein 
synthesis (Diatchenko et al., 2005; Nackley et al., 2006). However, to date, there have not 
been any studies investigating the differential effects of the COMT C/G SNP on levels of DA 
in the human brain.  
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COMT Predictions 
In relation to behavior, due to the higher activity COMT, Val allele carriers for the 
COMT Val158Met are hypothesized to perform worse on PFC-mediated executive control 
tasks (Chen et al., 2004; Egan et al., 2001; Goldberg et al., 2003; Malhotra et al., 2002; 
Mattay & Goldberg, 2004). Many studies have shown this relationship between the COMT 
Val158Met genotype and executive performance such that Met homozygotes do tend to 
outperform Val homozygotes on tasks requiring executive processing specifically and not 
tasks in other domains (Egan et al., 2001; Goldberg et al., 2003; Malhotra et al., 2002; Nagel 
et al., 2008; Savitz et al., 2006). For example, Egan et al. (2001) showed Val homozygotes 
committed significantly more perseverative errors compared to Met homozygotes on the 
Wisconsin Card Sorting Task (WCST), which showed an inability to flexibly adapt to a new 
rule. This effect was similar in normal subjects and schizophrenic patients, indicating the 
effect of variation was not related to the disease, but rather a generalizable human 
characteristic. Further, Goldberg et al. (2003) showed that Val homozygotes, compared to 
Met homozygotes, were significantly less accurate on the 1-back and 2-back conditions of 
an N-back task, revealing a deficit in working memory. Mattay et al. (2004) also showed 
that Val homozygotes made more perseverative errors on the WCST, but were matched on 
performance at all levels (1, 2, and 3-back) of an N-back task with Met homozygotes. 
Interestingly, administration of amphetamine (AMP; which increases PFC dopamine levels) 
to Val homozygotes improved response time, but not accuracy on the 3-back version of the 
N-back task and decreased perseverative errors on the WCST. In contrast, AMP 
administration to Met homozygotes diminished performance on both the 3-back task and 
WCST. This data is consistent with evidence that DA impacts PFC function in an inverted U-
shaped curve, and shows that the COMT Val158Met genotype can modify the relationship 
between dopamine availability in the PFC and executive functioning.  
The majority of studies have used young to middle-aged participants, but the 
question then arises as to whether the same results would be found in older adults due to 
aging-related declines in the DA system. Addressing this question, Nagel et al. (2008) 
showed that human aging magnifies the effect of the COMT Val158Met genotype on 
executive functioning such that only older adult Val homozygotes showed a higher number 
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of perseverative errors on the WCST. An association between COMT Val158Met genotype 
and number of perseverative errors was not found in their younger adult population. 
There are fewer studies exploring the effects of the COMT C/G polymorphism on 
cognition; however, Roussos et al. (Roussos, Giakoumaki, & Bitsios, 2009; Roussos, 
Giakoumaki, Pavlakis, & Bitsios, 2008) has found that the G/G genotype performs worse on 
tasks of executive control. In 2008, they found that young healthy males with the G/G 
genotype performed worse on the Stockings of Cambridge test (a modified, computerized 
version of the Tower of London), but better on the Iowa Gambling Test (a test requiring 
emotionally informed decision-making). In 2009, again using healthy young males, they 
found that the G/G genotype had a slower response time in an N-back test compared with 
the C/C genotype, and that Tolcapone (a COMT inhibitor) improved response times only for 
the G/G group.  
Although results have been equivocal, it is apparent that the COMT genotype is 
playing some role in PFC mediated cognitive functioning and this relationship may increase 
as a function of age. Therefore, I predict that in the current study there will be an 
interaction between Fitness Level and COMT genotypes such that the Val carriers and G 
carriers will show a positive relationship between cardiorespiratory fitness level and 
behavior, but the other genotypes will not. 
 
COMT Results 
COMT Val158Met (rs4680) 
There were no significant differences between the Val carriers and Met/Met 
Homozygotes on age, education, mMMSE, Body Mass Index (BMI) or VO2 (Table 3.14). Chi-
square analysis showed no differences in the distribution of males and females between 
the groups. Means and standard deviations for the primary measures on the behavioral 
tests are reported in Table 3.15 
 
Verbal crystallized intelligence. Verbal crystallized intelligence is believed to 
remain relatively stable in older adults (Hedden & Gabrieli, 2004; Park & Gutchess, 2002). I 
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hypothesize that there will be no significant differences between the genotypic groups on 
performance of the KBIT test, nor a significant interaction effect with fitness level. 
KBIT Test. The sample size for the KBIT test was N = 193 with the genotypic group 
sizes as follows: Val/Val = 31, Val/Met = 105, Met/Met = 57. Analysis of covariance 
(ANCOVA) showed no differences between the genotypes, F(2, 187) < 1, suggesting COMT 
Val158Met does not affect verbal crystallized intelligence. When cardiorespiratory fitness 
level was added to the model, the sample size for the KBIT test was reduced to N = 158 
with genotypic group sizes as follows: Val/Val = 27, Val/Met = 85, Met/Met = 46. 
Hierarchical regression showed the interaction between COMT Val158Met X Fitness Level 
did not significantly explain any variance in age-scaled scores, ΔR2 = .009, ΔF(2, 149) < 1. 
 
Memory tests. Performance on working and spatial memory tests decrease in older 
adults, in contrast to general sparing in tests of short-term memory (Hedden & Gabrieli, 
2004; Park & Gutchess, 2002). In terms of the COMT Val158Met SNP, Val carriers are 
believed to have lower prefrontal dopamine levels and perform worse on working and 
spatial memory measures compared to Met/Met homozygotes. Therefore, I predict there 
will be no genotypic effect on the test of short-term memory, but the Met/Met homozygotes 
will outperform any Val carriers. Furthermore, higher cardiorespiratory fitness levels are 
associated with better performance on measures of working and spatial memory. 
Therefore, I expect there will be no Genotype x Fitness Level interaction effect on the test of 
short-term memory, but the Val/Val homozygotes will show better performance on the 
measures of short term and spatial memory with increasing cardiorespiratory fitness 
levels.  
 Digit span test. The sample size for the digit span test was N = 195, with the 
genotypic group sizes as follows: Val/Val = 31, Val/Met = 107, Met/Met = 57. There were     
no significant differences between the genotypic groups on forward span, F(2, 189) = 1.05, 
p = .352 (Figure A.10). However, there was a marginal genotypic effect on the backward 
span, F(2, 189) = 2.45, p = .089 (Figure A.10). Bootstrapped pairwise comparisons revealed 
the Val/Val Homozygotes repeated more digits compared to both the Val/Met 
heterozygotes, mean difference = 0.53, p = .048, 95% CI [0.02, 1.01] and the Met/Met 
homozygotes, mean difference = 0.60, p = .040, 95% CI [0.04, 1.19]. There was not a 
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significant difference between the Val/Met heterozygotes and the Met/Met homozygotes, 
mean difference = .067, p = .787, 95% CI [-0.32, 0.47]. These results were inconsistent with 
the prediction. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 160, with genotypic group sizes as follows: Val/Val = 27, Val/Met = 87, 
Met/Met = 46. As expected, the interaction did not explain a significant amount of variance 
for the forward span, ΔR2 = .016, ΔF(2, 151) = 1.22, p = .271 (Figure 3.6a), but did 
significantly explain 5.4% of the variance for the backward span, ΔR2 = .054, ΔF(2, 151) = 
4.99, p = .008 (Figure 3.6b). Simple slopes analysis revealed a significant relationship 
between the number of digits and cardiorespiratory fitness level only for the Val/Val group, 
B = 0.24, β = .272, t(151) = 3.20, p = .000, 95% CI [0.09, 0.36], while the other two genotypic 
groups did not show a significant relationship, Val/Met, B = -0.00, β = -.010, t(151) = -0.12, 
p = .919, 95% CI [-0.07, 0.08], and Met/Met, B = 0.00, β = .000, t(151) = -0.01, p = .995, 95% 
CI [-0.08, 0.09]. These results followed prediction that increasing fitness level would 
specifically influence the Val/Val Homozygotes. 
Spatial memory test. The sample size for the spatial memory test was N = 175, with 
the genotypic group sizes as follows: Val/Val = 28, Val/Met = 96, Met/Met = 51. Analysis of 
covariance (ANCOVA) showed COMT Val158Met had a significant effect on response time 
(RT) for all memory loads: memory load 1, F(2, 169) = 4.81, p = .009; memory load 2, F(2, 
169) = 4.13, p = .018; memory load 3, F(2, 169) = 6.41, p = .002 (Figure A.11). Bootstrapped 
pairwise comparisons revealed the Met/Met homozygotes were significantly slower than 
both the Val/Val Homozygotes and Val/Met heterozygotes (Table A.3). There were no 
group differences on error rate (ER) for any memory load, suggesting there was no speed 
accuracy trade off: memory load 1, F(2, 169) < 1; memory load 2, F(2, 169) = 1.04, p = .355; 
memory load 3, F(2, 169) < 1. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the Spatial Memory test was reduced to N = 143 with genotypic group sizes as follows: 
Val/Val = 25, Val/Met = 77, Met/Met = 41. Although, a genotypic effect was seen, the 
interaction between COMT Val158Met x Fitness Level did not have a significant effect on 
either RT or ER for any memory load of the spatial memory test (Table 3.17). 
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Executive control function tests. Older adults have been shown to have decreasing 
performance on tests of executive control function , but higher levels of fitness tend to be 
associated with better executive control (Bherer, Erickson, & Liu-Ambrose, 2013; 
Colcombe & Kramer, 2003; Prakash et al., 2015). The Val allele is biologically associated 
with lower levels of prefrontal dopamine and behaviorally with worse performance on 
tests of executive control (Goldberg & Weinberger, 2004). Therefore, I expect a significant 
effect of COMT Val158Met Genotype such that Met/Met homozygotes will outperform Val 
carriers. Further, I expect cardiorespiratory fitness level to have a greater affect on 
performance in Val carriers compared to Met/Met homozygotes. 
 Wisconsin card sorting test (WCST). The sample size for the Wisconsin Card 
Sorting Test was N = 181 with genotypic group sizes as follows: Val/Val = 28, Val/Met = 98, 
Met/Met = 55. Against prediction, ANCOVA showed COMT Val158Met did not have an effect 
on either total errors, F(2, 175) < 1, or percent perseverative errors, F(2, 175) = 1.47, p = 
.234. 
When cardiorespiratory fitness level was added to the model, the sample size for the 
WCST was reduced to N = 149, with genotypic group sizes as follows: Val/Val = 24, Val/Met 
= 81, Met/Met = 44. The interaction did not significantly explain any variance for the two 
measures of the WCST: total errors, ΔR2 = .019, ΔF(2, 140) = 1.53, p = .221; percent 
perseverative errors, ΔR2 = .029, ΔF(2, 140) = 2.26, p = .108.  
Flanker test. The sample size for the Flanker test was N = 186, with genotypic group 
sizes as follows: Val/Val = 30, Val/Met = 101, Met/Met = 55. There was a marginal effect of 
the COMT Val158Met genotype on response time for congruent trials, F(2, 180) = 2.55, p = 
.081, and a significant effect for incongruent trials, F(2, 180) = 3.47, p = .033 (Figure A.12a). 
Unexpectedly, bootstrapped pairwise comparisons revealed that Met/Met homozygotes 
had the slowest response times, and the Val/Val Homozygotes were fastest, for both 
congruent and incongruent trials (Table A.4). There was not a significant difference for ER 
for congruent trials, F(2, 180) = 1.45, p = .238, however, there was a significant group 
difference on error rate (ER) for incongruent trials, F(2, 180) = 4.63, p = .011 (Figure 
A.12c), with the Val/Val group showing the highest ER compared to the other groups 
(Table A.4). There was also a group difference on an ER cost (i.e. Incongruent ER – 
Congruent ER), F(2, 180) = 3.86, p = .023 (Figure A.12d). This could be an indication of the 
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Val/Val homozygotes trading speed for accuracy. There was no significant genotypic effect 
on an RT cost score (i.e. incongruent RT – congruent RT), F(2, 180) = 1.15, p = .320 (Figure 
A.12b). 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 152 with genotypic group sizes as follows: Val/Val = 27, Val/Met = 81, 
Met/Met = 44. The interaction between COMT Val158Met x Fitness Level marginally 
explained 3.5% of the variance in RT for congruent trials, ΔR2 = .035, ΔF(2, 143) = 2.90, p = 
.058. The results suggest there was a difference in the direction of the relationship between 
response and cardiorespiratory fitness level between the groups: Val/Val vs Val/Met, B = 
10.24, β = .403, t(143) = 2.06, p = .060, 95% CI [0.43, 22.87]; Val/Val vs Met/Met, B = 12.61, 
β = .383, t(143) = 2.40, p = .031, 95% CI [1.74, 25.63] (Figure 3.7).  However, simple slopes 
analysis showed there was a non-significant relationship between response time and 
fitness level on congruent trials for each of the genotypic groups (Table 3.19). The 
interaction did not explain variance in RT for incongruent trials or ER for either congruent 
or incongruent trial types (Table 3.18). xxx 
Dual task test. The sample size for the dual task test was N = 157, with the 
genotypic group sizes as follows: Val/Val = 27, Val/Met = 83, Met/Met = 47. ANCOVA 
showed significant differences between the genotypic groups on response time (RT) for 
both single, F(2, 157) = 4.07, p = .019, and dual trial types, F(2, 151) = 5.50, p = .005, with 
Val/Val homozygotes being the fastest (Figure A.13a; Table A.5). There were also 
differences between the groups on error rate (ER) for both single, F(2, 157) = 2.99, p = .054, 
and dual trial types, F(2, 157) = 4.22, p = .017 (Figure A.13c; Table A.5). Val/Val 
homozygotes showed lower error rates, suggesting there was not a speed accuracy 
tradeoff. There were no group differences on an RT cost score (i.e. dual RT – single RT), F(2, 
151) = 2.16, p = .118 (Figure A.13b), but there was a marginal difference on an ER cost 
score (i.e. dual ER – single ER), F(2, 151) = 2.44, p = .091. Bootstrapped pairwise 
comparisons showed the Val/Val group had the lowest ER cost (Figure A.13d; Table A.5). 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 150, with genotypic group sizes as follows: Val/Val = 26, Val/Met = 81, 
Met/Met = 43. For response time, the interaction between COMT Val158Met x Fitness Level 
did not significantly explain any variance for either single trials, ΔR2 = .002, ΔF(2, 141) < 1, 
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or dual trials, ΔR2 = .010, ΔF(2, 141) < 1. However, the interaction did marginally explain 
3.1% of variance in a RT cost score (i.e. dual RT – single RT), ΔR2 = .031, ΔF(2, 141) = 2.55, p 
= .082 (Figure 3.8). Simple slopes analysis revealed an odd result suggesting cost 
significantly increased with increasing VO2 for the Val/Met heterozygotes, B = 7.99, β = 
.222, t(141) = 2.37, p = .025, 95% CI [0.70, 14.75], but not for the Val/Val group, B = 0.86, β 
= .012, t(141) = 0.13, p = .873, 95% CI [-10.14, 11.17], or the Met/Met group, B = -2.20, β = -
.048, t(141) = -0.54, p = .572, 95% CI [-9.40, 5.78]. Further, the slope for the Val/Met group 
was significantly different than the Met/Met group, B = -10.19, β = -.223, t(141) = -2.20, p = 
.031, 95% CI [-19.27, -0.75], but not different than the Val/Val group, B = -7.13, β = -.10, 
t(141) = -1.01, p = .217, 95% CI [-20.43, 4.81]. 
 
COMT C/G (rs4818) 
 There were no significant differences between the G Carriers and C/C Homozygotes 
on age, education, mMMSE, or VO2 (Table 3.20). The C/C Homozygotes did have a 
significantly lower BMI, t(82) = 2.71, p = .008. Chi-square analysis showed no differences in 
the distribution of males and females between the groups. Means and standard deviations 
for the primary measures on the behavioral tests are reported in Table 3.21. 
 
Verbal crystallized intelligence. Verbal crystallized intelligence is believed to 
remain relatively stable among older adults (Hedden & Gabrieli, 2004; D.C Park & Gutchess, 
2000). I hypothesize there will be no differences on performance of any of the following 
measures between the genotypic groups for the COMT C/G SNP. 
KBIT test. The sample size for the KBIT test was N = 193, with genotypic group sizes 
as follows: G Carriers = 113, C/C Homozygotes = 80. Following prediction, analysis of 
covariance (ANCOVA) showed no significant differences between the genotypic groups on 
age-scaled scores, F(1, 188) < 1. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 158, with allelic group sizes as follows: G Carriers = 92, C/C Homozygotes = 
66. Again following prediction, hierarchical regression showed the interaction between 
COMT C/G x Fitness Level did not significantly explain any variance in the age-scaled 
scores, ΔR2 = .000, ΔF(1, 151) < 1.  
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 Memory tests. Performance on working and spatial memory tests decreases in 
older adults, in contrast to general sparing in tests of short term memory (Hedden & 
Gabrieli, 2004; D.C Park & Gutchess, 2000). In terms of the COMT C/G SNP, G carriers have 
been shown to have lower prefrontal dopamine levels and perform worse on working and 
spatial memory measures compared to C/C Homozygotes. Therefore, I predict there will be 
no genotypic effect on the test of short-term memory, but the C/C Homozygotes will 
perform better than G Carriers on the tests of working and spatial memory. 
Digit span test. The sample size was N = 195 with allelic group sizes as follows: G 
Carriers = 115, C/C Homozygotes = 80. Analysis of covariance (ANCOVA) showed there 
were no differences between the groups on forward span, F(1, 190) < 1, but for backward 
span, G Carriers had marginally longer spans, F(1, 190) = 3.36, p = .068, mean difference = 
0.34, p = .068, 95% CI [-0.03, 0.71] (Figure A.14). When cardiorespiratory fitness level was 
added into the model, the COMT C/G x Fitness Level interaction did not explain variance in 
the forward span, ΔR2 = .002, ΔF(1, 153) = .321, p = .572, or backward span, ΔR2 = .007, 
ΔF(1, 153) = .1.27, p = .262. 
Spatial memory test. The sample size for the spatial memory test was N = 175 with 
allelic group sizes as follows: G Carriers = 105, C/C Homozygotes = 70. ANCOVA showed G 
Carriers had significantly faster response times (RT) for all memory loads: memory load 1, 
F(1, 170) = 5.00, p = .027, mean difference = -57.87, p = .029, 95% CI [-109.13, -6.10]; 
memory load 2, F(1, 170) = 4.21, p = .042, mean difference = -52.28, p = .045, 95% CI [-
103.64, -2.05]; memory load 3, F(1, 170) = 7.71, p = .006, mean difference = -76.46, p = .010, 
95% CI [-134.05, -20.85] (Figure A.15).  There were no differences on error rate for any 
memory load, suggesting there was no speed accuracy tradeoff, all F(1, 170) < 1 (Table 
3.22). 
When cardiorespiratory fitness level was added into the model, the sample size for 
the spatial memory test was reduced to N = 143, with genotypic samples sizes as follows: G 
Carriers = 85, C/C Homozygotes = 58. Hierarchical regression showed the interaction did 
not significantly explain any variance for either RT or ER for any memory load (Table 3.22). 
 Executive control function tests. Older adults have been shown to have decreasing 
performance on tests of executive control function (Hedden & Gabrieli, 2004; D.C Park & 
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Gutchess, 2000). Carriers of the G allele are believed to have the lower prefrontal dopamine 
levels and perform worse on measures of executive control (Roussos et al., 2009, 2008). 
Therefore, I expect a significant effect of COMT C/G genotype such that C/C Homozygotes 
will outperform G Carriers. 
Flanker test. The sample size for the Flanker test was N = 186, with genotypic group 
sizes as follows: G Carriers = 110, C/C Homozygotes = 76. ANCOVA showed the G Carriers 
were significantly faster than C/C Homozygotes on congruent trials, F(1, 181) = 5.22, p = 
.023, mean difference = -29.78, p = .024, 95% CI [-56.53, -3.90], and marginally faster on 
incongruent trials, F(1, 181) = 3.73, p = .055, mean difference = -31.14, p = .063, 95% CI [-
64.03, 1.35] (Figure A.16). However, there was no difference seen on an RT cost score (i.e. 
incongruent RT – congruent RT), F(1, 181) < 1. There was also no difference seen on error 
rate for either congruent or incongruent trials, both F(1, 181) < 1. Against prediction, these 
results suggest G Carriers are faster overall. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the Flanker test was reduced to N = 152, with genotypic group sizes as follows: G Carriers = 
90, C/C Homozygotes = 62. Hierarchical regression showed the interaction did not 
significantly explain any variance in RT or ER for either trial type (Table 3.23).  
Wisconsin card sort. The sample size for the WCST was N = 181, with allelic group 
sizes as follows: G Carriers = 105, C/C Homozygotes = 76. ANCOVA showed no differences 
between the groups on either total errors or percent perseverative errors, both F(1, 176) < 
1. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the WCST was reduced to N = 149, with allelic group sizes as follows: G Carriers = 86, C/C 
Homozygotes = 63. Hierarchical regression showed the interaction between COMT C/G x 
Fitness Level did not significantly explain any variance in performance total errors ΔR2 = 
.014, ΔF(1, 142) = 2.22, p = .139. However, the interaction did significantly explain 3% of 
the variance in percent perseverative errors, ΔR2 = .030, ΔF(1, 142) = 4.68, p = .032 (Figure 
3.9). Simple slopes analysis showed that percent perseverative errors marginally 
decreased with increasing VO2 only in the C/C group, B = -0.54,  = -.203, t(142) = -2.22, p = 
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.052, 95% CI [-1.11, -0.29], and not the G Carriers, B = 0.10,  = .041, t(142) = .430, p = .671, 
95% CI [-0.37, -0.59].   
Dual task test. The sample size for the dual task test was N = 157, with allelic group 
sizes as follows: G Carriers = 91, C/C Homozygotes = 66. ANCOVA showed G Carriers were 
significantly faster during dual trials, F(1, 152) = 4.86, p = .029, mean difference = -66.91, p 
= .029, 95% CI [-126.78, -8.42], but there were no difference single trials, F(1, 152) < 1 
(Figure A.17a). Further, G Carriers also showed a significantly lower RT cost (i.e. dual RT – 
single RT), F(1, 152) = 5.71, p = .018, mean difference = -46.95, p = .018, 95% CI [-84.77, -
9.17] (Figure A.17b). There were no differences seen in error rate for either single or dual 
trials, both F(1, 152) < 1), suggesting there was no speed accuracy tradeoff. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the dual task test was reduced to N = 150, with genotypic group sizes as follows: G Carriers 
= 89, C/C Homozygotes = 61. Hierarchical regression showed the interaction between 
COMT C/G x Fitness Level did not significantly explain any variance in response time in 
either the single trials, ΔR2 = .003, ΔF(1, 143) < 1, or dual trials, ΔR2 = .004, ΔF(1, 143) < 1. 
However, the interaction did significantly explain 2.9% of the variance in a RT cost score 
(i.e. dual RT – single RT), ΔR2 = .029, ΔF(1, 143) = 4.74, p = .031 (Figure 3.10). Simple slopes 
analysis showed RT cost increased with increasing VO2 for the G Carriers, B = 8.30,  = .230, 
t(143) = 2.46, p = .011, 95% CI [1.76, 14.59], but there was no relationship for the C/C 
Homozygotes, B = -0.79,  = -0.02, t(143) = -0.23, p = .835, 95% CI [-8.54, 6.31]. There was 
no effect on error rate (ER) for either trial type: single, ΔR2 = .001, ΔF(1, 143) < 1; dual, ΔR2 
= .000, ΔF(1, 143) < 1. 
 
COMT Combined SNPs 
To further study the effects of the COMT gene on cognition in healthy older adults, I 
conducted an analysis using a combination of the two SNPs. I created a high activity COMT 
(i.e. low prefrontal DA) group which included those that were Val/Val homozygotes on 
COMT Val158Met and the G allele on COMT C/G. I compared this group to a low activity 
COMT (i.e. high prefrontal DA) group which included those that were Met/Met 
homozygotes on the COMT Val158Met and C/C Homozygotes on COMT C/G.  
 
 
56 
There were no significant differences between the COMT Low DA and COMT High 
DA groups on age, education, mMMSE, BMI or VO2 (Table 3.24). Chi-square analysis showed 
no sex differences between the groups. Means and standard deviations for the primary 
measures on the behavioral tests are reported in in Table 3.25. 
 
Verbal crystallized intelligence. Verbal crystallized intelligence is believed to 
remain relatively stable among older adults (Hedden & Gabrieli, 2004; D.C Park & Gutchess, 
2000). I hypothesize there will be no group differences on performance of the following 
test of verbal crystallized intelligence. 
KBIT test. The sample size for the KBIT test was N = 81, with group sizes as follows: 
COMT Low DA = 28, COMT High DA = 53. Following prediction, analysis of covariance 
(ANCOVA) showed there were no significant differences between the genotypic groups on 
age-scaled scores, F(1, 81) < 1. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 67, with group sizes as follows: COMT Low DA = 24, COMT High DA = 43. 
Again following prediction, hierarchical regression showed the interaction between COMT 
x Fitness Level did not significantly explain any variance in the age-scaled scores, ΔR2 = 
.010, ΔF(1, 60) < 1.  
 
 Memory tests. Performance on working and spatial memory tests decrease in older 
adults, in contrast to general sparing in tests of short term memory (Hedden & Gabrieli, 
2004; D.C Park & Gutchess, 2000). In terms of the COMT gene, I expect group differences on 
the working and spatial memory measures, but not the test of short term memory and 
expect the low DA group will specifically benefit from increasing fitness level. 
 Digit span test. The sample size for the digit span test is N = 81, with group sizes as 
follows: COMT Low DA = 28, COMT High DA = 53. As predicted, there were no differences 
between the groups on the test of short term memory, forward span, F(1, 76) < 1, but 
against prediction, the Low DA group showed significantly better performance on the 
backward span test of working memory, F(1, 76) = 5.63, p = .020, mean difference = 0.72, p 
= .018, 95% CI [0.15, 1.31] (Figure A.18).  
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When cardiorespiratory fitness level was added into the model, the sample size for 
the spatial memory test was reduced to N = 67, with group sizes as follows: COMT Low DA 
= 24, COMT High DA = 43. Regression showed the interaction between COMT x Fitness 
Level did not significantly explain variance in forward span, ΔR2 = .013, ΔF(1, 60) = 1.06, p = 
.308, but did explain 6.6% of the variance in backward span, ΔR2 = .066, ΔF(1, 60) = 5.31, p 
= .025 (Figure 3.11). Simple slopes analysis showed the number of digits repeated 
significantly increased with increasing cardiorespiratory fitness level for the Low DA 
group, B = 0.18,  = 1.30, t(60) = 2.16, p = .042, 95% CI [-0.02, 0.33], but not for the High DA 
group, B = -0.28,  = -0.22, t(60) = -0.59, p = .597, 95% CI [-0.13, 0.08]. 
Spatial memory test. The sample size for the spatial memory test was N = 76, with 
group sizes as follows: COMT Low DA = 27, COMT High DA = 49. ANCOVA showed the Low 
DA group had significantly faster response times (RT) for all memory loads: memory load 
1, F(1, 71) = 8.53, p = .005, mean difference = -119.64, p = .005, 95% CI [-198.38, -43.13]; 
memory load 2, F(1, 71) = 6.17, p = .015, mean difference = -106.56, p = .013, 95% CI [-
191.22, -26.50]; memory load 3, F(1, 71) = 8.99, p = .004, mean difference = -139.73, p = 
.002, 95% CI [-223.21, -54.82] (Figure A.19).  There were no differences on error rate for 
any memory load suggesting there was no speed accuracy tradeoff: memory load 1, F(1, 
71) < 1; memory load 2, F(1, 71) = 1.24, p = .268; memory load 3, F(1, 71) < 1. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the spatial memory test was reduced to N = 64, with group sizes as follows: COMT Low DA 
= 24, COMT High DA = 40. Hierarchical regression showed the interaction did not 
significantly explain any variance for either RT or ER for any memory load (Table 3.24). 
 
 Executive control function tests. Older adults have been shown to have decreasing 
performance on tests of executive control function (Hedden & Gabrieli, 2004; D.C Park & 
Gutchess, 2000). Lower prefrontal DA is expected to lead to worse performance on 
measures of executive control (Roussos et al., 2009, 2008). Therefore, I expect a significant 
effect of the COMT combined groups such that the COMT High DA group will perform better 
on the following tasks. Further, I expect cardiorespiratory fitness level will have a greater 
affect on performance for COMT Low DA group. 
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Wisconsin card sorting test (WCST). The sample size for the WCST was N = 77, 
with group sizes as follows: COMT Low DA = 26, COMT High DA = 51. ANCOVA showed no 
differences between the allelic groups on either total errors, F(1, 72) < 1 or percent 
perseverative errors, F(1, 72) = 1.03, p = .314. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the WCST was reduced to N = 63, with group sizes as follows: COMT Low DA = 22, COMT 
High DA = 41. Hierarchical regression showed the interaction between COMT x Fitness 
Level did not significantly explain any variance in performance total errors ΔR2 = .027, 
ΔF(1, 56) = 2.02, p = 161. However, the interaction did marginally explain 4.8% of the 
variance in percent perseverative errors, ΔR2 = .048, ΔF(1, 56) = 3.49, p = .067 (Figure 3.12). 
Simple slopes analysis showed that percent perseverative errors marginally decreased 
with increasing VO2 only in the High DA group, B = -0.92,  = -1.38, t(56) = -3.60, p = .002, 
95% CI [-1.54, -0.48], but not the Low DA group, B = -0.32,  = -0.04, t(56) = -0.07, p = .930, 
95% CI [-0.69, 0.77].   
Dual task test. The sample size for the dual task test was N = 68, with group sizes as 
follows: COMT Low DA = 24, COMT High DA = 44. ANCOVA showed the Low DA group was 
significantly faster for both single, F(1, 68) = 3.99, p = .050, mean difference = -87.08, p = 
.040, 95% CI [-166.76, -3.55], and dual trials, F(1, 68) = 8.93, p = .004, mean difference = -
149.37, p = .003, 95% CI [-242.37, -55.75] (Figure A.20a). Further, the Low DA group also 
showed a significantly lower RT cost (i.e. dual RT – single RT), F(1, 68) = 5.90, p = .018, 
mean difference = -62.30, p = .015, 95% CI [-111.92, -15.29] (Figure A.20b). There were no 
differences seen in error rate for either single, F(1, 68) < 1, or dual trials, F(1, 68) = 1.65, p 
= 204, suggesting there was no speed accuracy tradeoff. 
When cardiorespiratory fitness level was added into the model, the sample size for 
the dual task test was reduced to N = 63, with genotypic group sizes as follows: COMT Low 
DA = 23, COMT High DA = 40. Hierarchical regression showed the interaction between 
COMT x Fitness Level did not significantly explain any variance in RT or ER for either trial 
type (Table 3.27).  
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Dopamine Tables 
 
 
Table 3.1 Demographics and physical assessment descriptive statistics for DBH 444 G/A (rs1108580)
Demographics Mean SD Mean SD Mean Mean SD
Age 66.59 (5.44) 66.46 (5.94) 66.24 66.43 (5.73)
Educuation (years) 15.02 (2.44) 16.33 (3.21) 15.63 15.88 (3.08)
mMMSE 54.00 (2.79) 54.79 (2.29) 54.67 54.60 (2.43)
mMMSE = modified mini mental status exam; m = males;  + p ≤ .10 χ
2 
(2, N = 197) = 4.95, p  = .084
Physical Assessment Mean SD Mean SD Mean Mean SD
Body mass index (kg⋅ m-2 ) 29.89 (3.93) 28.49 (4.51) 28.89 28.89 (4.32)
VO2 (mL⋅ kg -1 ⋅ min -1 ) 20.13 (4.93) 21.82 (4.58) 20.94 21.25 (4.75)
m = males χ
2 
(2, N = 163) = 3.94, p  = .139
SD
(5.59)
(3.15)
(2.39)
SD
(4.13)
N = 162 (58 m)n  = 37 (16 m)n  = 90 (34 m)n  = 36 (8 m)
G/A A/A Total
G/G
n  = 41 (10 m)
G/A
n  = 107 (42 m) n  = 49 (23 m)
G/G
A/A
N = 197 (75 m)
Total
(4.86)
F (2, 194)
  0.04 
2.92
+
  1.62 
F (2, 159)
  1.36 
  1.74 
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RT = response time 
 
 
Table 3.2 DBH 444 G/A (rs1108580) means and standard deviations
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Verbal Crystallized Intelligence
KBIT 109.07 (12.41) 113.21 (9.54) 113.46 (9.87) 112.42 (10.36)
Memory Tests
Digit Span
Forward 6.30 (1.24) 6.56 (1.18) 6.53 (1.06) 6.50 (1.16)
Backward 4.73 (1.28) 4.89 (1.38) 5.14 (1.49) 4.92 (1.39)
Spatial Memory
Load 1 RT (ms) 781.23 (161.18) 811.17 (190.22) 770.91 (175.55) 794.92 (181.02)
Load 2 RT (ms) 898.30 (150.56) 910.53 (194.68) 871.54 (157.68) 897.13 (177.48)
Load 3 RT (ms) 986.53 (160.37) 996.52 (210.71) 957.38 (174.13) 984.52 (192.33)
Load 1 Error Rate 0.10 (0.10) 0.10 (0.07) 0.11 (0.09) 0.10 (0.08)
Load 2 Error Rate 0.15 (0.09) 0.16 (0.11) 0.15 (0.10) 0.16 (0.10)
Load 3 Error Rate 0.20 (0.13) 0.20 (0.11) 0.19 (0.10) 0.20 (0.11)
Executive Control Function Tests
Task Switch
Single Condition RT (ms) 777.62 (126.93) 783.16 (114.19) 732.14 (99.01) 770.07 (114.66)
Mix Condition RT (ms) 1170.26 (163.56) 1162.21 (158.93) 1110.74 (131.55) 1151.61 (154.61)
Global RT Cost (ms) 392.64 (122.30) 379.05 (134.06) 378.60 (127.69) 381.54 (129.71)
Repeat Trial RT (ms) 984.17 (137.99) 991.78 (161.54) 926.18 (102.75) 974.87 (147.00)
Switch Trial RT (ms) 1356.35 (226.51) 1332.63 (194.90) 1295.30 (189.64) 1328.36 (199.82)
Local Cost (ms) 372.18 (183.57) 340.84 (164.70) 369.12 (154.31) 353.50 (165.69)
Single Condition Error Rate 0.09 (0.11) 0.05 (0.05) 0.09 (0.12) 0.06 (0.08)
Mix Condition Error Rate 0.16 (0.14) 0.11 (0.09) 0.10 (0.10) 0.12 (0.11)
Global Error Rate Cost 0.07 (0.12) 0.06 (0.09) 0.01 (0.12) 0.05 (0.11)
Repeat Error Rate 0.14 (0.13) 0.09 (0.09) 0.08 (0.10) 0.10 (0.10)
Switch Error Rate 0.19 (0.16) 0.13 (0.10) 0.11 (0.12) 0.14 (0.12)
Local Error Rate Cost 0.05 (0.07) 0.04 (0.06) 0.03 (0.06) 0.04 (0.06)
G/G G/A A/A Total
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Table 3.4 Demographics and physical assessment descriptive statistics for DBH -1021 C/T (rs1611115)
Demographics Mean SD Mean SD F (1, 195) Mean
Age 66.45 (5.69) 66.40 (5.86)   0.00 66.43
Educuation (years) 15.56 (2.84) 16.66 (3.51) 5.27* 15.88
mMMSE 54.23 (2.60) 55.48 (1.69) 11.43* 54.60
mMMSE = modified mini mental status exam; m = males; *p  ≤ .05 χ
2 
(1, N = 197) = 4.96, p  = .026*
Physical Assessment Mean SD Mean SD F (1, 160) Mean
Body mass index (kg⋅ m -2 ) 28.81 (4.50) 29.06 (3.88)   0.11 28.89
VO2 (mL⋅ kg -1 ⋅ min -1 ) 20.71 (4.71) 22.28 (4.58)   3.93 21.19
m = males χ
2 
(1, N=162) = 4.68, p  = .030*
C/C T allele
n  = 112 (34 m) n  = 50 (24 m)
n  = 139 (46 m) n  = 58 (29 m)
C/C T allele
N = 197 (75 m)
(3.08)
(2.43)
SD
(4.32)
N = 162 (58 m)
Total
Total
(4.71)
SD
(5.73)
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Dopamine Figures 
  
 
Figure 3.1 Interaction effect between DBH 44 G/A and cardiorespiratory fitness level (i.e. VO2) on error rate 
(ER) during the two conditions (i.e. single and mix) of the task switch test. 
a) Single condition: There was no significant interaction effect on ER for the single condition, ΔR2 = .002, ΔF(2, 
122) < 1 b) Mix condition: The interaction did marginally explain 3.9% of the variance in ER for the mix 
a 
b 
ΔR2 = .002, ΔF(2, 122) < 1 
ΔR2 = .039, p = .063 
G/G:  = -1.19, p = .008 
G/A:  = -0.37, p = .188 
A/A:  = -0.73, p = .038 
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condition, ΔR2 = .039, ΔF(2, 122) = 2.82, p = .063. Simple slopes: A/A group, B = -0.009,  = -0.73, t(122) = -
2.02, p = .038, 95% CI [-0.018, -0.001]; G/A group, B = -0.003,  = -0.37, t(122) = -1.17, p = .188, 95% CI [-
0.008, 0.002]; G/G group, B = -0.015,  = -1.19, t(122) = -3.25, p = .008, 95% CI [-0.027, -0.003] 
 
 
 
Figure 3.2 Interaction effect between DBH 444 G/A and cardiorespiratory fitness level (i.e. VO2) on error rate 
(ER) during the two trial types (i.e. repeat and switch) of the mix condition of the task switch test. 
a 
b 
ΔR2 = .019, p = .266 
ΔR2 = .057, p = .016 
G/G:  = -1.41, p = .001 
G/A:  = -0.38, p = .175 
A/A:  = -0.68, p = .057 
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a) Repeat trials: There was no significant interaction effect on ER for repeat trials, ΔR2 = .019, ΔF(2, 122) = 
1.34, p = .266 b) Switch trials: The interaction did marginally explain 5.7 % of the variance in ER for switch 
trials, ΔR2 = .057, ΔF(2, 122) = 4.308, p = .016. Simple slopes: A/A group, B = -0.009,  = -0.68, t(122) = -1.91, p 
= .057, 95% CI[-0.020, 0.000]; G/A group, B = -0.004,  = -0.38, t(122) = -1.21, p = .175, 95% CI[-0.009, 0.002]; 
G/G group, B = -0.020,  = -1.41, t(122) = -3.93, p = .001, 95% CI[-0.032, -0.009] 
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Figure 3.3 Interaction effect between DBH -1021 C/T and cardiorespiratory fitness level (i.e. VO2) on length 
of span for each version of the digit span test, forward and backward. 
a) Forward span: There was no significant interaction effect on the length of span, ΔR2 = .009, ΔF(1, 153) = 
1.59, p = .210 b) Backward span: The interaction did significantly explain 2.9% of the variance in backward 
span, ΔR2 = .029, ΔF(1, 153) = 6.00, p = .015. Simple slopes: C/C Homozygotes, B = -.026, β = -0.19, t(153) = -
0.86, p = .396, 95% CI [-0.080, 0.039]; T Carriers, B = 0.089, β = 0.67, t(153) = 2.00, p = .103, 95% CI [-0.013, 
a 
b 
ΔR2 = .009, p = .210 
ΔR2 = .029, p = .015 
T Carriers:  = 0.67, p = .175 
C/C:  = -0.19, p = .396 
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0.201. The slopes were significantly different from each other, B = 0.115, β = .862, t(153) = 2.45, p = .032, 95% 
CI [0.012, 0.221] 
 
 
 
Figure 3.4 Interaction effect between DBH -1021 C/T and cardiorespiratory fitness level (i.e. VO2) on 
performance of the Wisconsin Card Sorting Test (WCST) measured by total errors and percent perseverative 
a 
b 
ΔR2 = .031, p = .023 
ΔR2 = .021, p = .070 
T Carriers: β = -.951, p = .004 
C/C: β = -.116, p = .809 
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errors. a) Total errors: The interaction significantly explained 3.1% of the variance in total errors, ΔR2 = .031, 
ΔF(1, 142) = 5.28, p = .023. Simple slopes: T Carriers, B = -2.10, β = -.951, t(142) = -2.58, p = .004, 95% CI [-
3.57, -0.64]; C/C Homozygotes, B = -0.13, β = -.116, t(142) = -0.24, p = .809, 95% CI [-1.21, 0.84] b) Percent 
perseverative errors: The interaction marginally explained 2.1% of the variance in percent perseverative 
errors, ΔR2 = .021, ΔF(1, 142) = 3.33, p = .070. Simple slopes: T Carriers, B = -0.65, β = -.780, t(142) = -2.05, p = 
.109, 95% CI [-1.53, 0.11]; C/C Homozygotes, B = -0.04, β = -.009, t(142) = -0.20, p = .851, 95% CI [-0.47, 0.36]  
 
  
Figure 3.5 Interaction effect between DBH Combined SNPs and cardiorespiratory fitness level (i.e. VO2) on 
local error rate cost for the two trial types of the mix condition of the task switch test. The interaction did 
significantly explain 10.2% of the variance, ΔR2 = .102, ΔF(1, 27) = 4.83, p = .037. Simple slopes: DBH low DA 
group, B = -0.012, β = -1.84, t(27) = -3.57, p = .001, 95% CI [-.019, -.005]; DBH High DA group, B = -0.003, β = -
0.47, t(27) = -0.80, p = .430, 95% CI [-.011, .005] 
 
 
 
 ΔR2 = .102, p = .037 
DBH High DA: β = -0.47, p = .430 
DBH Low DA:  β = -1.84, p = .001 
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Figure 3.6 Interaction effect between COMT Val158Met and cardiorespiratory fitness level (i.e. VO2) on 
length of span for the dual task test. a) Forward span: ΔR2 = .016, ΔF(2, 151) = 1.22, p = .271 b) Backward 
span: ΔR2 = .054, ΔF(2, 151) = 4.99, p = .008. Simple slopes: Val/Val, B = 0.24, β = .272, t(151) = 3.20, p = .000, 
95% CI [0.09, 0.36]; Val/Met, B = -0.00, β = -.010, t(151) = -0.12, p = .919, 95% CI [-0.07, 0.08]; Met/Met, B = 
0.00, β = .000, t(151) = -0.01, p = .995, 95% CI [-0.08, 0.09] 
a 
b 
ΔR2 = .054, p = .008 
Met/Met: β = .000, p = .995 
Val/Met: β = -.010, p = .919 
Val/Val: β = .272, p = .000 
ΔR2 = .016, p = .271 
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Figure 3.7 Interaction effect between COMT Val158Met and cardiorespiratory fitness level (i.e. VO2) on 
response time for congruent trials on the Flanker test. The interaction marginally explained 3.5% of the 
variance in RT for congruent trials, ΔR2 = .035, ΔF(2, 143) = 2.90, p = .058. Simple slopes were non-significant 
for all groups (see Table 3.18). However, the results suggest there was a difference in the direction of the 
relationship between response and cardiorespiratory fitness level between the groups: Val/Val vs Val/Met, B 
= 10.24, β = .403, t(143) = 2.06, p = .060, 95% CI [0.43, 22.87]; Val/Val vs Met/Met, B = 12.61, β = .383, t(143) 
= 2.40, p = .031, 95% CI [1.74, 25.63]. 
ΔR2 = .035, p = .058 
Met/Met: β = 0.12, p = .163 
Val/Met: β = 0.06, p = .450 
Val/Val: β = -0.17, p = .114 
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Figure 3.8 Interaction effect between COMT Val158Met and cardiorespiratory fitness level (i.e. VO2) on 
response time cost for the dual task test. The interaction marginally explained 3.1% of variance in RT cost 
score, ΔR2 = .031, ΔF(2, 141) = 2.55, p = .082. Simple slopes: Val/Val group, B = 0.86, β = .012, t(141) = 0.13, p 
= .873, 95% CI [-10.14, 11.17; Val/Met heterozygotes, B = 7.99, β = .222, t(141) = 2.37, p = .025, 95% CI [0.70, 
14.75]; Met/Met, B = -2.20, β = -.048, t(141) = -0.54, p = .572, 95% CI [-9.40, 5.78]. 
 
ΔR2 = .031, p = .082 
Met/Met: β = -.048, p = .572 
Val/Met: β = .222, p = .025 
Val/Val: β = .012, p = .873 
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Figure 3.9 Interaction effect between COMT C/G and cardiorespiratory fitness level (i.e. VO2) on performance 
measured by percent perseverative errors on the Wisconsin Card Sorting Test. The interaction significantly 
explained 3% of the variance in percent perseverative errors, ΔR2 = .030, ΔF(1, 142) = 4.68, p = .032. Simple 
slopes: C/C group, B = -0.54,  = -.203, t(142) = -2.22, p = .052, 95% CI [-1.11, -0.29]; G Carriers, B = 0.10,  = 
.041, t(142) = .430, p = .671, 95% CI [-0.37, -0.59]. 
 
ΔR2 = .030, p = .032 
C/C: β = -0.54., p = .052 
G Carriers: β = .041, p = .671 
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Figure 3.10 Interaction effect between COMT C/G and cardiorespiratory fitness level (i.e. VO2) on a response 
time cost score for the dual task test. The interaction significantly explained 2.9% of the variance in a RT cost 
score, ΔR2 = .029, ΔF(1, 143) = 4.74, p = .031. Simple slopes: G Carriers, B = 8.30,  = .230, t(143) = 2.46, p = 
.011, 95% CI [1.76, 14.59]; C/C Homozygotes, B = -0.79,  = -0.02, t(143) = -0.23, p = .835, 95% CI [-8.54, 
6.31]. 
 
 
ΔR2 = .029, p = .031 
C/C: β = -0.02., p = .835 
G Carriers: β = 0.23, p = .011 
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Figure 3.11 Interaction effect between COMT Combined and cardiorespiratory fitness level (i.e. VO2) on the 
backward version of the digit span test. The interaction explained 6.6% of the variance in backward span, ΔR2 
= .066, ΔF(1, 60) = 5.31, p = .025. Simple slopes: Low DA group, B = 0.18,  = 1.30, t(60) = 2.16, p = .042, 95% 
CI [-0.02, 0.33]; High DA group, B = -0.28,  = -0.22, t(60) = -0.59, p = .597, 95% CI [-0.13, 0.08]. 
 
 
ΔR2 = .066, p = .025 
COMT High DA:  = -0.22, p = .597 
COMT Low DA: β = 1.30, p = .042 
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Figure 3.12 Interaction effect between COMT Combined and cardiorespiratory fitness level (i.e. VO2) on 
performance of the Wisconsin Card Sorting Test measured by percent perseverative errors. The interaction 
marginally explained 4.8% of the variance in percent perseverative errors, ΔR2 = .048, ΔF(1, 56) = 3.49, p = 
.067. Simple slopes: High DA group, B = -0.92,  = -1.38, t(56) = -3.60, p = .002, 95% CI [-1.54, -0.48]; Low DA 
group, B = -0.32,  = -0.04, t(56) = -0.07, p = .930, 95% CI [-0.69, 0.77]. 
 
ΔR2 = .048, p = .067 
COMT High DA:  = -1.38, p = .002 
COMT Low DA: β = -0.04, p = .930 
 
 
89 
Chapter 4: Growth Factor Genes 
Growth factors are proteins that participate in the survival, growth and 
differentiation of developing neurons. These growth factors are widely distributed in the 
peripheral and central nervous systems, both during development and throughout the 
lifespan. Two growth factors of particular interest in this study are Brain-Derived 
Neurotrophic Factor (BDNF) and Insulin-like Growth Factor I (IGF1) because of their 
modulation by exercise and influence on cognition.  
 
Methods 
Sample 
 The initial sample size of N = 242 was reduced due to participant drop out, 
experimenter error, failure to complete behavioral or fitness testing, and genotyping 
failure. The sample size was then reduced further with pairwise deletion of participants 
that performed below chance (i.e. greater 50% error rate). The final sample size and group 
sizes are indicated within the results section. Due to the fact that there were only 2 
Met/Met homozygotes, this group was combined with the Met/Val heterozygotes to 
conduct a Met carrier versus non-carrier analysis. 
 
Genotyping 
IGF1 G/A (rs6220). The IGF1 G/A polymorphism was assayed after nested PCR by 
using allele-specific Tm-shift primers in various combinations, together with automated 
melting curve analysis (Lipsky et al., 2001; Wang et al., 2005) on an iCycler real-time PCR 
machine (Bio-Rad, Hercules, CA). The yields of the PCR products corresponding to the A 
and G alleles were equalized by adjusting the concentrations of their respective 
oligonucleotide primers. Equalizing the yields of the two PCR products is necessary in part 
because they were designed to have different melting temperatures, and because accurate 
scoring requires detecting both alleles with equal sensitivity, particularly in heterozygotes. 
In this case, equalizing the yields also required the addition of DMSO (6.7%) and betaine 
monohydrate (333 mM) to the second round PCR buffer.  
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BDNF Val66Met (rs6265). The BDNF Val66Met polymorphism was also assayed 
after nested PCR by using allele-specific Tm-shift primers in various combinations, together 
with automated melting curve analysis (Lipsky et al., 2001; Wang et al., 2005) on an iCycler 
real-time PCR machine (Bio-Rad, Hercules, CA). The PCR product of the first round (outer) 
amplification was 184 bp in length. The PCR product of the second round (inner) 
amplification was 87 bp for the G allele, and 73 bp for the A allele.  
 
Statistical Analysis 
Hardy-Weinberg Equilibrium. Two hundred and forty samples were genotyped 
successfully for the IGF1 gene. The frequencies of the three IGF1 G/A genotypes were .10 
for G/G, .38 for G/A, and .52 for A/A. The Hardy-Weinberg exact test showed that the allelic 
distribution did not deviate from expectations, 2(1) = 1.25, p = .275.  
Two hundred and forty-two samples were genotyped successfully for the BDNF 
gene. The frequencies of the three BDNF Val66Met genotypes were .90 for Val/Val (G/G), 
.09 for Val/Met (G/A), and .01 for Met/Met (A/A). The Hardy-Weinberg exact test showed 
the allelic distribution did not deviate from expectations, 2(1) = 3.16, p = .122. 
SNP analysis. All performance measures were analyzed using analysis of covariance 
(ANCOVA) with age, education, and sex as covariates. Percentile bootstrapped 95% 
confidence intervals (CI) were calculated over 5000 samples for pairwise comparisons and 
are reported in text if there was a significant omnibus effect of the SNP.  
 SNP x Fitness Level interaction analysis. All performance measures were 
analyzed using stepwise multiple regression with age, education, and sex entered in the 
first step as control variables. The SNP dummy variable(s) and cardiorespiratory fitness 
level (i.e. VO2 scores) were both entered in the second step, and the SNP x Fitness Level 
interaction variable(s) was entered in the last step. If the SNP x Fitness Level interaction 
was significant (R2 was p  .05) or marginal (p  .10), simple slopes analysis was 
conducted to elucidate the nature of the interaction. For the simple slopes analysis, the 
control variables were entered in the first step, followed by the SNP dummy variable(s) in 
the second step, and then in the last step cardiorespiratory fitness level was added for each 
individual group (e.g. VO2 scores for Met Carriers with Val/Val Homozygotes coded 0 and 
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VO2 scores for Val/Val Homozygotes with Met Carriers coded 0 as two separate interaction 
variables for the BDNF Val66Met SNP). 
 
Cognitive Assessment 
This section is included here to help remind the reader of the variables of interest 
for each particular test. Full descriptions of the tests can be found in Chapter 2: General 
Methods. 
Verbal crystallized intelligence. One test was used to asses verbal crystallized 
intelligence. 
K-BIT test. The primary measure was an age-scaled score of correct items divided 
by the total number of items attempted on the verbal subscale of the Kaufman Brief 
Intelligence Test (K-BIT; Kaufman & Kaufman, 1990). Higher scores indicate better 
performance.  
Memory. Two tests were used to assess various aspects of memory (i.e. short-term, 
working, and spatial).  
Digit span test. Two versions of the digit span test, forward and backward, were 
used to assess short-term and working memory, respectively. For both versions of the digit 
span, the primary measure was the total number of digits in the maximum span length 
repeated; therefore, higher scores indicate better performance. 
 Spatial memory test. The primary measures were response time (RT) and error 
rate (ER) for each of the three memory loads (i.e. 1, 2 or 3). Lower scores (i.e. faster RT and 
lower ER) indicate better performance. 
Executive control functioning. Six tests were used to assess various aspects of 
executive control functioning.  
Verbal fluency test (FAS). The verbal fluency test assessed fluid intelligence and the 
primary measure was the total number of words named in 180 seconds for three phonetic 
categories (i.e. 60 seconds for F, A, & S separately). Higher scores indicate better 
performance. 
Flanker test. The Flanker test assessed inhibitory processing. The primary 
measures were RT and ER for the two trial types (i.e. congruent and incongruent). 
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Comparison of these two trial types assessed the ability to inhibit conflicting information. 
Lower scores indicate better performance. 
  Wisconsin card sorting test. The Wisconsin Card Sorting Test (WCST) assessed 
many aspects of executive functioning including inhibitory processing and concept shifting. 
The primary measures were percent perseverative errors and total errors; therefore, lower 
scores indicate better performance. 
 Task switch test. The task switch test assessed maintenance and coordination of 
multiple sets. The primary measures were RT and ER for the two conditions (i.e. single and 
mix), which can be compared to assess the cost of maintaining one versus two rule sets. 
The mix condition can be further split into repeat and switch trial types, which can be 
compared to assess the cost of rule switching. Lower scores indicate better performance. 
 Dual task test. The dual task test assessed coordination of multiple sets. The 
primary measures were RT and ER for the two trial types (i.e. single and dual), which can 
be compared to assess the cost of responding to one versus two stimuli. Lower scores 
indicate better performance. 
 
Insulin-Like Growth Factor 
Insulin-like growth factor I (IGF1) belongs to a family of growth factors known as 
somatomedins that play an important role in mammalian growth and development 
(Froesch, Schmid, Schwander, & Zapf, 1985). Although all tissues express IGFs (Fernandez 
& Torres-Alemán, 2012), 90% of the body’s total IGF1 is synthesized and steadily secreted 
by the liver into the serum where it is bound by specific carrier proteins, insulin-like 
growth factor binding proteins (IGFBP), allowing it to be present in high concentrations 
within the serum without causing hypoglycemia (Froesch et al., 1985). It is generally 
considered to be a peripheral peptide hormone that regulates fuel metabolism (Fernandez 
& Torres-Alemán, 2012), but also exerts neurotrophic and neuroprotective effects in the 
central nervous system (CNS) by stimulating the viability and functioning of different 
neuronal and glial cell types (van Dam et al., 2000; van Dam & Aleman, 2004).  
Serum IGF1 is able to cross the blood brain barrier (Reinhardt & Bondy, 1994) into 
active brain regions through brain vessels by means of an activity-dependent mechanism 
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that is coupled to neuronal activity (Nishijima et al., 2010). This crossing is mediated by 
IGF1 receptors that are highly expressed in endothelial cells of blood vessels in the brain 
(Bondy & Lee, 1993) allowing for transcytosis of IGF1 (i.e. regulated endocytosis and 
transport from one side of the cell to the other for eventual release; Fernandez & Torres-
Alemán, 2012). IGF1 can also enter the cerebrospinal fluid (CSF) flow through the same 
mechanism since IGF1 receptors are also highly expressed in epithelial cells of the choroid 
plexus (Bondy & Lee, 1993). These two methods of entry from the circulation into the brain 
suggest that peripheral IGF1 may mediate actions of IGF1 in various brain areas. Not 
surprisingly, an increase in IGF1 blood levels in the periphery leads to  increased levels in 
the CSF (Carro, Nez, Busiguina, & Torres-Aleman, 2000), and once in the CSF, IGF1 can 
easily diffuse to periventricular brain areas, such as the hippocampus. However, IGF1 does 
not only operate through an endocrine system (Fernandez & Torres-Alemán, 2012). Local 
synthesis also occurs within all cell types of the brain (Fernandez & Torres-Alemán, 2012; 
Han, 1995), and the IGF1 receptor has been detected in neuronal nuclei where it is thought 
to affect gene transcription directly by acting as a transcriptional modulator (Sehat et al., 
2010). 
Indicative of its importance in brain development and overall brain health, IGF1 has 
a diffuse expression pattern including the cortex, hippocampus, cerebellum, brainstem, 
hypothalamus and the spinal cord (Bach, Shen-Orr, Lowe, Roberts, & Leroith, 1991). 
Experimentally, IGF1 has been shown to rescue degenerating motoneurons after axotomy 
in young mice (Li, Oppenheim, Lei, & Houenou, 1994), and increased IGF1 levels are also 
observed in experimental animals during recovery from brain injuries caused by trauma 
(Garcia-Estrada, Garcia-Segura, & Torres-Aleman, 1992), hypoxic-ischaemic injury (Guan, 
Williams, Skinner, Mallard, & Gluckman, 1996; Guan, Williams, Gunning, Mallard, & 
Gluckman, 1993), or induced by electrolytic lesions (Yamaguchi et al., 1991). On the other 
hand, knocking out IGF1 in mice impairs neuronal somatic and dendritic growth (Cheng et 
al., 2003).  
In concert with IGF1’s support of overall brain health, there is evidence for a similar 
support of cognitive ability. For example, in liver-IGF-1 deficient mice, IGF1 administration 
can restore adult hippocampal neurogenesis and improve spatial memory (Trejo, Llorens-
Martín, & Torres-Alemán, 2008). Further, human patients with growth hormone 
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deficiencies show reduced cognitive performance, in part due to severe reductions in IFG1 
levels in both plasma and the CNS (van Dam et al., 2000). Experimentally, several studies of 
healthy adults have found positive associations between IGF1 and cognitive functions, 
including working memory (Bellar, Glickman, Juvancic-Heltzel, & Gunstad, 2011), as 
evidenced in a meta-analysis conducted by (Arwert, Deijen, & Drent, 2005).  
Developmentally, high concentrations of IGF1 are observed during puberty, with a 
sharp decline during the first years after puberty and further reduction between the ages of 
30 to 75 (van Dam & Aleman, 2004). This age-related decline, along with its role in 
cognition, implicate a potential role for IGF1 in aging-related cognitive decline (Aleman et 
al., 1999; Markowska, Mooney, & Sonntag, 1998; van Dam & Aleman, 2004). In line with 
this, Morely et al. (1997) found significant correlations between IGF1:GH ratio and 
cognitive performance, including visual and verbal memory in a sample of 56 men aged 20 
to 84. In older populations, lower levels of IGF1 are associated with lower levels of 
cognitive functions such as processing speed, memory, and executive functioning (for 
review see van Dam & Aleman, 2004). For example, Aleman et al. (1999) found a positive 
correlation between circulating IGF1 levels and speed of information processing, measured 
by performance on a digit symbol substitution and a concept-shifting task (similar to Trails 
B) in a sample of 25 men between 65 to76 years of age. Vitiello et al. (2006) found a 
positive association between IGF1 levels and age-sensitive problem-solving abilities in 
elderly men and women (aged 60 to 85 years).   
Furthermore, Dik et al. (2003) found a cross sectional assocation between IGF1 
levels and information processing speed and moreover, low IGF1 levels were associated 
with a 3-year decline in information processing speed in older adults aged 65 to 88 years. 
This evidence suggests IGF1 levels may have a protective effect against aging related 
cognitive decline (Aleman & Torres-Alemán, 2009). In line with this, research in non-
human animals has shown that intraventricular infusion of IGF1 can improve working 
memory in a repeated acquisition task, an object recognition task, and a place 
discrimination task in aged rats, but does not affect sensorimotor skills or exploration 
(Markowska et al., 1998).  
 Although an age-related decline in circulating levels of IGF1 is a general trend, there 
are substantial individual differences in existing IGF1 levels (van Dam & Aleman, 2004). In 
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fact, 40-60% of variation in circulating IGF1 levels is determined by genetic factors (Hall, 
Hilding, & Thorén, 1999; Harrela et al., 1996; Hong, Pedersen, Brismar, Hall, & de Faire, 
1996; Verhaeghe et al., 1996). The IGF1 gene is located on chromosome 12q and there is a 
common SNP resulting in a G to A switch in exon 4 of the 3’ untranslated region (rs6220; 
http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs6220). This region contains regulatory 
domains for mRNA expression and may alter the RNA stability and regulation of protein 
expression (Al-Zahrani et al., 2006; Huuskonen et al., 2011). This SNP has been associated 
with circulating levels of IGF1 protein such that the minor G allele is associated with higher 
levels of circulating IGF1 (Diorio, Brisson, Bérubé, & Pollak, 2008; Johansson et al., 2007; 
Verheus et al., 2008). Therefore, this study was conducted to investigate whether the IGF1 
G/A SNP would have an effect on cognitive performance in healthy elderly adults due to its 
influence on circulating levels of IGF1. 
 A low expression of IGF1 mRNA, but a wide expression of IGF1 receptors in the 
adult mammalian brain, suggests that peripherally produced IGF1 plays an important role 
in the adult brain (Carro et al., 2000; Trejo, Carro, & Torres-Aleman, 2001). Generally, IGF1 
levels in the serum are primarily regulated by growth hormone (Froesch et al., 1985), but 
levels can also be moderated by other factors such as exercise. Exercise has been shown to 
increase the expression of IGF1, BDNF, enhance learning acquisition, and augment recall in 
rats (Cotman, Berchtold, & Christie, 2007). Interestingly, blockade of the IGF1 receptor 
diminishes exercise-induced increases in levels of BDNF and eliminates the augmentation 
of recall , indicating that IGF1 may modulate exercise-induced benefits (Carro et al., 2000; 
Carro, Trejo, Busiguina, & Torres-Aleman, 2001; Trejo et al., 2001, 2008). Therefore, we 
also investigated the possibility of an interaction between IGF1 G/A and cardiorespiratory 
fitness levels in the same subjects. 
 
IGF1 G/A (rs6220) Predictions 
 This study takes two novel approaches to investigate the relationship between IGF1 
and cognition. It will be the first time to date that the IGF1 gene and, furthermore, the 
interaction between the IGF1 gene and cardiorespiratory fitness level has been related to 
cognition. For the IGF1 G/A SNP, since the A allele is associated with lower levels of 
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circulating IGF1, I predict A carriers will show poorer cognitive performance on tests of 
memory and executive control, but show a positive relationship between cardiorespiratory 
fitness level and behavioral performance. This prediction is extrapolated from the findings 
in the extant literature showing: 1) an association between the IGF1 gene and IGF1 levels; 
2) evidence that IGF1 levels can be modulated by exercise; and 3) a positive association 
between circulating IGF1 levels and cognition. 
 
IGF1 G/A (rs6220) Results 
There were no significant differences between the genotypic groups on age, 
education, mMMSE, BMI or VO2 (Table 4.1). Chi-square analysis showed the distribution of 
males and females was not significantly different between the groups (Table 4.1). Task 
means and standard deviations are reported in Table 4.3. 
 
IGF1: Verbal Crystallized Intelligence 
Verbal crystallized intelligence has been shown to remain relatively stable in older 
adult populations (Hedden & Gabrieli, 2004; Park & Gutchess, 2002). Due to the relative 
stability of the verbal crystallized intelligence, I do not expect to find an effect of IGF1 G/A 
or its interaction with cardiorespiratory fitness level. 
KBIT test. The sample size for the KBIT test was N = 192, with genotypic group 
sizes as follows: A/A = 101, G/A = 71, G/G = 20. As expected, there was no significant 
difference between the IGF1 G/A genotypic groups on the age-scaled scores F(2, 186) < 1, 
suggesting that IGF1 G/A genotype does not influence verbal crystallized intelligence.  
When cardiorespiratory fitness level was added to the model, the sample size for the 
KBIT test was reduced to N = 158, with genotypic group sizes as follows: A/A = 79, G/A = 
60, G/G = 19. Hierarchical regression showed the interaction between IGF1 G/A x Fitness 
Level did not explain a significant proportion of variance in the age-scaled score, ΔR2 = 
.012, ΔF(2, 149) = 1.10, p = .336. This was expected since neither IGF1 nor 
cardiorespiratory fitness level were predicted to affect verbal crystallized intelligence. 
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IGF1: Memory Tests 
Performance on tests of working and spatial memory are seen to decrease in older 
adult populations, in contrast to more stable performance on tests of short-term memory 
(Hedden & Gabrieli, 2004; Park & Gutchess, 2002).  In terms of the IGF1 G/A SNP, the G 
allele has been associated with higher levels of circulating IGF1 (Diorio et al., 2008; 
Johansson et al., 2007; Verheus et al., 2008), and in general, there is a positive association 
between IGF1 levels and cognitive functioning (Arwert et al., 2005; Bellar et al., 2011). 
Therefore, I predict G carriers will perform better on the various memory tests. Further, 
the extant literature shows that exercised-induced increases in both memory performance 
and IGF1 levels, and that blocking IGF1 receptors can block exercise-induced behvavioral 
gains. Thus, I expect to find an interaction between the IGF1 G/A SNP and 
cardiorespiratory fitness levels such that A allele carriers will show the strongest 
relationship between cardiorespiratory fitness level and memory performance.  
Digit span test. The sample size for the digit span test was N = 194, with genotypic 
group sizes as follows: A/A = 102, G/A = 72, G/G = 20. No significant differences were 
found between the IGF1 genotypic groups for either forward span, F(2, 188) = 1.44, p = 
.204, or backward span, F(2, 188) < 1. This was expected for the forward version of the 
digit span, a test of short-term memory, but I expected the A/A group would perform better 
on the backward version, a test of working memory.  
 When cardiorespiratory fitness level was added into the model the sample size for 
the digit span tests was reduced to N = 160, with genotypic group sizes as follows: A/A = 
80, G/A = 61, G/G = 19. Hierarchical regression showed no interaction effect of IGF1 G/A x 
Fitness Level on either forward span, ΔR2 = .009, ΔF(2, 151) < 1, or backward span, ΔR2 = 
.024, ΔF(2, 151) = 2.09, p = .128. Again, this was expected for forward span, but not for 
backward span. Based on previous studies that showed increasing fitness levels can 
increase IGF1 levels, and that the IGF1 G/A genotype influences IGF1 levels, I expected a 
potential interaction between the two variables. 
Spatial memory test. The sample size for the spatial memory test was N = 175, 
with genotypic group sizes as follows: A/A = 94, G/A = 67, G/G = 14. The G/A group 
showed the fastest response times (RT) across all memory loads, while the G/G group 
(expected to perform the best) were slowest (Figure B.1). This difference was significant 
 
 
98 
for memory load 1, F(2, 169) = 3.46, p = .034, and memory load 3, F(2, 169) = 4.30, p = .015. 
Although the differences between genotypic groups were not significant for memory load 
2, F(2, 169) = 1.35, p = .262, the groups followed the same trend with the G/A group 
showing the fastest response times and the G/G group the slowest. Bootstrapped pairwise 
comparisons are reported in Table B.1. The genotypic groups did not differ on error rate 
(ER) for any Memory Load, all F(2, 169) < 1, suggesting differences in RT were not due to 
an accuracy versus speed trade off. These results suggest that the IGF1 G/A genotype 
influences spatial memory (although not in the expected direction), but not short-term or 
working memory.  
Addition of cardiorespiratory fitness level reduced the sample size for the spatial 
memory test to N = 144 with genotypic group sizes as follows: A/A = 75, G/A = 56, G/G = 
13. The interaction between IGF1 G/A x Fitness Level significantly explained 4.7% of the 
variation in error rate for memory load 2, ΔR2 = .047, ΔF(2, 135) = 3.56, p = .031. Simple 
slopes analysis revealed that increasing VO2 led to decreasing errors only for the G/A 
group, B = -.008,  = -0.88, t(135) = -2.40, p = .037, 95% CI [-.015, .000], but there was a 
non-significant relationship for both the A/A, B = -.001,  = -0.10, t(135) = -0.33, p = .682, 
95% CI [-.005, .003], and G/G group, B = .008,  = 0.53, t(135) = 1.37, p = .181, 95% CI [-
.007, .022] (Figure 4.1). The interaction did not significantly explain variance in error rate 
or response time for any other memory loads (Table 4.3).  
 
IGF1: Executive Control Function Tests 
Increasing age most negatively affects performances on tests requiring some form of 
executive control (Hedden & Gabrieli, 2004; Park & Gutchess, 2002), but higher levels of 
fitness tend to be associated with better executive control (Colcombe & Kramer, 2003). As 
mentioned in the previous section, since the G allele of the IGF1 G/A SNP is been associated 
with higher levels of circulating IGF1 (Diorio et al., 2008; Johansson et al., 2007; Verheus et 
al., 2008), and there is a positive association between IGF1 levels and cognitive functioning 
(Arwert et al., 2005; Bellar et al., 2011), I again predict G carriers will perform better on the 
various tests of executive control. I also expect to find an interaction between the IGF1 G/A 
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SNP and cardiorespiratory fitness levels such that A allele carriers will show the strongest 
relationship between cardiorespiratory fitness level and executive control performance.  
Stroop test. The sample size for the Stroop test was N = 157 with genotypic group 
sizes as follows: A/A = 80, G/A = 59, G/G = 18. ANCOVA showed a significant difference 
between the groups on RT for the incongruent-ineligible trial types, F(2, 151) = 3.08, p = 
.049 (Figure B.2). Bootstrapped pairwise comparisons showed the A/A group was 
significantly slower than the G/G group, mean difference = 57.71, 95% CI [14.95, 100.35], 
and marginally slower than the G/A group, mean difference = 29.74, 95% CI [-5.21, 63.73]. 
The groups did not significantly differ on RT for any other trial type but did follow the same 
trend with the A/A group showing the slowest RTs, neutral RT, F(2, 151) = 2.24, p = .110; 
congruent RT, F(2, 151) < 1; incongruent eligible RT, F(2, 151) = 1.60, p = .204. There were 
also no significant differences between the genotypic groups on error rate (ER) for any of 
the trial types: neutral ER, F(2, 151) < 1; congruent ER, F(2, 151) = 1.14, p = .332; 
incongruent-ineligible ER, F(2, 151) = 2.17, p = .118; incongruent eligible ER, F(2, 151) = 
1.56, p = .213. This follows predictions that the G allele carriers will show greater cognitive 
performance.  
When cardiorespiratory fitness level was added to the model the sample size for the 
Stroop test was reduced to N = 151, with genotypic group sizes as follows: A/A = 75, G/A = 
58, G/G = 18. Hierarchical regression showed the interaction between IGF1 G/A x Fitness 
Level significantly explained variance in response time for each trial type (Table 4.4): 
neutral RT, ΔR2 = .066, ΔF(2, 142) = 5.50, p = .005 (Figure 4.2a); congruent RT, ΔR2 = .041, 
ΔF(2, 142) = 3.29, p = .040 (Figure 4.2b); incongruent-ineligible RT, ΔR2 = .040, ΔF(2, 142) = 
3.28, p = .041 (Figure 4.2c); incongruent eligible RT, ΔR2 = .038, ΔF(2, 142) = 3.08, p = .049 
(Figure 4.2d). Simple slopes analysis showed RT significantly decreased with increasing 
VO2 only for the G/A group for each trial type, neutral RT, B = -9.15,  = -1.14, t(142) = -
3.16, p = .002, 95% CI [-15.31, -3.58], congruent RT, B = -7.01,  = -0.91,  t(142) = -2.48, p = 
.028, 95% CI [-13.83, -1.32], incongruent-ineligible RT, B = -8.31,  = -0.88,  t(142) = -2.42, p 
= .012, 95% CI [-14.85, -1.42], incongruent eligible RT, B = -8.98,  = -0.88, t(142) = -2.40, p 
= .016, 95% CI [-16.89, -2.01] (Figure 4.2; other simple slopes reported in Table 4.5). There 
was also a marginal interaction effect on error rate for the incongruent eligible trial type, 
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ΔR2 = .033, ΔF(2, 142) = 2.83, p = .062 (Figure 4.3d). Simple slopes analysis again revealed 
that error rate decreased with increasing VO2 only for the G/A group, B = -.006, t(142) = -
1.49, p = .052, 95% CI [-.013, -.000], but a non-significant relationship in the A/A group. 
The interaction did not significantly explain variance for any other trial type, but the trend 
was similar (Figure 4.3a-c) These results suggest that the moderate level of IGF1 benefits 
the most from increasing VO2. 
Task switch test. The sample size for the task switch test was N = 157 with 
genotypic group sizes as follows: A/A = 84, G/A = 55, G/G =18. ANCOVA showed no 
significant differences between genotypic groups on response time for either condition, 
single or mix, both F(2, 151) < 1. There were also no differences between the groups on a 
global RT cost (i.e. mix RT – single RT), F(2, 151) < 1. There was, however, a marginal 
difference on error rate (ER) in the single condition, F(2, 151) = 2.72, p = .069, but 
bootstrapped pairwise comparisons showed no significant differences between the groups 
(Table B.2; Figure B.3a). There were no differences in ER in the mix Condition, F(2, 151) = 
2.14, p = .121. 
Further analysis of the Mix Condition showed no differences between the groups on 
RT for either trial type: repeat, F(2, 151) < 1; switch, F(2, 151) = 1.04, p = .357. There were 
also no group differences on a local RT cost (i.e. switch RT – repeat RT), F(2, 151) =2.13, p = 
.123. Although there were no differences on error rate (ER) for repeat trials, F(2, 151) = 
1.44, p = .241, there was a marginal difference on ER for switch trials, F(2, 151) = 2.64, p = 
.074 (Figure B.3b). Bootstrapped pairwise comparisons revealed the G/G group had 
significantly more errors compared to the G/A group, mean difference = .064, 95% CI [.003, 
.125], and the A/A group, mean difference = .073, 95% CI [.009, .137]. Although there were 
no significant differences between the groups on RT, the G/G group showed the highest RT 
and a significantly higher error rate, so there was no accuracy versus speed tradeoff. This 
suggests that the G/G group had a more difficult time switching between two task sets. 
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 131 with group sizes as follows: A/A = 68, G/A = 45, G/G = 18. The 
interaction between IGF1 G/A x Fitness Level did not significantly explain RT in either the 
single, ΔR2 = .047, ΔF(2, 122) = 3.08, p = .050 (the overall model was not significant, F(8, 
122) = 1.04, p = .409), or mix Condition, ΔR2 = .012, ΔF(2, 122) < 1. The interaction did 
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marginally explain 3.6% of the variance in ER for the single condition, ΔR2 = .036, ΔF(2, 
122) = 2.54, p = .083 (Figure 4.4), but not the mix condition, ΔR2 = .005, ΔF(2, 122) < 1. 
Simple slopes analysis revealed ER significantly decreased with increasing VO2 for the G/G 
group, B = -.012,  = -0.99, t(122) = -2.94, p = .049, 95% CI [-.023, .000], but there was no 
significant relationship for either the G/A, B = -.005,  = -0.63, t(122) = -1.61, p = .156, 95% 
CI [-.012, .003], or the A/A group, B = -.002,  = -0.29, t(122) = -0.87, p = .350, 95% CI [-
.007, .002]. 
Further analysis of the mix condition showed the interaction marginally explained 
4.3% of the variance in RT for repeat trials, ΔR2 = .043, ΔF(2, 122) = 3.02, p = .052 (Figure 
4.5), but not for switch trials, ΔR2 = .003, ΔF(2, 122) < 1 (Figure 4.5). Simple slopes analysis 
showed RT significantly decreased with increasing VO2 for the G/A group, B = -11.31,  = -
.607, t(122) = -1.70, p = .041, 95% CI [-22.95, -1.07], but not for the A/A, B = 2.65,  = .149, 
t(122) = 0.49, p = .673, 95% CI [-10.19, 14.39], or the G/G group, B = -8.49,  = -.288, t(122) 
= -0.92, p = .199, 95% CI [-26.64, 9.66]. There was no interactive effect on ER for either 
repeat, ΔR2 = .007, ΔF(2, 122) < 1, or switch trials, ΔR2 = .004, ΔF(2, 122) < 1. There was 
also no effect on local cost scores for RT, ΔR2 = .028, ΔF(2, 122) = 1.92, p = .151, or ER, ΔR2 = 
.006, ΔF(2, 122) < 1. 
Dual task test. The sample size for the dual task test was N = 156, with genotypic 
group sizes as follows: A/A = 79, G/A = 59, G/G = 18. ANCOVA showed no significant 
differences between the genotypic groups on response time (RT) for either the single, F(2, 
150) < 1, or dual trial types, F(2, 150) = 1.69, p = .189 (Figure B.4a). However, there was a 
significant difference between the groups on a RT cost score (i.e. dual RT – single RT), F(2, 
150) = 3.87, p = .023 (Figure B.4b). Bootstrapped pairwise comparisons revealed the A/A 
group showed a significantly higher cost than the G/G group, mean difference = 82.95, p = 
.016, 95% CI [15.70, 152.60], and marginally higher cost compared to the G/A group, mean 
difference = 36.33, p = .078, 95% CI [-3.23, 16.12]. There was also a significant difference 
between the genotypic groups on error rate for single trials, F(2, 150) = 3.05, p = .050, and 
a marginal difference on dual trials, F(2, 150) = 2.42, p = .092 (Figure 4.8c). Bootstrapped 
pairwise comparisons for single trials revealed the G/A group showed significantly higher 
error rates compared to the G/G group, mean difference = .023, p = .069, 95% CI [-.002, 
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.048], and marginally higher than the A/A group, mean difference = .023, p = .069, 95% CI [-
.002, .048]. For dual trials, bootstrapped pairwise comparisons revealed the G/G group had 
significantly lower error rates compared to both the A/A group, mean difference = -.062, p 
= .003, 95% CI [-.100, -.026], and the G/A group, mean difference = -.078, p = .004, 95% CI 
[-.125, -.029]. This suggests the A/A group was having more difficulty with the dual task, in 
maintaining the rules and coordinating two responses.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 150 with group sizes as follows: A/A = 75, G/A = 58, and G/G = 17. 
Hierarchical regression showed the interaction between IGF1 G/A x Fitness Level did not 
significantly explain variance in RT for single trials, ΔR2 = .023, ΔF(2, 141) = 1.75, p = .178, 
but marginally explained 2.8% of the variance in RT for dual trials, ΔR2 = .028, ΔF(2, 141) = 
2.35, p = .099. Simple slopes analysis revealed that dual RT marginally decreased with 
increasing VO2 for the G/G group, B = -14.26,  = -0.48, t(141) = -1.52, p = .058, 95% CI [-
30.98, 0.27] (Figure 4.6). The relationship was not significant for the G/A group, B = -8.48,  
= -0.46, t(141) = -1.33, p = .154, 95% CI [-21.14, 2.62] or the A/A group, B = 3.60,  = 0.21, 
t(141) = 0.70, p = .559, 95% CI [-8.50, 15.60]. Also, the interaction did not explain variance 
in error rate (ER) for either single, ΔR2 = .001, ΔF(2, 141) < 1, or dual trials, ΔR2 = .007, 
ΔF(2, 141) < 1. 
 
Brain-Derived Neurotrophic Factor 
Brain-derived neurotrophic factor (BDNF) belongs to a family of growth factors 
called neurotrophins. Neurotrophins are regulatory factors that mediate the 
differentiation, proliferation and survival of cholinergic, dopaminergic and serotonergic 
neurons (Savitz et al., 2006). BDNF exerts long-term effects on neuronal survival, 
migration, and dendritic and axonal growth mostly in the prefrontal cortex (PFC) and 
hippocampus (HC), even though it is expressed throughout the brain (Savitz et al., 2006). 
BDNF also displays neurotrophic and neuroprotective properties and can affect functions 
that underlie brain plasticity (Meeusen, 2005). For example, it is known to be important in 
modulating synaptic changes, such as hippocampal long-term potentiation (LTP), which is 
associated with learning and memory (Egan et al., 2003; Hariri et al., 2003). For these 
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reasons, BDNF is considered a major contributor to alterations in hippocampal function 
and hippocampal-dependent learning and memory and has also been implicated in 
neurogenesis in the HC (Egan et al., 2003; Hariri et al., 2003; Savitz et al., 2006). In rodents, 
blocking either the release of BDNF or the binding of BDNF to its receptor TrkB eliminates 
LTP in the HC (for review see Pang & Lu, 2004). BDNF specifically moderates synaptic 
plasticity and neurogenesis in the dentate gyrus and has been directly related to learning 
rates in spatial memory paradigms (Hwang et al., 2006; Silhol, Arancibia, Maurice, & Tapia-
Arancibia, 2007). 
A frequent functional SNP in the BDNF gene that swaps a G to an A at nucleotide 
196, results in a valine (Val) to methionine (Met) amino acid substitution at codon 66 
(Val66Met; rs6265). Although this SNP is located in the 5’ pro-BDNF sequence, making it 
unlikely to affect the actual biological activity of the mature protein, it is believed to alter 
the intracellular processing and regulated activity-dependent secretion of mature BDNF 
(Egan et al., 2003). The Met allele is thought to selectively impair secretion and 
intracellular trafficking of BDNF in primary cortical neurons and neurosecretory cells 
(Egan et al., 2003; Savitz et al., 2006).  
To further the understanding of how Val66Met may elicit in vivo phenotypes, Egan 
et al. (2003) examined Val- and Met-BDNF expression and secretion using cultured 
hippocampal neurons. They found that Val-BDNF was mostly localized in cell bodies and 
dendrites, whereas Met-BDNF was primarily localized in cell bodies and only in a few 
proximal dendrites. They also found that while constitutive secretion of Met-BDNF and Val-
BDNF did not differ, secretion of Met-BDNF after neuronal depolarization was severely 
attenuated. Properties and biological function of the secreted Val- and Met-BDNF did not 
differ and both were successfully targeted into Golgi, but only Val-BDNF seems to be sorted 
from Golgi to secretory granules and localized to synapses. 
Several studies have also shown that diminished secretion in Met carriers is related 
to reductions in hippocampal and prefrontal grey matter volume (Bueller et al., 2006; 
Erickson et al., 2010; Pezawas et al., 2004), alterations in hippocampal function (Egan et al., 
2003; Hariri et al., 2003), and cognitive impairments (Egan et al., 2003; Hariri et al., 2003; 
Miyajima et al., 2008; Rybakowski, Borkowska, Czerski, Skibińska, & Hauser, 2003). 
Further, BDNF levels decline with advancing age (Gunstad et al., 2008; Lommatzsch et al., 
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2005; Ziegenhorn et al., 2007). Ziegenhorn et al. (2007) found serum BDNF levels were 
negatively correlated with age in healthy old adults ranging in age from 70 to 103 years (i.e. 
levels decreased with increasing age). Bringing all of this evidence together, Erickson et al., 
(2010) also found increasing age was associated with reduced levels of BDNF, and further 
that reduced levels of BDNF were related to both a decline in HC volume and elevated 
memory deficits. xxx 
In a rodent model of successful aging (i.e. longer lifespans and preserved memory 
capacities), BDNF levels were higher than compared to those experiencing normal age-
related patterns of decline (Silhol et al., 2008). This is evidence that natural genetic 
variation can contribute to successful aging. But is there anything that can be done for 
those with naturally lower levels of BDNF? Yes, induction of BDNF production and 
secretion in the HC has been shown to rescue LTP and relieve spatial memory deficits in 
aged mice (Rex et al., 2006, 2007; Simmons et al., 2009). So is there an easy solution? Again, 
the answer is yes. Exercise has been shown to increase BDNF levels in the rat hippocampus, 
cerebellum and frontal cortex, most likely through increased gene expression (Ding et al., 
2006; Neeper et al., 1995). In fact, Vaynman, Ying, & Gomez-Pinilla (2004) found that 
inhibiting BDNF action blocked the beneficial effects of exercise on performance of the 
Morris water maze in rats, indicating that BDNF may be one of the mediators of exercise-
induced cognitive enhancement (Ding et al., 2006; Vaynman et al., 2004). Further, regular 
physical exercise in rats, specifically wheel-running, stimulates brain vascularization 
(Kleim, Cooper, & VandenBerg, 2002), increases levels in brain catecholamines, particularly 
dopamine and noradrenaline (Sutoo & Akiyama, 2003), and BDNF, which in turn increases 
neuronal survival (Berchtold, Castello, & Cotman, 2010; Barde, 1994) and neurogenesis 
(Creer et al., 2010; van Praag, Christie, et al., 1999; van Praag, Kempermann, et al., 1999). 
In summary, animal studies suggest BDNF protects neurons from effects of damage, 
plays a role in modifying synaptic connections, modulates hippocampal LTP, and can 
influence behavior – specifically memory. BDNF levels are influenced by age, exercise, and 
under some level of genetic control. Studies in human subjects demonstrate that the Met 
allele of the BDNF Val66Met SNP is associated with lower hippocampal volume, functional 
activity, and with weaker performance on tests of memory and executive function.  
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BDNF Val66Met (rs6265) Predictions 
 The extant literature suggests that Met Carriers have diminished activity-dependent 
secretion of  BDNF and reduced performance on behavioral tests. Therefore, I expect that in 
my sample, the Met Carriers will also show reduced cognitive  performance compared to 
non-Met Carriers. In terms of the interaction between BDNF Val66Met and 
cardiorespiratory fitness level, I predict a stronger positive relationship between Fitness 
Level and behavioral performance in Met Carriers compared to non-Met Carriers. This 
prediction is based on the assumption that Met Carriers will benefit cognitively from a 
fitness-induced increase of BDNF. 
 
BDNF Val66Met (rs6265) Results 
There were no significant differences between the groups on age, education, 
mMMSE, BMI or VO2 (Table 4.6). Chi-square analysis showed the distribution of males and 
females was not significantly difference between the groups (Table 4.6). Task means and 
standard deviations are reported in Table 4.7. 
 
BDNF: Verbal Crystallized Intelligence 
Verbal crystallized intelligence has been shown to remain relatively stable in older 
adult populations (Hedden & Gabrieli, 2004; Park & Gutchess, 2002). Due to the relative 
stability of the verbal crystallized intelligence, I do not expect to find an effect of the BDNF 
Val66Met SNP or its interaction with cardiorespiratory fitness level. 
KBIT test. The sample size for the KBIT test was N = 194, with group sizes as 
follows: Val/Val = 177, Met Carriers = 17. Analysis of covariance (ANCOVA) showed non-
significant differences between the BDNF Val66Met allelic groups, F(1, 189) < 1.  
When cardiorespiratory fitness level was added into the model, the sample size was 
reduced to N = 159, with allelic group sizes as follows: Val/Val = 144, Met Carriers = 15. 
The interaction between BDNF Val66Met X Fitness Level explained 2.8% of the variance in 
age-scaled scores, ΔR2 = .028, ΔF(1, 152) = 5.56, p = .020 (Figure 4.10). Simple slopes 
analysis revealed the age-scaled scores increased with increasing VO2 for the Met Carriers, 
B = 2.22,  = 1.31, t(152) = 2.64, p = .002, 95% CI [-0.10, 3.31], but not for Val/Val 
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Homozygotes, B = 0.20,  = 0.15, t(152) = 0.94, p = .372, 95% CI [-0.23, 0.64]. These results 
suggest verbal crystallized intelligence can be differentially influenced by varying 
cardiorespiratory fitness level and BDNF secretion. 
 
BDNF: Memory Tests 
Performance on tests of working and spatial memory are seen to decrease in older 
adult populations, in contrast to more stable performance on tests of short-term memory 
(Hedden & Gabrieli, 2004; Park & Gutchess, 2002).  In terms of the BDNF Val66Met SNP, 
Met Carriers are biologically associated with less BDNF secretion and have been shown to 
have a reduced performance compared to Val/Val homozygotes on tests of working and 
spatial memory, but not short-term memory (Egan et al., 2003; Hariri et al., 2003). In terms 
of the BDNF Val66Met allele, Met Carriers have been shown to have a reduced performance 
compared to Val/Val homozygotes on tests of working and spatial memory, but not short-
term memory (Egan et al., 2003; Hariri et al., 2003). The extant literature shows that 
memory performance increases with increasing fitness levels. Taking into consideration 
these previous findings, I expect that Met Carriers will show a greater behavioral benefit 
from increasing cardiorespiratory fitness levels compared to Val/Val homozygotes.  
Digit span test. The sample size was N = 196 with allelic group sizes as follows: 
Val/Val = 179, Met Carriers = 17. There were no significant group differences on the 
number of digits repeated for either version of the digit span test, forward and backward 
both F(1, 191) <1. When cardiorespiratory fitness level was added into the model, the 
sample size was reduced to N = 161 with allelic group sizes as follows: Val/Val = 146, Met 
Carriers = 15. The interaction did not significantly explain variance in either version: 
forward, ΔR2 = .000, ΔF(1, 154) < 1; backward, ΔR2 = .001, ΔF(1, 154) < 1.  
Spatial memory test. The sample size was N = 176 with allelic group sizes as 
follows: Val/Val = 160, Met Carriers = 16. There were no significant group differences on 
response time (RT) or error rate (ER) for any memory load (Table B.3). When 
cardiorespiratory fitness level was added into the model, the sample size was reduced by N 
= 144 with allelic group sizes as follows: Val/Val = 130, Met Carriers = 14. The interaction 
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between BDNF Val66Met X Fitness Level did not significantly explain variance in RT or ER 
for any memory load (Table 4.8). 
 
BDNF: Executive Control Function Tests 
Increasing age most negatively affects performances on tests requiring some form of 
executive control (Hedden & Gabrieli, 2004; Park & Gutchess, 2002). I expect Val/Val 
homozygotes to perform better than Met allele carriers. Increasing age most negatively 
affects performances on tests requiring some form of executive control (Hedden & Gabrieli, 
2004; Park & Gutchess, 2002), but higher levels of fitness tend to be associated with better 
executive control (Colcombe & Kramer, 2003). The Met allele is biologically associated with 
less BDNF secretion and behaviorally with worse performance on tests of executive control 
(Egan et al., 2003). Therefore, I expect Val/Val homozygotes to outperform carriers of the 
Met allele, and an interaction effect such that Met Carriers will show a positive fitness 
effect, but the Val/Val homozygotes will show less of an effect or no effect at all. 
Verbal fluency test (FAS). The sample size for the word fluency test was N = 196, 
with group sizes as follows: Met Carriers = 17, Val/Val = 179. ANCOVA showed no 
differences between the allelic groups on words named, F(1, 191) < 1. When 
cardiorespiratory fitness level was added into the model, the sample size was reduced to N 
= 161, with group sizes as follows: Met Carriers = 15, Val/Val = 146. Hierarchical regression 
showed the interaction between BDNF Val66Met x Fitness Level marginally explained 1.7% 
of the variance in the number of words named, ΔR2 = .017, ΔF(1, 154) = 2.98, p = .086 
(Figure 4.8). Simple slopes analysis revealed the number of words named marginally 
increased with increasing VO2 for the Met Carriers, B = 1.70,  = 0.98, t(154) = 1.84, p = 
.074, 95% CI [-0.70, 3.67], but not for the Val/Val Homozygotes, B = 0.08,  = 0.06, t(154) = 
0.34, p = .706, 95% CI [-0.32, 0.53].  
Wisconsin card sorting test (WCST). The sample size for the WCST was N = 182, 
with group sizes as follows: Met Carriers = 14, Val/Val = 168. ANCOVA did not show 
significant difference between the groups on performance measured by total errors, F(1, 
177) = 1.68, p = .196, or percent perseverative errors, F(1, 177) < 1. When 
cardiorespiratory fitness level was added into the model, the sample size was reduced to N 
 
 
108 
= 150, with group sizes as follows: Met Carriers = 13, Val/Val = 137. Hierarchical regression 
showed the interaction between BDNF Val66Met x Fitness Level did not significantly 
explain any variance in total errors, ΔR2 = .007, ΔF(1, 143) = 1.09, p = .298, but it did 
marginally explain 2.2% of the variance in percent perseverative errors, ΔR2 = .022, ΔF(1, 
143) = 3.44, p = .066 (Figure 4.12). Simple slopes analysis revealed percent perseverative 
errors increased with increasing VO2 for the Met Carriers, B = 1.26,  = 0.87, t(143) = 1.52, 
p = .029, 95% CI [0.20, 3.08], but not for the Val/Val Homozygotes, B = -0.30,  = -0.26, 
t(143) = -1.55, p = .134, 95% CI [-0.71, 0.07]. This was unexpected since higher levels of 
cardiorespiratory fitness are typically associated with increased cognitive flexibility. These 
results suggest a more complex relationship between fitness and behavior overall, and 
further when other factors, such as the BDNF Val66Met SNP, are taken into account. 
Dual task test. The sample size for the dual task test N = 158, with group sizes as 
follows: Met Carriers = 15, Val/Val = 143. ANCOVA showed no differences between the 
groups on response time (RT) for either single, F(1, 153) < 1, or dual trials, F(1, 153) = 1.59, 
p = .209 (Figure B.5a). However, the groups did significantly differ on an RT cost score (i.e. 
dual RT – single RT), F(1, 153) = 4.34, p = .039, with the Met Carriers showing a lower RT 
cost compared to the Val/Val Homozygotes, mean difference = -69.12, p = .011, 95% CI [-
120.74, -13.84] (Figure B.5b).  Further, there were no differences between the groups on 
error rate (ER) for either trial type, both F(1, 153) < 1. When cardiorespiratory fitness level 
was added into the model, the sample size was reduced to N = 151, with group sizes as 
follows: Met Carriers = 14, Val/Val = 137. Hierarchical regression showed that the 
interaction between BDNF Val66Met x Fitness Level did not significantly explain any 
variance in RT or ER for either trial type (Table 4.9). 
 
Growth Factors Combined 
To further study the effects of the growth factor genes on cognition in healthy older 
adults, I conducted an analysis using a combination of the two SNPs. I created a high 
growth factor (high GF; i.e. high IGF1 and BDNF) group which included those that were 
Val/Val homozygotes on the BDNF Val66Met SNP and G/G homozygotes on the IGF1 G/A 
SNP. I compared this group to a low growth factor (low GF; i.e. low IGF1 and BDNF) group 
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which included those that were Met allele carriers on the BDNF Val66Met SNP and A/A 
homozygotes on the IGF1 G/A SNP.  
There were no significant differences between the Low GF and High GF groups on 
education, mMMSE, BMI or VO2, but there was a marginal age difference (Table 4.10). Chi-
square analysis showed the low GF group had less males and more females than expected 
and vice versa for the high GF group. Means and standard deviations for the primary 
measures on the behavioral tests are reported in in Table 4.11. 
 
Verbal Crystallized Intelligence 
KBIT test. The sample size for the KBIT test was N = 30, with genotypic group sizes 
as follows: low GF = 10, high GF = 20. As expected, there was no significant difference 
between the groups on the age-scaled scores F(1, 25) < 1, suggesting the growth factor 
genes does not influence verbal crystallized intelligence.  
When cardiorespiratory fitness level was added to the model, the sample size for the 
KBIT test was reduced to N = 27, with genotypic group sizes as follows: low GF = 8, high GF 
= 19. Hierarchical regression showed the interaction between GF Genes x Fitness Level did 
not explain a significant proportion of variance in the age-scaled scores, ΔR2 = .024, ΔF(1, 
20) = 1.01, p = .328. This followed predictions that the growth factor genes nor 
cardiorespiratory fitness level would affect verbal crystallized intelligence. 
 
Memory Tests 
Digit span test. The sample size for the digit span test was N = 30, with genotypic 
group sizes as follows: low GF = 10, high GF = 20. No significant differences were found 
between the groups for forward span, F(1, 25) < 1, but the low GF group performed 
significantly better on the backward span, F(1, 25) = 4.60, p = .042, mean difference = 1.09, 
p = .042, 95% CI [-0.04, 1.99] (Figure B.6). These results were expected for the forward 
span, a test of short-term memory, but for the backward span, a test of working memory, I 
did not expect the low GF group to perform better than the high GF group.  
 When cardiorespiratory fitness level was added into the model the sample size for 
the digit span tests was reduced to N = 27, with genotypic group sizes as follows: low GF = 
8, high GF = 19. Hierarchical regression showed no interaction effect of GF Genes x Fitness 
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Level on either forward span, ΔR2 = .068, ΔF(1, 20) = 1.71, p = .205, or backward span, ΔR2 
= .014, ΔF(1, 20) < 1. Based on previous studies showing increasing fitness levels can 
increase GF levels, and that the GF genotypes influences GF levels, I expected a potential 
interaction between the two variables. 
Spatial memory test. The sample size for the spatial memory test was N = 23 with 
genotypic group sizes as follows: low GF = 9, high GF = 14. Against prediction, there were 
no significant differences between the groups on either response time (RT) or error rate 
(ER) for any memory load (Table B.3).  
Addition of cardiorespiratory fitness level reduced the sample size to N = 20, with 
genotypic group sizes as follows: low GF = 7, high GF = 13. The interaction between GF 
Genes x Fitness Level did not significantly explain variance in RT or ER for any memory 
load (Table 4.12). 
 
Executive Control Function Tests 
 Verbal fluency test (FAS). The sample size was N = 30, with genotypic group sizes 
as follows: low GF = 10, high GF = 20. There were no significant group differences on the 
number of words named, F(1, 25) < 1. When cardiorespiratory fitness level was added to 
the model, the sample size was reduced to N = 27, with genotypic group sizes as follows: 
low GF = 8, high GF = 19. The interaction between the GF Genes and Fitness significantly 
explained 11.3% of the variance in performance of the verbal fluency test, ΔR2 = .113, ΔF(1, 
20) = 5.74, p = .026 (Figure 4.10). Simple slopes analysis showed the number of words 
named significantly increased with VO2 only for the low GF group, B = 2.92,  = 2.65, t(20) = 
3.09, p = .014, 95% CI [-0.80, 5.86], but not the high GF group, B = 0.55,  = 0.50, t(20) = 
1.04, p = .408, 95% CI [-0.48, 1.78].  
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Growth Factor Figures 
 
  
Figure 4.1 Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on error 
rate for memory load 2 of the spatial memory test. The interaction significantly explained 4.7% of the 
variation in error rate for memory load 2, ΔR2 = .047, ΔF(2, 135) = 3.56, p = .031. Simple slopes A/A, B = -.001, 
 = -0.10, t(135) = -0.33, p = .682, 95% CI [-.005, .003]; G/A group, B = -.008,  = -0.88, t(135) = -2.40, p = .037, 
95% CI [-.015, .000]; G/G, B = .008,  = 0.53, t(135) = 1.37, p = .181, 95% CI [-.007, .022]. 
 
 
 
 
 
ΔR2 = .047, p = .031 
G/G:  = 0.53, p = .181 
G/A:  = -0.88, p = .037 
A/A:  = -0.10, p = .682 
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Figure 4.2 Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on 
response time for all trial types of the Stroop test. The interaction between IGF1 G/A x Fitness Level 
significantly explained variance in response time for each trial type (simple slopes reported in Table 4.5) a) 
neutral RT, ΔR2 = .066, ΔF(2, 142) = 5.50, p = .005 b) congruent RT, ΔR2 = .041, ΔF(2, 142) = 3.29, p = .040 
a 
b 
ΔR2 = .066, p = .005 
G/G:  = 0.03, p = .921 
G/A:  = -1.14, p = .002 
A/A:  = 0.01, p = .968 
ΔR2 = .041, p = .040 
G/G:  = -0.32, p = .240 
G/A:  = -0.91, p = .028 
A/A:  = 0.04, p = .888 
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Figure 4.2 cont. Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on 
response time for all trial types of the Stroop test. The interaction between IGF1 G/A x Fitness Level 
significantly explained variance in response time for each trial type (simple slopes reported in Table 4.5) c) 
incongruent-ineligible RT, ΔR2 = .040, ΔF(2, 142) = 3.28, p = .041 d) incongruent eligible RT, ΔR2 = .038, ΔF(2, 
142) = 3.08, p = .049. 
c 
d 
ΔR2 = .040, p = .041 
G/G:  = 0.14, p = .582 
G/A:  = -0.88, p = .012 
A/A:  = -0.09, p = .784 
ΔR2 = .038, p = .049 
G/G:  = 0.13, p = .662 
G/A:  = -0.88, p = .016 
A/A:  = -0.03, p = .929 
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Figure 4.3 Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on error 
rate for all trial types of the Stroop test. The interaction between IGF1 G/A x Fitness Level marginally 
explained variance in error rate only for the incongruent eligible trials but the trend was similarly for other 
trial types a) neutral RT, ΔR2 = 0.01, ΔF(2, 142) = 1.06, p = .349 b) congruent RT, ΔR2 = 0.01, ΔF(2, 142) = 0.96, 
p = .387 
a 
b 
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Figure 4.3 cont. Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on 
error rate for all trial types of the Stroop test. The interaction between IGF1 G/A x Fitness Level marginally 
explained variance in error rate only for the incongruent eligible trials but the trend was similar for other 
trial types c) incongruent-ineligible RT, ΔR2 = 0.02, ΔF(2, 142) = 1.62, p = .201 d) incongruent eligible RT, ΔR2 
=0.03, ΔF(2, 142) = 2.83, p = .062 
 
c 
d 
ΔR2 = .033, p = .062 
G/G:  = 0.01, p = .961 
G/A:  = -0.56, p = .052 
A/A:  = 0.20, p = .533 
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Figure 4.4 Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on error 
rate for the singe condition of the task switch test. The interaction marginally explained 3.6% of the variance 
in ER for the single condition, ΔR2 = .036, ΔF(2, 122) = 2.54, p = .083. Simple slopes: A/A group, B = -.002,  = -
0.29, t(122) = -0.87, p = .350, 95% CI [-.007, .002]; G/A, B = -.005,  = -0.63, t(122) = -1.61, p = .156, 95% CI [-
.012, .003]; G/G group, B = -.012,  = -0.99, t(122) = -2.94, p = .049, 95% CI [-.023, .000].   
 
 
Figure 4.5 Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on 
response time for the mix condition repeat trial type of the task switch test. The interaction marginally 
explained 4.3% of the variance in RT for repeat trials, ΔR2 = .043, ΔF(2, 122) = 3.02, p = .052. Simple slopes: 
ΔR2 = .036, p = .083 
G/G:  = 0.99, p = .049 
G/A:  = -0.63, p = .156 
A/A:  = 0.29, p = .350 
ΔR2 = .043, p = .052 
G/G:  = -.288, p = .199 
G/A:  = -.607, p = .041 
A/A:  = .149, p = .673 
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A/A, B = 2.65,  = .149, t(122) = 0.49, p = .673, 95% CI [-10.19, 14.39]; G/A group, B = -11.31,  = -.607, t(122) 
= -1.70, p = .041, 95% CI [-22.95, -1.07], G/G group, B = -8.49,  = -.288, t(122) = -0.92, p = .199, 95% CI [-
26.64, 9.66] 
 
 
Figure 4.6 Interaction effect between the IGF1 G/A SNP and cardiorespiratory fitness level (i.e. VO2) on 
response time for the dual trial type of the dual task test. The interaction marginally explained 2.8% of the 
variance in RT for dual trials, ΔR2 = .028, ΔF(2, 141) = 2.35, p = .099. Simple slopes: A/A, B = 3.60,  = 0.21, 
t(141) = 0.70, p = .559, 95% CI [-8.50, 15.60]; G/A, B = -8.48,  = -0.46, t(141) = -1.33, p = .154, 95% CI [-21.14, 
2.62]; G/G group, B = -14.26,  = -0.48, t(141) = -1.52, p = .058, 95% CI [-30.98, 0.27] 
 
ΔR2 = .028, p = .099 
G/G:  = -.483, p = .058 
G/A:  = -.462, p = .154 
A/A:  = .205, p = .559 
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Figure 4.7 Interaction effect between BDNF Val66Met and cardiorespiratory fitness level (i.e. VO2) on the 
KBIT test. The interaction explained 2.8% of the variance in age-scaled scores, ΔR2 = .028, ΔF(1, 152) = 5.56, p 
= .020. Simple slopes: Met Carriers, B = 2.22,  = 1.31, t(152) = 2.64, p = .002, 95% CI [-0.10, 3.31]; Val/Val 
Homozygotes, B = 0.20,  = 0.15, t(152) = 0.94, p = .372, 95% CI [-0.23, 0.64] 
 
 
Figure 4.8 Interaction effect between BDNF Val66Met and cardiorespiratory fitness level (i.e. VO2) on the 
verbal fluency test. The interaction marginally explained 1.7% of the variance in the number of words named, 
ΔR2 = .017, ΔF(1, 154) = 2.98, p = .086. Simple slopes: Met Carriers, B = 1.70,  = 0.98, t(154) = 1.84, p = .074, 
95% CI [-0.70, 3.67]; Val/Val Homozygotes, B = 0.08,  = 0.06, t(154) = 0.34, p = .706, 95% CI [-0.32, 0.53]. 
ΔR2 = .028, p = .020 
Val/Val:  = 0.15, p = .372 
Met Carriers:  = 1.31, p = .002 
ΔR2 = .017, p = .086 
Val/Val:  = 0.06, p = .706 
Met Carriers:  = 0.98, p = .074 
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Figure 4.9 Interaction effect between BDNF Val66Met and cardiorespiratory fitness level (i.e. VO2) on 
performance of the Wisconsin Card Sorting Test measured by percent perseverative errors. The interaction 
marginally explained 2.2% of the variance in percent perseverative errors, ΔR2 = .022, ΔF(1, 143) = 3.44, p = 
.066. Simple slopes: Met Carriers, B = 1.26,  = 0.87, t(143) = 1.52, p = .029, 95% CI [0.20, 3.08]; Val/Val 
Homozygotes, B = -0.30,  = -0.26, t(143) = -1.55, p = .134, 95% CI [-0.71, 0.07]. 
 
 
Figure 4.10 Interaction effect between the growth factor (GF) genes combined and cardiorespiratory fitness 
level (i.e. VO2) on performance of the verbal fluency test. The interaction significantly explained 11.3% of the 
ΔR2 = .022, p = .066 
Val/Val:  = -0.26, p = .134 
Met Carriers:  = 0.87, p = .029 
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variance, ΔR2 = .113, ΔF(1, 20) = 5.74, p = .026. Simple slopes: low GF group, B = 2.92,  = 2.65, t(20) = 3.09, p 
= .014, 95% CI [-0.80, 5.86]; high GF group, B = 0.55,  = 0.50, t(20) = 1.04, p = .408, 95% CI [-0.48, 1.78]. 
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Chapter 5: General Discussion 
 This study was conducted as an exploratory investigation into the interactive effects 
of genes and cardiorespiratory fitness level on cognition in healthy older adults. Specific 
genes were chosen because of the neurobiological significance of the protein products.  
Specifically, two dopamine related genes, Catechol-O-Methyltransferase (COMT) and 
Dopamine Beta Hydroxylase (DBH), each with two different single nucleotide 
polymorphisms (SNPs); and two growth factor related genes, Brain-derived Neurotrophic 
Factor (BDNF) and Insulin-like Growth Factor I (IGF1). In animal models it is possible to 
measure and manipulate neurochemical levels (e.g. gene knock outs, microdialysis, or 
direct injection of a neurochemical or receptor agonist/antagonist into the brain) and 
observe its effects on behavior. However, this level of control or even monitoring of any 
neurochemical level within the human brain can be difficult and impractical. Enter natural 
genetic variation. By investigating naturally occurring variation in genes whose products 
have well-defined biological actions, it is possible to infer high-medium-low neurochemical 
groups (Raz & Lustig, 2014) and observe their effects on behavior.  
Further, considering external factors and investigating potential interactions with 
genetics acknowledges the complexity of what contributes to variability in behavior. Twin 
studies lay the foundation for the heritability of cognitive abilities and the increasing 
influence of genetics on various aspects of cognition in later life. Therefore, genetic and 
interactive effects not seen in young and middle adult populations may be elucidated 
through older adult populations. Studying the effects of genetics and its interaction with 
positive lifestyle factors, such as exercise or physical activity, is also interesting as it could 
lead to easy ways to counterbalance negative genetic predisposition. For example, there is 
already a company offering personalized weight loss and fitness plans based on genetic 
status (www.fitnessgenes.com), and it is conceivable that the future holds individualized 
cognitive therapies based on genetic status. 
 
Dopamine Related Genes 
Dopamine (DA) related genes were chosen due to DA’s known role in cognitive 
functioning (Cools & Robbins, 2004; Seamans & Yang, 2004), as well the contribution 
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aging-related decline in the DA system has toward aging-related cognitive decline (Cabeza, 
2001a). Dopamine Beta Hydroxylase (DBH) and Catechol-O-Methyltransferase (COMT) 
were chosen because of their influence on the variability of dopamine (DA) levels in the 
body and brain. I investigated the genotypic effect of each SNP for each gene independently 
and then brought cardiorespiratory fitness into the mix. There are two perspectives here: 
1) can a “bad” genotype be rescued? and 2) can genetics help explain the variability in the 
relationship between cardiorespiratory fitness level and cognition? Based on aging and 
exercise effects on the DA system, I predicted cardiorespiratory fitness level would have a 
positive influence on performance for tests of memory and executive control. I expected 
this relationship to be strongest for those with the allele that leads to the lowest DA levels 
under the assumption they had the most to gain. 
 
Dopamine Beta Hydroxylase 
Dopamine Beta Hydroxylase (DBH) is an enzyme that converts dopamine (DA) into 
norepinephrine (NE) and variation in the DBH gene leads to variability in the DA:NE ratios 
in the brain (Cubells & Zabetian, 2004). I investigated two common single nucleotide 
polymorphisms (SNP), DBH 444 G/A and DBH -1021 C/T, related to the DBH gene. 
Previous literature showed the groups with alleles translating to higher DBH levels and 
thus lower DA:NE ratios (i.e. G allele for the DBH444 G/A SNP and C allele for the DBH -
1021 C/T SNP) showed better cognitive functioning. Specifically, spatial memory 
performance increased with increasing G allele load for the DBH 444 G/A SNP (Greenwood 
et al., 2009; Parasuraman et al., 2005), and better response inhibition was seen with 
increasing C allele load for the DBH -1021 C/T SNP (Greene et al., 2009). However, these 
studies used middle aged or a mixed middle and older adult samples. I predicted in our 
sample of older adults, we would observe a reversal of this genetic effect such that the 
groups with the allele that is believed to translate to lower DBH levels and in turn higher 
DA:NE (i.e. A allele for DBH 444 G/A and T allele for the DBH -1201 C/T) would show 
better performance on various tests of memory and executive control and that is what I 
found. 
For the DBH 444 G/A analysis, results point to the A allele leading to better 
maintenance and switching of sets. For the DBH -1021 C/T SNP, T Carriers showed better 
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performance on a test of working memory and were faster on a test of spatial memory. 
Furthermore, T Carriers had better performance on a test of verbal fluency and were found 
to be faster across several tasks of executive control. In all cases, there were no differences 
found between the groups on error, implying there was no sacrifice of accuracy for speed of 
response. These results are consistent with a more recent study that found cognitive costs 
to the C allele of the DBH -1021 C/T SNP only in their older adult group (Greenwood, Lin, 
Sundararajan, Fryxell, & Parasuraman, 2014). 
 
DBH genotypic effects. The DBH 444 G/A SNP showed a genotypic effect on 
executive function, specifically maintenance and coordination of multiple task goals. This 
effect was seen on error rates (ER) of the task switch test. For the single condition, the G/A 
group showed the lowest error rates, while the G/G group showed the highest error rates 
during the mix condition (Figure A.1a). Overall, the A/A group showed the lowest global 
error cost (i.e. mix condition ER -  single condition ER; Figure A.1b). Further, the G/G group 
had the highest errors on both the repeat and single trials of the mix condition (Figure A.2). 
Taken together, the results support the prediction that the A allele of the DBH 444 G/A SNP 
leads to better executive functioning. 
The DBH -1021 C/T SNP had effects on both memory and executive control tests. 
Specifically, T Carriers were faster across all memory loads of the spatial memory test 
while showing no differences on error rate (Figure A.3). T Carriers were also faster on both 
trial types of the Flanker test, with no group differences on error rate for either trial type, 
suggesting T Carriers were generally faster and had better inhibitory processing compared 
to C/C Homozygotes. Further, T Carriers showed better maintenance and coordination of 
multiple task goals, evidenced by better performance on both the task switch test and the 
dual task test. For the task switch test, T Carriers had faster response times on the more 
difficult mix condition of the task switch test (Figure A.5a) and lower global cost scores (i.e. 
mix condition – single condition) for both response time and error rate (Figure A.5b and d 
respectively). Additionally, within the mix condition, T Carriers were significantly faster on 
switch trials and marginally faster on repeat trials (Figure A.6), while showing no group 
differences on error rate for either trial type. For the dual task test, T Carriers were 
significantly faster on single trials and marginally faster on dual trials (Figure A.7), with no 
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group differences on error rate. These results suggest that carriers of the T allele for the 
DBH -1021 SNP are more effective at both shifting and time-sharing. 
Further, there was an additive effect of the two DBH SNPs on executive functioning. 
The DBH High DA group showed better inhibitory processing through significantly faster 
response times on both congruent and incongruent trials of the Flanker test (Figure A.8). 
This group also showed a trend toward more effective maintenance and coordination of 
multiple tasks through marginally lower global error cost (i.e. mix condition ER – single 
condition ER; Figure A.9). 
Collectively, these results follow the prediction that possession of the alleles that 
translate to higher DA levels (i.e. A allele for DBH 444 G/A and T allele for DBH -1021 C/T) 
would lead to better cognitive functioning. 
 
DBH x Fitness Level interactive effects. Results also showed DBH genotype 
moderated the effect of cardiorespiratory fitness level (CRF; measured by VO2) on cognitive 
test performance in this sample of healthy sedentary older adults. Specifically, the DBH 444 
G/A SNP moderated the effect of CRF on maintenance of multiple task goals and shifting. 
The G/G and A/A groups both showed a significant decrease in errors during the mix 
condition with increasing VO2 scores (Figure 3.1b). This effect was driven by the G/G and 
A/A groups showing a decrease in errors during switch trials with increasing VO2 (effect 
was marginal in A/A group; Figure 3.2b). 
For the DBH -1021 C/T SNP, there was a significant interaction effect on working 
memory measured by the backward span test, suggesting the relationship between CRF 
and working memory differs for T Carriers versus C/C Homozygotes (Figure 2.3b). 
Although simple slopes analysis did not reveal a significant relationship between VO2 and 
backward span length, the trend was a positive relationship in T Carriers. Further, the DBH 
-1021 C/T SNP moderated the effect of CRF on cognitive flexibility measured by total errors 
on the Wisconsin Card Sorting Test. Again, only T Carriers showed a decrease in total 
errors with increasing VO2 (Figure 3.4).  
The analysis with the combined DBH SNPs showed an interactive effect on shifting 
as measured by the task switch test. The DBH Low DA group showed a significant decrease 
in local ER cost (i.e. switch trial ER – repeat trial ER) with increasing VO2.  
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My prediction was that the group with the alleles translating to lower DA levels (i.e. 
G allele for DBH 444 G/A and C allele for DBH -1021 C/T) would show the greatest benefit 
from increasing CRF. Although, the combined DBH SNPs followed my prediction, a clear 
pattern did not emerge from the results of the individual SNPS, suggesting each SNP may 
moderate the relationship differently. This study suggests there is an interactive effect of 
the DBH gene and cardiorespiratory fitness level on cognition in healthy older adults, but 
further investigations with greater power are needed to elucidate the nature of the 
interaction. 
 
Catechol-O-Methyltransferase 
The Catechol-O-Methyltransferase (COMT) gene encodes for a methylation enzyme 
that metabolizes catecholamines including dopamine (Axelrod & Tomchick, 1958), and 
plays a key role in the prefrontal cortex (PFC) where there is a low level of dopamine 
transporters (DAT; Chen et al., 2004). COMT was chosen as a candidate gene because of its 
potential to control the basal DA neurotransmission levels within the PFC, which could 
contribute to individual differences in human behavior. Two common SNPs in the COMT 
gene were chosen for investigation: 1) COMT Val158Met, which effects enzymatic activity, 
and 2) COMT C/G, which affects enzyme availability. 
COMT Val158Met is a functional SNP that causes a valine (Val) to methionine (Met) 
switch in the amino acid sequence at codon 158. This change to Met produces a less 
thermostable enzyme, leading to a 40% decrease in enzymatic activity and resulting in 
higher PFC DA levels (Chen et al., 2004; Lotta et al., 1995; Savitz et al., 2006). The COMT 
C/G SNP affects mRNA secondary structure, consequently affecting protein synthesis, but 
not the functioning of the enzyme itself (Nackley et al., 2006). Carriers of the C allele are 
believed to have lower COMT activity due to less efficient protein synthesis (Diatchenko et 
al., 2005; Nackley et al., 2006).  
The results from this study also add to the many findings related to the COMT 
Val158Met SNP and extend the findings of the less investigated SNP, COMT C/G. Further, 
the study explores the results of an additive effect of the two polymorphisms on cognition 
as well as the interactive effect of the COMT gene with cardiorespiratory fitness level in a 
sample of healthy older adults. 
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COMT genotypic effects. The COMT Val158Met SNP had an effect on both memory 
and executive control tests, with Val/Val homozygotes generally showing better 
performance. Specifically, Val/Val homozygotes showed better working memory as 
evidenced by marginally larger backward span lengths compared to both Val/Met 
heterozygotes and Met/Met homozygotes (Figure A.10). Val/Val homozygotes were also 
significantly faster on all memory loads of the spatial memory test (Figure A.11), with no 
differences found on error rate. 
 On tests of executive control, Val/Val homozygotes were significantly faster on both 
congruent and incongruent trial types for the Flanker test (Figure A.12a), but this group 
also showed the highest error rates on incongruent trials (Figure A.12c) and ER cost (i.e. 
incongruent trial ER – congruent trial ER; Figure A.12d). There is potential that the Val/Val 
group sacrificed accuracy for speed, therefore I am hesitant to interpret these results since 
the instructions to favor accuracy over speed were not followed. 
However, the COMT Val158Met SNP did have an effect on coordination, specifically 
time-sharing, with the Val/Val group showing the fastest response times on both single and 
dual trials of the dual task test (Figure A.13a and b), and a marginally lower ER cost (i.e. 
dual trial ER – single trial ER; Figure A.13d).  
The COMT C/G SNP also had an effect on both memory and executive control tests. 
Specifically, G Carriers showed marginally larger backward span lengths (Figure A.14) and 
were faster on all memory loads of the spatial memory test with no differences found on 
error rate (Figure A.15). These results suggest that the COMT C/G SNP influences working 
and spatial memory. Furthermore, G Carriers showed marginally better inhibitory 
processing as evidenced by faster RTs on incongruent trials of the Flanker test (Figure 
A.16), with no differences on error rate. G Carriers also showed a significantly lower RT 
cost (i.e. dual trial RT – single trial RT; Figure A.17b) compared to C/C Homozygotes, 
suggesting they were better at time-sharing.  
When both COMT SNPs were combined, there was an additive effect on the tests of 
working and spatial memory. The COMT Low DA group (i.e. Val/Val + G Carriers) had 
significantly longer backward span lengths and were faster across all memory loads of the 
spatial memory test. Further, the COMT Low DA group showed better time-sharing ability. 
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They were significantly faster on both single and dual trials of the dual task test and 
showed a significantly lower RT cost to the dual trial type. 
Collectively, the results are in the opposite direction of prediction. Based on the 
extant literature and the assumption that the Val allele of the COMT Val158Met SNP and 
the G allele of the COMT C/G SNP lead to lower prefrontal dopamine availability, I expected 
Val/Val homozygotes and G Carriers to show worse performance on the tests of memory 
and executive control functioning. These results add to the equivocal literature and 
implicate the need to take other factors into consideration such as gene x gene or gene x 
external factor interactions. 
 
COMT x Fitness Level interactive effects. When cardiorespiratory fitness level 
(CRF) was taken into account, I did find that the COMT Val158Met SNP moderated its effect 
on working memory such that only the Val/Val group showed an increase in backward 
span length with increasing VO2 (Figure 3.6b). There was also a marginal interactive effect 
on processing speed measured by congruent trials of the Flanker test. Results suggest the 
relationship between CRF and response time in congruent trials are different, but there 
was not enough power to tease apart the different directions for each group (Figure 3.7). 
On the dual task test, somewhat oddly, Val/Met heterozygotes showed an increase in the 
RT cost (i.e. dual trial RT – single trial RT; Figure 3.8) with increasing cardiorespiratory 
fitness level. This was unexpected since increases in cardiorespiratory level are typically 
associated with increases in performance on a variety of cognitive tests.  
The COMT C/G SNP moderated the relationship between CRF and executive 
functioning. Specifically, there was a significant interaction on the WCST with the C/C 
Homozygotes showing a marginal decrease in percent perseverative errors with increasing 
VO2. There was also an interactive effect on the dual task test, with G Carriers showing a 
significant increase in RT cost (i.e. dual trial RT – single trial RT), which again was 
unexpected for the same reason as mentioned above.  
When the two COMT SNPs were combined, there was an interactive effect on 
working memory with the COMT Low DA group showing an increase in backward span 
length with increasing VO2. There was also a marginal effect on the WCST with the COMT 
High DA group showing a decrease in percent perseverative errors with increasing VO2.  
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My prediction was that the alleles translating to lower prefrontal dopamine (i.e. Val 
allele on COMT Val158Met and G allele on COMT C/G) would benefit the most from an 
increased CRF, but the results of this study are difficult to interpret. Taken together, they 
suggest the COMT gene may moderate the relationship between cardiorespiratory fitness 
levels on cognition in healthy older adults, but further investigation is needed to discern 
the pattern of this moderation.  
Overall, these results imply that carriers of an allele that leads to higher COMT 
activity and thus lower DA levels show better performance on tests of spatial memory and 
executive functioning, specifically inhibition and multi-tasking. There is a hypothesis that 
Met Carriers of the COMT G/A SNP have higher PFC dopamine levels, allowing DA to diffuse 
away from the activated synapse and activate extrasynaptic D1 receptors. This D1 
activation enhances input-related neuronal excitability and increases inhibitory feedback 
to neurons not receiving input. On the other hand, in Val carriers who are thought to have 
less PFC DA levels, the DA remains local to the activated synapse and activates D2 
receptors, which reduces inhibitory interneuron activity, which leads to increases in non-
specific neuronal excitability. So Met carriers are used to “working” with a clearer signal to 
noise ratio, and with age-related declines in DA levels and D1 receptors, the shift from an 
efficient to a noisy system is detrimental. In other words, the age-related decline in D1 
receptors could be more detrimental to Met carriers because of the added noise to the 
signal (Tunbridge, Harrison, & Weinberger, 2006).  
However, since Val carriers are used to “working” with a noisy system, the age-
related declines in DA levels and D2 receptors may not have as detrimental an effect on 
them as for Met carriers. In fact, D2 receptor decline may actually help, because the 
inhibitory interneurons would not be activated by local DA, and with increasing task 
demands, the increased DA may be helpful. This same reasoning can be extended to the 
results from the COMT C/G SNP. 
Further, when cardiorespiratory fitness level is taken into account, there may be 
differential results due to the differences in the degree to which each test taxes the DA 
system. That is to say, the effects that cardiorespiratory fitness level has on the DA system 
(e.g. increased DA receptor density) may lead to benefits in one test, but be detrimental in 
another test for particular genotypes. 
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Growth Factor Genes 
Insulin-like Growth Factor I 
 Insulin-like growth factor I (IGF1) belongs to a family of growth factors known as 
somatomedins that play an important role in mammalian growth and development 
(Froesch et al., 1985). IGF1 contributes to brain development and overall brain health, 
evidenced by its diffuse expression pattern including the cortex, hippocampus, cerebellum, 
brainstem, hypothalamus and the spinal cord (Bach 1991). IGF1 has also been found to 
support cognitive ability (Arwert et al., 2005; Trejo et al., 2008; van Dam & Aleman, 2004). 
Further, exercise has been shown to increase IGF1 levels and blockage of IGF1 receptors 
eliminates exercise-induced augmentation of recall in rats (Ding et al., 2006). 
 The IGF1 gene was selected for investigation because 40-60% of variation in 
circulating IGF1 levels is determined by genetic factors (Harrela et al 1996; Verhaeghe et al 
1996; Hong et al 1997; Hall et al 1999), and there is a common SNP resulting in a G to A 
switch in exon 4 of the 3’ untranslated region containing regulatory domains for mRNA 
expression (rs6220; http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs6220). This SNP 
may alter the RNA stability and regulation of protein expression (Al-Zahrani et al., 2006; 
Huuskonen et al., 2011), and studies have shown that this SNP is associated with 
circulating levels of IGF1 protein such that the minor G allele is associated with higher 
levels of circulating IGF1 (Diorio et al., 2008; Johansson et al., 2007; Verheus et al., 2008). 
 To date, there are no studies investigating the relationship between the IGF1 G/A 
SNP and cognition. However, in a population-based study (N = 278), Licht et al., (2014) 
found no association between a different IGF1 polymorphism (i.e. variable length cytosine-
adenine repeat sequence) and cognitive functioning in their middle aged sample. 
Therefore, the results of this study are novel and predictions were based on the 
relationship between the IGF1 G/A SNP and IGF1 serum levels, and the effect of IGF1 serum 
levels on cognitive functioning. Since the  IGF1 G allele has been associated with higher 
levels of circulating IGF1 (Diorio et al., 2008; Johansson et al., 2007; Verheus et al., 2008), 
and in general, there is a positive association between IGF1 levels and cognitive functioning 
(Arwert et al., 2005; Bellar et al., 2011), I expected G carriers to perform better on both 
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tests of memory and executive functioning. Further, due to aging-related decreases in IGF1 
levels and exercise-induced increases, I expected A/A homozygotes to show cognitive 
benefits from higher cardiorespiratory levels. 
IGF1 genotypic effects. Following prediction, I found a genetic effect of the IGF G/A 
SNP on spatial memory. The G/A group was faster across all memory loads, and did not 
show differences on error rate. The IGF1 G/A polymorphism also showed effects on a few 
tests of executive control, and mostly followed my predictions. On the Stroop test, the G/G 
group was significantly faster than the other two groups on incongruent-ineligible trials. 
Although there were no significant differences for the other trial types, the trend remained 
the same. Further, on the dual task test, the G/G group showed the lowest RT cost, followed 
by the G/A, then A/A groups. The G/G group also showed the lowest error rate on both 
single and dual trial types. For the task switch test, the A/A group showed marginally less 
errors on switch trials compared to the G/A and G/G (highest errors) groups. This 
departure from prediction could point IGF1 having a differential effect on time-sharing 
versus shifting, but further investigation with more power would be required to confirm 
and elucidate this potential difference. 
Taken together, if the inference that the G allele leads to higher IGF1 levels holds 
true, these results are mostly consistent with the literature in which higher circulating IGF1 
levels were associated with better performance in a variety of cognitive domains including 
memory and executive functioning (Aleman et al., 1999; Rollero et al., 1998; van Dam & 
Aleman, 2004; Vitiello et al., 2006). 
IGF x Fitness Level interactive effects. When cardiorespiratory fitness level was 
taken into consideration, the interaction between IGF1 G/A x Fitness Level had an effect on 
spatial memory. The G/A group showed a significant decrease in errors with increasing VO2 
for Memory Load 2, implying that moderate levels of IGF1 lead to better spatial memory. 
 For the Stroop test, increasing levels of VO2 led to a significant decrease in response 
time across all trial types and a decrease in error rate for incongruent-ineligible trials for 
the G/A group. Again, this trend was seen across all trials. These results suggest higher 
levels of IGF1 may benefit response inhibition, and increased levels of cardiorespiratory 
fitness can benefit those expected to have moderate levels of IGF1 (i.e. G/A heterozygotes).  
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 On the task switch test, the G/G group showed a significant decrease in errors 
during the single condition with increasing VO2 levels. The G/A group showed a significant 
decrease in RT for repeat trials with increasing VO2 levels. For the dual task test, the G/G 
group showed a marginal decrease in RT with increasing VO2 during dual trials. These 
results suggest higher IGF1 levels are good for multiple set coordination. 
 Overall, the results imply those with a genetic predisposition for moderate to higher 
levels of IGF1 benefit the most from increased cardiorespiratory fitness level. 
Conclusions. The present study showed for the first time that the IGF1 G/A 
genotype (rs6220) may influence cognitive performance in healthy sedentary older adults, 
specifically spatial memory and executive functioning.  
 Results imply that having a G Allele may lead to better spatial memory, inhibitory 
processing and multi-tasking. Further, cardiorespiratory fitness level seems to have a 
positive association with cognitive functioning in G allele carriers, suggesting that 
cardiorespiratory fitness may benefit those that are genetically predisposed to higher 
levels of IGF1. That is to say, since IGF1 levels decrease with increased age, having the G 
allele may provide some cognitive protection, and higher levels of cardiorespiratory fitness 
can help even more. 
It is difficult to determine what is truly driving these effects, since variance in 
cardiorespiratory fitness level alone may not be enough to have an effect on cognitive 
performance. For example, in mice that were showing impaired spatial learning and 
reduced hippocampal adult neurogenesis due to low serum IGF1 levels, running exercise 
alone was not able to restore spatial learning ability or hippocampal neurogenesis – 
restoration only occurred with external IGF1 administration (Trejo et al., 2008). 
The IGF1 G/A genotype may have a real effect on cognitive performance in healthy 
older adults, and future investigations with larger sample sizes and consistent sampling of 
serum IGF1 levels would strengthen and further elucidate this relationship. Future 
investigations could not only expand the understanding of the association between IGF1 
G/A genotype and serum levels, but also the effects of serum levels on cognitive 
performance. 
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Brain-derived Neurotrophic Factor 
Brain-derived neurotrophic factor (BDNF) belongs to a family of growth factors 
called neurotrophins which are regulatory factors that mediate the differentiation, 
proliferation and survival of cholinergic, dopaminergic and serotonergic neurons (Savitz et 
al., 2006). Although BDNF is expressed throughout the brain, its effects are most apparent 
in the prefrontal cortex (PFC) and hippocampus (HC; Savitz et al., 2006). A common 
functional SNP in the BDNF gene (rs6265), G to A switch at nucleotide 196, results in a 
Valine (Val) to Methionine (Met) amino acid substitution at codon 66 (Val66Met). This SNP 
is located in the 5’ pro-BDNF sequence and it is unlikely that it affects the actual biological 
activity of the mature protein. Instead, it is believed to alter the intracellular processing 
and regulated activity-dependent secretion of mature BDNF (Egan et al., 2003). The Met 
allele is thought to selectively impair secretion and intracellular trafficking of BDNF in 
primary cortical neurons and neurosecretory cells (Egan et al., 2003; Savitz et al., 2006).  
The extant literature suggests Met allele carriers have reduced hippocampal volume 
(Bueller et al., 2006; Erickson et al., 2010; Pezawas et al., 2004), and cognitive impairments 
(Dincheva, Glatt, & Lee, 2012; Dincheva et al., 2012; Egan et al., 2003; Hariri et al., 2003; 
Miyajima et al., 2008).  
BDNF genotypic effects. My findings were not consistent with the literature in that 
Met Carriers showed a significantly lower RT cost in the dual task test. Although the allelic 
distribution did follow the Hardy-Weinberg equilibrium, I hesitate to draw conclusions 
from these results due to the small size of the Met group. Further investigations with a 
better distribution and more power to differentiate the effects between the groups are 
merited. 
BDNF x Fitness Level interactive effects. In relation to cardiorespiratory fitness 
level, Met Carriers showed a marginal increase in the number of words named during the 
verbal fluency test with an increase in VO2. And, oddly, the Met carriers also showed an 
increase in percent perseverative errors with an increase in VO2 on the Wisconsin Card 
Sorting Test. Again, the small size of the Met group most likely contributes to this odd 
result, but these results could also suggest a more complex relationship between 
cardiorespiratory fitness level and cognition. That is to say, higher is not always better; and 
other factors, such as genetics and external risk factors (not investigated here), may play a 
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role in the direction of the association between cardiorespiratory fitness level and 
cognition in healthy older adults. 
Conclusions. Results implied Met carriers of the BDNF SNP were better at multi-
tasking and verbal fluency, but also that an increase in cardiorespiratory fitness level may 
lead to more perseverative behavior. The low sample size for the Met Carriers in this 
sample make it difficult to detect true differences in the present study, even though the 
distribution of the BDNF alleles did conform to Hardy-Weinberg expectations.  
There is no doubt that BDNF is important to the development of a healthy brain, but 
evidence that varying levels due to a genetic basis influence higher level brain functioning 
is equivocal and further research with larger sample sizes is necessary. 
 
Growth Factor (GF) Genes Combined 
 GF Genes genotypic effects. When the two SNPS were combined into low and high 
growth factor (GF) groups, the low GF group performed significantly better on backward 
span. This was unexpected since growth factors are thought to have a protective effect 
against age-related cognitive declines through increases in brain health.  
GF Genes x Fitness Level interactive effects. However, the low GF group also 
showed a significant increase in the number of words named during the verbal fluency test 
with increasing VO2 suggesting increased cardiorespiratory fitness levels is beneficial to the 
cognitive flexibility of those with lower levels of growth factors. This analysis was purely 
exploratory and interpretations should be made cautiously due to the small group sizes. 
 
Caveats and Future Directions 
This study was undertaken as an exploratory analysis. One of the main limitations of 
this study was the sample size. Although the sample size was large for a functional 
neuroimaging study and a randomized controlled trial, it was small for a genetic analysis. 
Further, the cross-sectional nature of this particular analysis does not allow for knowledge 
of what contributed to the variability in participants’ cardiorespiratory fitness level. On top 
of that, this study was conducted on healthy older adults that were specifically recruited 
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because they were sedentary. This contributes to the small range of cardiorespiratory 
fitness in this sample. 
 A strength and a weakness of this study was the testing of different domains of 
cognitive behavior with a wide variety of tests. The strength is in the careful choosing of 
tasks to test associations with specific cognitive behaviors. And considering this was an 
exploratory investigation, analysis of individual performance measures is a good place to 
start. However, results may be more generalizable if performance measures were 
investigated: 1) where applicable, within task measures were standardized and combined 
to take both speed and accuracy into account or 2) latent factors created based on 
theoretical or statistical similarity. An investigation into intra-individual variability of 
performance measures would also be of interest to see if it is more sensitive to genetic 
variation in a healthy older adult population. Further, a longitudinal as opposed to cross-
sectional analysis could reveal what role genetics has on the trajectory of cognitive aging, 
and how external factors may speed up or slow down aging related deficits (i.e. brain 
structure, function, or cognition). 
The future of the analysis of genetic influence on cognitive ability is moving away 
from single candidate gene analyses since each has such a small effect, and each gene does 
not act alone. It is important to take into consideration status of other gene variants and 
external factors such as risk factors for disease and positive lifestyle factors like exercise 
and physical activity (Raz & Lustig, 2014). Other alternative methods include genome wide 
associates studies (GWAS), proteomics and epigenetics. GWAS employs whole-genome 
sequencing to detect associations between rare variants and complex traits and is 
hypothesis-free. This allows for investigations of up to 1 million SNPs at once, to identify 
genomic regions associated with particular traits or common genetic variation associated 
with diseases. Technological advancement has made it affordable and feasible to sequence 
the exomes of large numbers of individuals, allowing sufficient power to detect these 
associations (for review Harris & Deary, 2011). In proteomics, one can look directly at the 
proteins under the control of multiple genetic variants by using methods such as mass 
spectrometry. This technique can help in the understanding of the biological foundations of 
cognitive differences. 
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Epigenetic mechanisms refer to DNA modifications that do not alter the sequence of 
the DNA, but change gene expression and in turn cell function (Harris & Deary, 2011; 
Mather, Kwok, Armstrong, & Sachdev, 2014). Examples of epigenetic modifications and 
mechanisms include post-translational histone modification, DNA methylation, and non-
coding RNAs. The investigation of epigenetics in cognitive aging is in its early stages, but 
there have been both animal and human studies that have observed epigenetic changes 
with cognitive aging (Mather et al., 2014; Spiegel, Sewal, & Rapp, 2014). 
 In conclusion, this thesis study has shown that a relationship between cognition and 
genetic variation in genes related to specific neurochemicals may be modified by 
cardiorespiratory fitness level in a sample of healthy sedentary older adults. Further, it 
highlights the importance of exploratory analyses to help guide future interests. 
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Appendix A: Dopamine Related Genes Supplemental Tables and Figures 
Tables for DBH 444 G/A genotypic analysis 
 
 
 
Tables for DBH Combined analysis 
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Tables for COMT Val158Met genotypic analysis 
 
 
* p  .05; + p  .15 
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RT = response time, ER = error rate; * p  .05; + p  .10 
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RT = response time, ER = error rate; * p  .05; + p  .10 
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Figures for DBH 444 G/A genotypic analysis 
 
 
Figure A.1 Effect of the DBH 444 G/A SNP on error rate during the two conditions (i.e. single and mix) of the 
task switch test. a) There was a significant effect of genotype on error rate (ER) for the single condition, F(2, 
151) = 4.28, p = .016. Bootstrapped pairwise comparisons: G/A vs G/G, mean difference = -.040, p = .058, 95% 
CI [-.084, -.002]; G/A vs A/A, mean difference = -.039, p = .060, 95% CI [-.080, -.002]. There was also marginal 
genotypic effect on ER in the mix condition, F(2, 151) = 2.79, p = .064. Bootstrapped pairwise comparisons: 
G/G vs G/A, mean difference = .048, p = .083, 95% CI [.003, .092]; G/G/ vs A/A, mean difference = .057, p = 
.069, 95% CI [.005, .109] b) There was a significant difference between the groups on a global error cost score 
(i.e. mix condition ER – single condition ER), F(2, 151) = 3.34, p = .038. Bootstrapped pairwise comparisons: 
A/A vs G/A, mean difference = -.048, p = .031, 95% CI [-.094, -.004]; A/A/ vs G/G group, mean difference = -
.056, p = .065, 95% CI [-0.117, 0.00]. * p  .05; + p  .10 
 
  
Figure A.2 Effect of the DBH 444 G/A SNP on error rate during the two trial types (i.e. repeat and switch) of 
the mix condition of the task switch test. There was a marginal genotypic effect on ER for repeat trials, F(2, 
151) = 2.60, p = .077. Bootstrapped pairwise comparisons: G/G vs G/A, mean difference = .044, p = .100, 95% 
CI [-.005, .098]; G/G vs A/A, mean difference = .051, p = .089, 95% CI [-.007, .111]. There was also a marginal 
effect on ER for switch trials, F(2, 151) = 2.61, p = .077; G/G vs G/A, mean difference = .051, p = .094, 95% CI [-
.006, .114]; G/G vs A/A, mean difference = .063, p = .066, 95% CI [-.002, .132]. + p  .10 
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Figures for DBH -1021 C/T allelic analysis 
 
 
  
Figure A.3 Effect of the DBH -1021 C/T SNP on response time (RT) during the three memory loads of the 
spatial memory test (i.e. load 1, 2, and 3). T Carriers showed faster response times (RT) across all memory 
loads (i.e. 1, 2, and 3) on the spatial memory test: memory load 1 RT, F(1, 170) = 5.14, p = .025, mean 
difference = -65.43, p = .029, 95% CI [-122.79, -6.16]; memory load 2 RT, F(1, 170) = 4.94, p = .028, mean 
difference = -62.50, p = .027, 95% CI [-116.79, -7.09]; memory load 3 RT, F(1, 170) = 2.34, p = .088, mean 
difference = -52.98, p = .083, 95% CI [-112.40, 6.54]. * p  .05, + p  .10 
 
 
Figure A.4 Effect of the DBH -1021 C/T SNP on response time (RT) for the two trial types (i.e. congruent and 
incongruent) of the Flanker test. T Carriers showed faster response times (RT) on both trial types: Congruent, 
F(1, 181) = 4.13, p = .044, mean difference = -29.83, p = .051, 95% CI [-59.33, 0.50]; Incongruent, F(1, 181) = 
4.09, p = .045, mean difference = -36.58, p = .049, 95% CI [-72.23, -0.61]. * p  .05 
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Figure A.5 Effect of the DBH -1021 C/T SNP on response time (RT) during the two conditions (i.e. single and 
mix) of the task switch test. a) No significant differences between the groups on response time (RT) for the 
single condition, F(1, 151) < 1, but the T Carriers were significantly faster during the mix condition F(1, 151) 
= 6.20, p = .014, mean difference = -62.63, p = .016, 95% CI [-113.36, -13.37] b) T Carriers had a significantly 
lower global RT cost, F(1, 151) = 5.21, p = .024, mean difference = -50.71, p = .014, 95% CI [-92.19, -9.81] c) 
No group differences on error rate (ER) for either the single condition, F(1, 151) < 1, or the mix condition, F(1, 
151) = 1.85, p = .176 d) There was a marginal group difference on a global error rate cost score, F(1, 151) = 
3.88, p = .051, with T Carriers showing a lower cost to the mix compared to the single condition in terms of 
error rate compared to the C/C group, mean difference = -.037, p = .058, 95% CI [-.075, .001]. * p  .05, + p  
.10 
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Figure A.6 Effect of the DBH -1021 C/T SNP on response time (RT) for the two trial types (i.e. repeat and 
switch) of the mix condition of the task switch test. a) T Carriers were marginally faster than C/C 
Homozygotes on RT for repeat trials, F(1, 151) = 2.97, p = .087, mean difference = -42.95, p = .079, 95% CI [-
89.77, 6.16], and significantly faster on switch trials, F(1, 151) = 6.28, p = .013, mean difference = -82.31, p = 
.017, 95% CI [-146.96, -15.73]. * p  .05, + p  .10 
 
  
Figure A.7 Effect of the DBH -1021 C/T SNP on response time (RT) for the two trial types (i.e. single and 
dual) of dual task test. T Carriers showed significantly faster response times (RT) on both single trials, F(1, 
152) = 4.82, p = .030, mean difference = -62.06, p = .014, 95% CI [-113.51, -13.48], and marginally on dual 
trials, F(1, 152) = 2.77, p = .098, mean difference = -55.11, p = .091, 95% CI [-118.77, 9.57]. * p  .05, + p  .10 
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Figures for DBH Combined allelic analysis 
  
Figure A.8 Effect of the Combined DBH SNPs on response time (RT) for the two trial types (i.e. congruent and 
incongruent) of Flanker test. The DBH High DA group was significantly faster than the DBH Low DA group on 
both trial types: congruent, F(1, 41) = 4.96, p = .031, mean difference = -77.53, p = .058, 95% CI [-158.23, -
3.81]; incongruent, F(1, 41) = 5.11, p = .029, mean difference = -89.48, p = .045, 95% CI [-179.08, -13.43]. * p  
.05 
 
 
   
Figure A.9 Effect of the Combined DBH SNPs on error rate (ER) for the two conditions (i.e. single and mix) of 
task switch test. the DBH High DA group showed a marginally lower global ER cost (i.e. mix RT – Single RT), 
F(1, 36) = 3.17, p = .083, mean difference = -.074, p = .094, 95% CI [-.161, .005]. + p  .10 
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Figures for COMT Val158Met genotypic analysis 
 
 
Figure A.10 Effect of the COMT Val158Met SNP on the length of span for the digit span test. forward span: 
F(2, 189) = 1.05, p = .352. backward span: F(2, 189) = 2.45, p = .089. Val/Val vs Val/Met, mean difference = 
0.53, p = .048, 95% CI [0.02, 1.01]; Val/Val vs Met/Met, mean difference = 0.60, p = .040, 95% CI [0.04, 1.19]; 
Val/Met vs Met/Met, mean difference = .067, p = .787, 95% CI [-0.32, 0.47]. * p  .05 
 
 
Figure A.11 Effect of COMT Val158Met on response time (RT) during the three memory loads of the spatial 
memory test: memory load 1, F(2, 169) = 4.81, p = .009; memory load 2, F(2, 169) = 4.13, p = .018; memory 
load 3, F(2, 169) = 6.41, p = .002. * p  .05 
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Figure A.12 Effect of COMT Val158Met on response time (RT) and error rate (ER) for the two trial types (i.e. 
congruent and incongruent) of Flanker test. a) Marginal effect on RT for congruent trials, F(2, 180) = 2.55, p = 
.081; significant effect on RT for incongruent trials, F(2, 180) = 3.47, p = .033 b) Non-significant effect on an 
RT cost score, F(2, 180) = 1.15, p = .320 c) Non-significant effect on ER for congruent trials, F(2, 180) = 1.45, p 
= .238; significant effect on ER for incongruent trials, F(2, 180) = 4.63, p = .011. d) Significant difference on ER 
cost, F(2, 180) = 3.86, p = .023. See Table A.4 for bootstrapped pairwise comparisons. * p  .05; + p  .10 
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Figure A.13 Effect of the COMT Val158Met SNP on response time and error rate for the dual task test. a) 
There were significant differences between the genotypic groups on response time (RT) for both single, F(2, 
157) = 4.07, p = .019, and dual trial types, F(2, 151) = 5.50, p = .005 b) There were no no group differences on 
an RT cost score, F(2, 151) = 2.16, p = .118 c) There were differences between the groups on error rate (ER) 
for both single, F(2, 157) = 2.99, p = .054, and dual trial types, F(2, 157) = 4.22, p = .017 d) There was a 
marginal difference on an ER cost score, F(2, 151) = 2.44, p = .091. See Table A.5 for bootstrap pairwise 
comparisons. * p  .05; + p  .10 
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Figures for COMT C/G allelic analysis 
 
Figure A.14 Effect of COMT Val158Met SNP on length of span for both versions of the digit span test. There 
were no group differences on forward span, F(1, 190) < 1, but for backward span, G Carriers had marginally 
longer spans, F(1, 190) = 3.36, p = .068, mean difference = 0.34, p = .068, 95% CI [-0.03, 0.71].+ p  .10 
 
 
Figure A.15 Effect of the COMT C/G SNP on response time (RT) during the three memory loads of the spatial 
memory test (i.e. load 1, 2, and 3). G Carriers had significantly faster response times (RT) for all memory 
loads: memory load 1, F(1, 170) = 5.00, p = .027, mean difference = -57.87, p = .029, 95% CI [-109.13, -6.10]; 
memory load 2, F(1, 170) = 4.21, p = .042, mean difference = -52.28, p = .045, 95% CI [-103.64, -2.05]; 
memory load 3, F(1, 170) = 7.71, p = .006, mean difference = -76.46, p = .010, 95% CI [-134.05, -20.85].  
* p  .05 
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Figure A.16 Effect of the COMT C/G SNP on response time (RT) during the two trial types of the Flanker Test. 
G Carriers were significantly faster than C/C Homozygotes on congruent trials, F(1, 181) = 5.22, p = .023, 
mean difference = -29.78, p = .024, 95% CI [-56.53, -3.90], and marginally faster on incongruent trials, F(1, 
181) = 3.73, p = .055, mean difference = -31.14, p = .063, 95% CI [-64.03, 1.35]. * p  .05; + p  .10 
 
 
  
Figure A.17 Effect of the COMT C/G SNP on response time (RT) for the two trial types (i.e. single and dual) of 
dual task test. a) G Carriers were significantly faster on dual trials, F(1, 152) = 4.86, p = .029, mean difference 
= -66.91, p = .029, 95% CI [-126.78, -8.42], but there was no difference on single trials, F(1, 152) < 1 b) G 
Carriers also showed a significantly lower RT cost, F(1, 152) = 5.71, p = .018, mean difference = -46.95, p = 
.018, 95% CI [-84.77, -9.17]. * p  .05 
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Figures for COMT Combined analysis 
 
 
Figure A.18 Effect of the COMT Combined on the length of span for the digit span test. Forward span: F(1, 76) 
< 1. Backward span: F(1, 76) = 5.63, p = .020, mean difference = 0.72, p = .018, 95% CI [0.15, 1.31]. * p  .05 
 
 
Figure A.19 Effect of COMT Combined on response time (RT) during the three memory loads of the spatial 
memory test (i.e. load 1, 2, and 3). The Low DA group had significantly faster response times (RT) for all 
memory loads: memory load 1, F(1, 71) = 8.53, p = .005, mean difference = -119.64, p = .005, 95% CI [-198.38, 
-43.13]; memory load 2, F(1, 71) = 6.17, p = .015, mean difference = -106.56, p = .013, 95% CI [-191.22, -
26.50]; memory load 3, F(1, 71) = 8.99, p = .004, mean difference = -139.73, p = .002, 95% CI [-223.21, -54.82]. 
* p  .05 
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Figure A.20 Effect of COMT Combined on response time (RT) during the two trial types (i.e. single and dual) 
of the dual task test. a) The Low DA group was significantly faster for both single, F(1, 68) = 3.99, p = .050, 
mean difference = -87.08, p = .040, 95% CI [-166.76, -3.55], and dual trials, F(1, 68) = 8.93, p = .004, mean 
difference = -149.37, p = .003, 95% CI [-242.37, -55.75]. b) The Low DA group had a significantly lower RT, 
F(1, 68) = 5.90, p = .018, mean difference = -62.30, p = .015, 95% CI [-111.92, -15.29]. * p  .05 
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Appendix B: Growth Factor Genes Supplemental Figures and Tables 
Tables for IGF1 G/A genotypic analysis 
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Figures for IGF1 G/A genotypic analysis 
 
 
Figure B.1 Effect of the IGF1 G/A SNP on response time (RT) during the three memory loads of the spatial 
memory test (i.e. load 1, 2, and 3). There was a significant difference between the groups on response time for 
memory load 1, F(2, 169) = 3.46, p = .034, and memory load 3, F(2, 169) = 4.30, p = .015. Although the 
differences between genotypic groups were not significant for memory load 2, F(2, 169) = 1.35, p = .262, the 
trend was the same. Bootstrapped pairwise comparisons are reported in Table B.1. * p  .05 
 
 
Figure B.2 Effect of the IGF1 G/A SNP on response time (RT) during the four trial types of the  
Stroop test. There was a significant group difference on RT for the incongruent-ineligible trial types, F(2, 151) 
= 3.08, p = .049, with the A/A group showing the slowest RTs. Bootstrapped pairwise comparisons: A/A vs 
G/A, mean difference = 29.74, p = .091, 95% CI [-5.21, 63.73], A/A vs G/G, mean difference = 57.71, p = .007, 
95% CI [14.95, 100.35], G/A vs G/G, mean difference = 27.97, p = .213, 95% CI [-17.31, 72.64]. * p  .05 
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Figure B.3 Effect of the IGF1 G/A SNP on error rate (ER) for the task switch test. a) There was a marginal 
difference on error rate (ER) in the single condition, F(2, 151) = 2.72, p = .069. Bootstrapped pairwise 
comparisons: A/A vs G/A, mean difference = -0.01, p = .439, 95% CI [-0.04, 0.02]; A/A vs G/G, mean difference 
= -0.05, p = .147, 95% CI [-0.12, 0.01]; G/A vs G/G, mean difference = -0.04, p = .245, 95% CI [-0.11, 0.02]. 
There were no differences in ER in the mix Condition, F(2, 151) = 2.14, p = .121. b) There were no differences 
on error rate (ER) for repeat trials, F(2, 151) = 1.44, p = .241, but there was a marginal difference on ER for 
switch trials, F(2, 151) = 2.64, p = .074. Bootstrapped pairwise comparisons: A/A vs G/A, mean difference = 
.008, p = .695, 95% CI [-.033, .048]; A/A vs G/G group, mean difference = .064, p = .046, 95% CI [-.130, -.002]; 
G/A vs G/G group, mean difference = -.073, p = .032, 95% CI [-.140, -.007] * p  .05 
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Figure B.4 Effect of the IGF1 G/A SNP on the dual task test. a) There were no significant differences between 
the genotypic groups on response time (RT) for either the single, F(2, 150) < 1, or dual trial types, F(2, 150) = 
1.69, p = .189 b) There was a significant difference between the groups on a RT cost score, F(2, 150) = 3.87, p 
= .023. Bootstrapped pairwise comparisons: A/A vs G/A, mean difference = 36.33, p = .078, 95% CI [-3.23, 
16.12]; A/A vs G/G, mean difference = 82.95, p = .016, 95% CI [15.70, 152.60], G/A vs G/G, mean difference = 
34.06, p = .171, 95% CI [-19.32, 113.72] c) There was also a significant difference between the genotypic 
groups on error rate for single trials, F(2, 150) = 3.05, p = .050. Bootstrapped pairwise comparisons: A/A vs 
G/A, mean difference = -.023, p = .069, 95% CI [-.048, .002]; A/A vs G/G, mean difference = .017, p = .268, 95% 
CI [-.016, .046]; G/A vs G/G, mean difference = .040, p = .020, 95% CI [.005, .072]. There was also a marginal 
difference for error rate on dual trials, F(2, 150) = 2.42, p = .092. Bootstrapped pairwise comparisons: A/A vs 
G/A, mean difference = -.016, p = .509, 95% CI [-.061, .031]; A/A vs G/G group, mean difference = .062, p = 
.003, 95% CI [.026, .100]; G/A vs G/G, mean difference = .078, p = .004, 95% CI [.029, .125]. * p  .05, + p  .10 
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Figures for BDNF Val66Met 
 
Figure B.5 Effect of the BDNF Val66Met on response time (RT) for the dual task test. a) There were no group 
differences RT for either single, F(1, 153) < 1, or dual trials, F(1, 153) = 1.59, p = .209 b) The groups did 
significantly differ on an RT cost score, F(1, 153) = 4.34, p = .039, with the Met Carriers showing a lower RT 
cost compared to the Val/Val Homozygotes, mean difference = -69.12, p = .011, 95% CI [-120.74, -13.84].  
* p  .05 
 
 
Figure B.6 Effect of the BDNF Val66Met on response time (RT) for the dual task test. There were no 
significant differences between the groups for forward span, F(1, 25) < 1, but the low GF group performed 
significantly better on the backward span, F(1, 25) = 4.60, p = .042, mean difference = 1.09, p = .042, 95% CI [-
0.04, 1.99]. 
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